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Oxysterol binding protein (OSBP) and its homologues constitute a large family of 
conserved proteins present in many eukaryotes, and they have been shown to regulate 
lipid metabolism and vesicular transport. The seven yeast homologues (OSH) collectively 
are essential for sterol homeostasis and cell viability, but each OSH exhibits distinct 
function. Here, we examined the:  
 1. Localization of Osh6p. Osh6p was largely soluble with a small pool peripherally 
associated with membranes, possibly the endosomal membranes.  
2. Roles of Osh6p in sterol metabolism and vesicular transport. Osh6p played a role 
primarily in maintaining sterol homeostasis, not in endocytic trafficking or protein 
transport to the vacuole.  Deletion of OSH6 caused a significant increase in total 
ergosterol; whereas overexpression of OSH6 reduced total ergosterol and lipid bodies, 
and caused nystatin resistance.  The rate of sterol esterification was mildly decreased in 
both ∆osh6 and overexpression cells; while sterol biosynthesis was enhanced in ∆osh6. 
Free sterols were found to accumulate in the intracellular compartments in ∆osh6. 
However, deletion or overexpression of OSH6 showed no effect on Lucifer yellow 
internalization, and FM4-64 transport. Furthermore, ∆osh6 exhibited no defect in 
carboxypeptidase Y (CPY) transport and maturation. Osh6p was shown to bind 
phosphoinositides and phosphatidic acid through its conserved OSBP related domain 
(ORD). The ORD of Osh6p was shown to associate with endosomes, whereas the C-
terminal putative coiled coil (CC) localized to the nucleoplasm. However, both the ORD 
and CC domains were indispensable for the in vivo function of Osh6p.  
 IX
3. Interaction between AAA ATPases and Osh proteins. We showed that a subset of 
AAA ATPases regulated the membrane association of Osh proteins. First, Osh6p 
interacted with Vps4p, a member of the AAA protein family, both in vitro and in vivo. 
Deletion of VPS4 induced a dramatic increase in the membrane associated pool of Osh6p. 
In addition, the ATPase activity of Vps4p was essential for this regulatory process. 
Second, the ORD domain-containing fragment of Osh1p interacted with the ATPase 
domain-containing fragment of Afg2p, another member of the AAA family, in vivo. 
Interestingly, when Afg2p was inactivated, a significant pool of Osh1p was redistributed 
from the cytosol to the ER membrane.  
4. Roles of AAA ATPases in lipid metabolism. Deletion of VPS4 resulted in a 
significant decrease in sterol esterification. Inactivation of Afg2p led to a substantial 
reduction of oleate incorporation into both sterol esters (SE) and triacylglycerol (TAG), 
and accumulation of free sterols in the intracellular compartments.   
5. Functional interaction between Osh6/7p and Vps4p. 
Overexpression of Osh6/7p suppressed the defect in sterol esterification in vps4∆. 
Overexpression of the coiled coil motif of Osh7p resulted in a multi-vesicular body 
sorting (MVB) defect, suggesting a dominant negative role of Osh7pCC possibly through 
inhibiting Vps4p function. Moreover, the physical interaction between Osh7p and Vps4p 
was regulated by ergosterol.  
In summary, our data suggest that a common mechanism may exist for AAA proteins to 
regulate the membrane association of yeast OSBP proteins and that these two protein 
families may function together to control subcellular sterol transport.   
 
 X
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Chapter I   Introduction 
 2
Part1 Intracellular Cholesterol Homeostasis 
1.1 Overview 
The major lipid components of eukaryotic membranes are phospholipids, sterols, 
sphingolipids and glycoglycerolipids (Alberts et al., 1994), of which phospholipids are 
the ‘backbone’. Although less enriched, sterols are important regulators of membrane 
permeability, rigidity and fluidity and eukaryotic cells without sterols are unable to 
maintain viability (Daum et al., 1998). Membrane sterols also play a role in regulating 
gene transcription (Luskey et al., 1983), protein degradation (Faust et al., 1982), enzyme 
activity (Doolittle and Chang, 1982), and membrane trafficking (Heiniger et al., 1976; 
Heese-Peck et al., 2002; Munn et al., 1995, 1999; Kato and Wickner, 2001; Grimmer et 
al., 2000; Chang et al., 1992; Mayor et al., 1998). In mammals, sterols are also precursors 
of steroid hormones, bile acids and lipoproteins (Liscum and Underwood, 1995).  Since 
sterols are so important for a variety of cellular activities, their biosynthesis, metabolism 
and intracellular transport must be subject to complex and stringent regulation. The 
mechanisms underlying the synthesis and uptake of sterols in eukaryotic cells are now 
relatively established; however, much less is known about how cells regulate their 
intracellular sterol levels, how cells maintain a non-homogenous distribution of sterols 
between different internal membranes, and how sterols are transported from one 













                             
 
Figure1.1 Structures of cholesterol and ergosterol (Daum et al., 1998). The bottom structure shows the 
numbering of carbons.  
The major sterol species is cholesterol in mammals or ergosterol in fungi like 
Saccharomyces cerevisiae, which accounts for ~77% of total sterols (Bard et al., 1977; 
Heese-Peck et al., 2002). The structure of ergosterol is a little different from that of 
cholesterol as ergosterol contains two extra unsaturated bonds at C-7, 8 in the ring 
structure and C-22 in the side chain, and a methyl group at C-24 in the side chain 
(Figure1.1); however, ergosterol is synthesized (Basson et al., 1986), regulated (Hampton 
and Rine, 1994), and esterified (Yang et al., 1996) in very similar processes happening in 
mammalian cells and possibly carries out  similar physiological function in the respect of 
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bulk and microdomain membrane function as mammalian cholesterol (Parks et al., 1995; 
Bagnat et al., 2000). Therefore, many genetic components participating in sterol 
metabolism are well conserved from yeast to humans (Sturley, 1998). 
 
1.2 Regulation of cholesterol biosynthesis 
      Cholesterol biosynthesis is a major cellular metabolic activity and a complex process 
that involves over 20 distinct reactions. This process, also known as the mevalonate 
pathway, is initiated with the synthesis of acetoacetyl-CoA from two molecules of acetyl-
CoA, which is derived from several sources including: the β-oxidation of fatty acids, the 
oxidation of ketogenic amino acids such as leucine and isolecine, and the pyruvate 
dehydrogenase reaction (Devlin, 1997). After many reactions, acetoacetyl-CoA is 
converted into farnesyl pyrophosphate, which is a pivotal intermediate metabolite for 
cholesterol, heme (Weinstein et al., 1986), quinones (Olso and Rudney, 1983), and 
dichols (Matsuoka et al., 1991).  
      Cholesterol biosynthesis is stringently regulated. The primary site for control of 
cholesterol biosynthesis is the third enzyme in the mevalonate pathway, HMG-CoA 
reductase (3-hydroxy-3-methyl glutaryl-CoA reductase), which catalyzes the formation 
of mevalonic acid. The unicellular yeast has two genes encoding HMG-CoA reducatse, 
HMG1 and HMG2 (Rine et al., 1983).  Both HMG-CoA and Hmg1p/Hmg2p are the 
major targets of regulation and the reaction they catalyze is the rate-limiting step in this 
pathway. Cholesterol affects its own biosynthesis by inhibiting the activity of preexisting 
HMG-CoA reductase and also by promoting rapid proteolytic degradation of the enzyme 
(Rodwell et al., 1976; Schroepfer, 1981; Goldstein and Brown, 1980; 1990). Yeast 
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Hmg1p/Hmg2p activity is inhibited in the presence of ergosterol and is subject to 
catabolite repression (Ashman et al., 1991; Quain and Haslam, 1979). How does 
cholesterol exert its feedback inhibition on its biosynthesis? The question has been 
largely answered by Brown and Goldstein who found that a family of transcription 
factors, sterol response element binding proteins (SREBP), controls the key enzyme 
levels in the mevalonate pathway such as HMG-CoA reductase and the synthesis of low-
density lipoprotein (LDL) receptors that mediate the endocytosis of cholesterol-rich LDL 
particles (Wang et al., 1994). The molecular mechanisms underlying SREBP-mediated 
cholesterol feedback inhibition of cholesterol biosynthesis have been intensively studied. 
As illustrated in Figure 1.2, cellular cholesterol levels are the key factor to determine 
whether newly synthesized SREBP can be delivered through coatomer protein II 
(COPII)-mediated vesicular transport pathway to the Golgi apparatus, where SREBP is 
cleaved by two Golgi-localized proteases S1P and S2P sequentially. This cleavage results 
in the soluble NH2-terminal domain of SREBP, which enters the nucleus as an active 
positive transcription factor. Normal or high levels of cholesterol block the incorporation 
of SREBP and SREBP-cleavage activation protein (SCAP) into COPII vesicles by 
retaining their interaction with an ER membrane protein-INSIG (insulin-induced protein); 
however, low cholesterol level promotes the release of SREBP and disassociation of 
SCAP from INSIG (Brown and Goldstein, 1999; Brown et al., 2002; Yang et al., 2002; 
Espenshade et al., 2002. See Figure 1.2). 
    More details remain to be understood concerning the regulation of cholesterol 
biosynthesis. For example, how does INSIG retain SCAP and how does SCAP sense 
changes of cholesterol levels?  
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Figure 1.2 Regulation of cholesterol biosynthesis (Anderson, 2003). (a) Formation of a macromolecular 
complex containing SREBP, SCAP and Insig-1 in the ER in the presence of normal or higher cellular 
cholesterol levels. (b), (c) Disassociation of Insig-1 from the complex stimulated by a low level of 
cholesterol, allowing SCAP and SREBP to be packaged into COP II-coated vesicles and then delivered to 





1.3 Intracellular cholesterol transport 
The correct intracellular distribution of cholesterol among cellular membranes is 
essential for many biological functions including signaling and membrane trafficking. In 
mammalian cells cholesterol can be obtained by internalization of low density 
lipoproteins (LDL) (Colbeau et al., 1971) or by biosynthesis in the ER. Newly 
synthesized cholesterol can be incorporated into vesicle membranes and exported to 
extracellular acceptors, and converted into esters (esterification), bile acids or steroid 
hormones depending on cell types. The rates of cholesterol biosynthesis, LDL 
internalization, and esterification are exquisitely dependent on cellular levels of free 
cholesterol (Liscum and Underwood, 1995). In addition, cholesterol is not uniformly 
distributed among cell membranes (Colbeau et al., 1971; Lange, 1991) or even within 
membranes (Rothblat et al., 1992; Glaser, 1993). Obviously，intracellular cholesterol 
transport must be tightly controlled, but the mechanisms are not well elucidated 
(Maxfield and Wüstner, 2002).   
 
1.3.1 Regulated cholesterol transport 
     Cholesterol or ergosterol is found in the highest concentration in the plasma 
membrane (accounting for more than 85% of total free cholesterol) and most of the 
remainder is associated with membranes especially the Golgi, transport vesicles and 
endosomal membranes (Lange et al., 1991; Brown and Rose, 1992). In contrast, other 
intracellular membranes such as the microsomes, mitochondria and ER contain 
significantly lower concentrations of cholesterol and relatively higher concentrations of 
sterol intermediates (Fielding and Fielding, 1997). An exception is the trans-Golgi 
 8
network (TGN) distal to the Golgi stacks, which contains cholesterol content as high as 
that of the plasma membrane (Orci et al., 1981). The major synthesis site of sterols, the 
ER, has a very low concentration of cholesterol accounting for less than 1% of total 
cholesterol (Ikonen and Parton, 2000).  It is a challenging task for the cells to maintain 
this uneven distribution of sterols and efficiently transport sterols to their destinations. To 
maintain this uneven distribution of sterols, mechanisms to sense cellular sterol levels 
and transport machinery are required. Although much progress in identifying some of the 
key regulators of cholesterol metabolism has been made (Brown and Goldstein, 1999), 
how the sensing occurs and how sterols are transported between membranes remain to be 
defined. Intracellular sterol trafficking appears also to be important for the feedback 
regulation of sterol biosynthesis (Lange and Steck, 1996). However, unlike protein 
trafficking that utilizes defined pathways; sterol transport seems to take multiple 
pathways simultaneously. The combined action of multiple pathways makes it hard to 
obtain a clear overall understanding of cholesterol transport. One view is that cholesterol 
transport is spontaneous and passive based on in vitro observations (Dawidowicz, 1987; 
Phillips et al., 1987). However, the non-uniform distribution of cholesterol would not be 
expected if cholesterol movement were spontaneous. Moreover, the in vitro spontaneous 
cholesterol transfer between membranes with a T 1/2 of 1-2 h is slower than that in vivo 
(Phillips et al., 1987; DeGrella and Simoni, 1982; Brasaemle and Attie, 1990; Lange et 
al., 1991). Genetic evidence that cellular factors mediate intracellular cholesterol 
transport comes from the analysis of mammalian cells with specific gene defects like 
Niemann-Pick disease type C (NPC) showing accumulation cholesterol in the late 
endosome / lysosome (Bhuvaneswaran et al., 1982; Pentchev et al., 1985; 1986; 1987; 
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Liscum and Faust, 1987; Liscum et al., 1989), and Niemann-Pick disease type D (NPD) 
(Butler et al., 1987). Pharmacological evidence comes from studies with energy poisons 
(DeGrella and Simoni, 1982; Kaplan and Simoni, 1985), and hydrophobic amines 
(Liscum and Faust, 1989; Liscum and Collins, 1991; Rodriguez-Lafrasse, 1990). 
Although passive transport plays a role in intracellular cholesterol transport, highly 
controlled and directed transport pathway may be more important for maintaining 
cholesterol homeostasis.     
 
1.3.2 Mechanisms of intracellular transport  
Vesicle-dependent transport: Sterols can be incorporated into transport vesicles or 
tubules that carry membrane constituents from one membrane compartment to another. 
For example, cholesterol can be delivered to the plasma membrane via the established 
secretory pathway for glycoprotein secretion (Kaplan and Simoni, 1985; Urbani and 
Simoni, 1990; Heino et al., 2000), and plasma membrane cholesterol is also continuously 
internalized by endocytosis and then returned to the cell surface (Ikonen and Parton, 
2000).  
Carrier-protein mediated transport: Cells have many possible soluble lipid-transfer 
proteins, which may extract sterols from one membrane and carry sterols through the 
aqueous cytoplasm to another membrane. This transport pathway is important for sterol 
transport from the plasma membrane to the early recycling compartment and for delivery 
of cholesterol to the inner mitochondrial membrane in steriodogenic cells (Strauss et al., 
1999). A family of carrier proteins with high-affinity for lipids has been identified, one of 
which is the steroidogenic acute regulatory protein (StAR/StarD1) containing a lipid-
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binding domain (START) (Stocco, 2001). StAR has been implicated in the delivery of 
cholesterol to the site of mitochondrial cytochrome P450 in steroidogenic cells (Lange, 
1992; Jefcoate, 2002), where cholesterol is converted into steroid hormones. Another 
family, sterol carrier proteins (SCP), is mainly present in peroxisomes, the significant site 
of cholesterol synthesis in hepatocytes (Thompson et al., 1987), and has been shown to 
facilitate delivery of cholesterol to the plasma membrane (Fielding and Fielding, 1997). 
Carrier-mediated transport provides a rapid mechanism for shuttling cholesterol among 
membranes, and these proteins have multiple membrane-targeting domains, which can 
bind to proteins or lipids in those membranes.  
Membrane contact: Membrane contacts such as ER-mitochondria contacts (Daum et al., 
1997), ER and trans-Golgi contacts (Ladinsky et al., 1999), and nucleus-vacuole 
junctions (Pan et al., 2000) could be the sites for rapid intermembrane exchange of 
cholesterol with the assistance of lipid transfer proteins, possibly without consuming 
energy. The cholesterol-esterifying enzyme ACAT is enriched in ER-Golgi and ER- ERC 
(early recycling compartment) contact (Khelef et al., 2000), perhaps allowing efficient 
transport of cholesterol from these cholesterol-rich membranes to the vicinity of ACAT 
for esterification.   
Caveolae-mediated transport:  Cholesterol is not distributed uniformly within biological 
membrane biolayers. Cholesterol and sphingolipid-enriched microdomains or lipid rafts, 
which are resistant to solubilization with non-ionic detergents at low temperature, have 
been proposed to play an important role in cholesterol transport (Simons and Ikonen, 
1997; Ikonen, 2001; Fielding and Fielding, 2001). Caveolae are clathrin free, raft-like 
membrane invaginations with sizes of 50-100 nm (Simionescu et al., 1983; Anderson, 
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1998). Caveolae can receive cholesterol from both the plasma membrane and ER 
(Fielding and Fielding, 1995) and may transport cholesterol between the plasma 
membrane, ER, and Golgi membranes (Conrad, 1995; Smart, 1994). Cholesterol heading 
for the plasma membrane reaches the caveolae domain first and then redistributes to other 
parts of the plasma membrane (Smart et al., 1996; Fielding and Fielding, 1995). Caveolae 
may also facilitate the export of intracellular cholesterol to high-density plasma 
lipoproteins (Fielding and Fielding, 1995). However, hepatocytes with active LDL 
internalization have few caveolae (Fielding and Fielding, 1997)，suggesting caveolae are 
largely involved in cholesterol trafficking to the plasma membrane.  
 
1.3.3 General intracellular transport pathways 
Nascent cholesterol transport out of ER: The ER is the site of cholesterol synthesis but 
it maintains a low steady-state level of cholesterol, so efficient transport of cholesterol 
out of the ER must exist. In addition, the ER is also the site of cholesterol esterification, 
where two ACATs (acyl-CoA cholesterol acyltransferase) function to convert free 
cholesterol into cholesterol esters. So the cholesterol transport to and out of the ER must 
be well controlled (Maxfield and Wüstner, 2002). Newly synthesized cholesterol can be 
directly esterified as it arises in the ER, but it is so rapidly transported to the plasma 
membrane that only a minute fraction is converted to cholesterol ester (Lange et al., 
1993). The largest pool of nascent cholesterol is transported to the plasma membrane 
with a half-life of 10 min in an ATP-dependent manner (DeGrella and Simoni, 1982; 
Kaplan and Simoni, 1985). In principle, it can follow the vesicle-mediated protein 
secretory pathway by transiting the Golgi apparatus and reaches plasma membrane by 
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consuming metabolic energy. However, it seems that this is not a major pathway. 
Brefeldin A treatment which causes the fusion of the Golgi into ER (Heino et al., 2000) 
effectively suppresses protein secretion but only partly inhibits cholesterol transport to 
the plasma membrane (Urbani and Simoni, 1990; Heino et al., 2000). Drugs that affect 
the cytoskeletal network, lysosomal function, and protein synthesis also have no 
significant effect on cholesterol transport (Kaplan and Simoni, 1985). Obviously there is 
at least another unidentified pathway (s) operating simultaneously with the biosynthetic 
secretory pathway to deliver cholesterol from the ER to plasma membrane.  
 Transport of LDL-derived cholesterol to the ER and plasma membrane: In mammalian 
cells, cholesterol can be internalized in the form of cholesterol esters through LDL-
receptor (Brown and Goldstein, 1986). The exogenous / LDL-derived cholesterol esters 
are transported via sorting endosomes and late endosomes to the lysosomes, where 
cholesterol esters are hydrolyzed into free cholesterol. The resultant cholesterol is then 
delivered to the ER (Fielding and Fielding, 1985) for esterification or to the plasma 
membrane (Brasaemle and Attie, 1990) by an unknown mechanism. Transport of 
exogenous cholesterol to the plasma membrane is rapid and probably caveolae are the 
first destination (Johnson et al., 1990; Brasaemle and Attie, 1990), and this pathway 
could be vesicle-independent since it is not dependent on cytoskeleton. However, 
transport of cholesterol from the lysosome to the ER may be vesicle-dependent because 
this pathway is inhibited by energy poisons, disruption of actin filaments, PtdIns-3-kinase 
inhibitors, N-ethylmaleimide and Niemann-Pick C gene mutation (Liscum and Munn, 
1999). Although the molecules functioning in sterol transport from the lysosome to the 
ER or the plasma membrane are not well elucidated, at least both pathways require the 
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Niemann-Pick (NPC) gene product, mutation of which leads to an inherited recessive 
disorder characterized by accumulation of LDL-derived cholesterol and other lipids in 
late endosomes / lysosomes (Blanchette-Mackie, 2000; Kobayashi et al., 1999).   
Transport from plasma membrane to the cell interior: Like plasma membrane receptors, 
cholesterol in the plasma membrane can also recycle via the early recycling compartment 
(ERC) in a vesicle, ATP-independent manner and return to the plasma membrane via 
vesicles. Plasma membrane cholesterol may also return to the ER for esterification. The 
cholesterol incorporated into cholesterol esters comes primarily from the plasma 
membrane (Lange et al., 1993) by an unknown mechanism. Most likely, plasma 
membrane cholesterol returns to the ER in a vesicle-dependent manner since cytoskeleton, 
intact intermediate filament network, and acidic compartments are required for this 
transport pathway (Lange and Steck, 1994; Sarria et al., 1992; Evans, 1994).  However, 
this pathway is independent of metabolic energy (Skiba et al., 1996), which is usually 
required for membrane trafficking. One explanation is that there is a ‘novel’ energy-
independent vesicular transport pathway delivering plasma membrane cholesterol to the 
ER-resident ACAT site. In support of this, SMase (sphingomyelinase) treatment that 
digests plasma membrane sphingomyelin (Slotte, 1997) will stimulate the formation of 
plasma membrane-derived vesicles with a size of ~400 nm, which lack either clathrin or 
caveolin coat and carry cholesterol back to the ER or late endosomes / lysosomes (Skiba 





                     
Figure 1.3 Intracellular cholesterol transport pathways (Maxfield and Wüstner, 2002). Internalized LDL 
containing cholesterol (Ch) and CE (esterified cholesterol) is transported (a) from sorting endosomes (SE) 
to late endosomes (LE) and lysosomes (Ly), from which cholesterol can be delivered to the plasma 
membrane or the ER for re-esterification (b). Cholesterol can move from the plasma membrane to the early 
recycling compartment (ERC) in a nonvesicular, ATP-independent manner(c). In contrast, recycling of 
cholesterol occurs almost exclusively in vesicles also carrying other recycling markers (d). Newly 
synthesized cholesterol is transported from the ER either directly to the plasma membrane (f), or indirectly 
trespassing TGN following the biosynthetic secretory pathway (e). Excess cholesterol (Ch) in the ER is 
esterified (CE) and stored in cytoplasmic lipid droplets (D).  
1.3.4 Sterol transport in yeast   
    The mechanisms underlying sterol transport in Saccaromyces cerevisiae are poorly 
understood. Yeast cells obtain sterols via two major routes: 1) under aerobic growth 
conditions, biosynthesis through the mevalonate pathway is almost the sole source of 
sterols; 2) however, under anaerobic conditions, since sterol biosynthesis requires 
oxygen, uptake of exogenous sterols becomes essential for viability (Henneberry and 
Sturley, 2005). Unlike mammalian cells that take up sterols through LDL-receptors 
(Brown and Goldstein, 1986), yeast cells cannot acquire sterols through classical 
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receptor-mediated endocytosis due to the lack of LDL-receptors. Recently, a few gene 
products have been shown to regulate sterol uptake and transport between membranes. 
The SREBP-like proteins Upc2p and Ecm22p can activate transcription of genes 
involved in ergosterol biosynthesis (Vik and Rine, 2001) and a UPC2 mutant upc2-1 is 
able to take up exogenous sterols under aerobic conditions (Crowley et al., 1998). Two 
ATP-binding cassette transporters (ABC) Aus1p and its ortholog Pdr1p were recently 
found to facilitate sterol influx when sterol biosynthesis was compromised (Wilcox et al., 
2002), and they likely mediate sterol movement from the plasma membrane to the ER in 
a non-vesicular manner (Li and Prinz, 2004). A more recent report showed that newly 
synthesized ergosterol is delivered to the plasma membrane via a non-vesicular pathway 
(Baumann et al., 2005). A possible molecule involved in this process could be Arv1p, 
which is required for viability of cells deficient in sterol ester biosynthesis (devoid of 
ACAT activity, see below 1.4).  arv1 mutants exhibit elevated free sterol and sterol ester 
levels and defects in sterol distribution (Tinkelenberg et al., 2000). In addition, Arv1p has 
also been implicated in sphingolipid biosynthesis and metabolism (Swain et al., 2002). 
Most importantly, ARV1 homologues have been identified in every eukaryotic genome 
currently sequenced, suggesting a conserved role for Arv1p in regulating 
sterol/sphingolipid transport from the ER to the plasma membrane (Henneberry and 
Sturley, 2005). Sterol transport out of the vacuole could be mediated by the yeast NPC 
orthologue-Ncr1p, a trans-membrane protein with a sterol sensing domain. Ncr1p is 
localized to the vacuolar membrane (Zhang et al., 2004) and is implicated in sphingolipid 
transport from the plasma membrane to the vacuole and other internal membranes by 
using a dominant mutant without obvious changes in sterol metabolism (Malathi et al., 
 16
2004). This suggests that NPC1 or its yeast counterpart Ncr1p primarily functions to 
recycle sphingolipids. 
1.4 ACAT and cholesterol homeostasis  
ACAT (acyl-CoA: cholesterol acyltransferase) catalyzes the conversion of free 
cholesterol and fatty acyl-CoAs into cholesterol esters, thus contributing to cholesterol 
homeostasis (Brown and Goldstein, 1986). Cholesterol esters are stored in lipid droplets 
together with triacylglycerols (TAG), which serves to protect cells from the toxicity of 
free cholesterol (Warner et al., 1995; Tabas, 1997; Kellner-Weibel et al., 1998).  In 
macrophages, excess accumulation of lipid droplets leads to the formation of ‘foam 
cells’, a hallmark of early atherosclerosis lesions (Brown and Goldstein, 1983; Chang et 
al., 1994).  
ACAT is largely regulated by its substrate availability, particularly cholesterol levels; 
however, oxygenated sterols such as 25-hydroxycholesterol, are also potential activators 
of ACAT activity (Brown et al., 1975; Doolittle and Chang, 1982). How is ACAT 
involved in maintaining cholesterol homeostasis? Since ACAT can efficiently remove 
free cholesterol that arises in the ER, a number of studies suggest that ACAT helps guard 
against excessive build-up of cholesterol in the ER (Chang et al., 1997). Because the ER 
is also the site of cholesterol biosynthesis, low cholesterol levels would be advantageous 
for cells to sense subtle changes that could produce sensitive signals for regulating sterol-
regulated enzymes or proteins in the ER (Chang et al., 1995; Cheng et al., 1995). Thus 
both sterol biosynthesis and esterification processes may be subject to regulation by 
cholesterol levels in the ER. Although overall ER cholesterol is very low, it is possible 
that a local cholesterol pool surrounds ACAT and serves as the regulatory pool that 
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suppresses various cholesterol-sensors in the ER including SREBP, HMGCo-A 
reductase, LDL receptor (Roitleman et., 1992; Meigs and Simoni, 1992; Correll and 
Edwards, 1994; Wang et al., 1993; Hua et al., 1996a, b). It has been shown that ACAT 
can inactivate the regulatory cholesterol pool in the ER (Tabas et al., 1986; Candigan et 
al., 1988; Havekes et al., 1987; Salter et al., 1989; Daumerie et al., 1992; Rumsey et al., 
1995); i.e. the ACAT cholesterol pool may be in partial equilibration with the regulatory 
cholesterol pool. By this mechanism, ACAT may indirectly regulate sterol biosynthesis 
and uptake, thus contributing to the intracellular cholesterol homeostasis. 
     In S. cerevisiae, sterol esterification is catalyzed by two ACATs, which are Are1p and 
Are2p (Yang et al., 1996). Are2p contributes to the majority of sterol esters in the cell 
(Yu et al., 1996) and shows substrate preference for ergosterol; while Are1p exhibits 
substrate priority for lanosterol and zymosterol (Zweytick et al., 2000).  
   
1.5 Oxysterols and cholesterol homeostasis 
    Oxysterols are biosynthetic metabolites of sterols, steroids and bile acids and are also 
produced when sterols are exposed to oxidants (Lund et al., 1998; 1999; Russell, 2000), 
or lipid peroxidation (Bjorkhem and Diczfalusy, 2002). Oxysterols are short-lived 
relative to cholesterol, so they are present in very low concentrations (103-106 fold less 
than cholesterol) (Björkhem, 2002). However, oxysterols are much more water-soluble 
and active than cholesterol in suppressing cholesterol synthesis; suppressing effects are 
apparent at concentrations as low as 10-9M (Kandutsch et al., 1978). Feedback regulation 
mediated by oxysterols may be 1000 times higher than that mediated by cholesterol itself. 
Surprisingly, unlike cholesterol, oxysterols are not sensed directly by SCAP as SCAP 
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undergoes a conformational change in response to cholesterol but not to oxysterols 
(Brown et al., 2002). Rather, oxysterols may inhibit sterol biosynthesis through SREBP 
by promoting cholesterol transport to the ER, where cholesterol induces a conformational 
change in SCAP thus retaining SREBP in the ER (Brown et al., 2002). Oxysterols are 
also believed to play a role in the development of atherosclerosis (Brown and Jessup, 
1999), gene expression (Russell, 2000; Bjorkhem and Eggertsen, 2001), and biosynthesis 
of steroid hormones and development of steroidogenic tissues by regulating the activity 
of steroidogenic factor-1 (Schoonjans et al., 2000; Repa and Mangelsdorf, 2000). 
Moreover, since oxysterols can pass through lipophilic membranes much more quickly 
than cholesterol itself does (Lange et al., 1995), they are also involved in sterol transport. 
Bjorkhem et al. (1999) found that macrophages and neurons could export bulk of 
oxysterols to high density lipoprotein particles in the plasma.  Since oxysterols play an 
important role in sterol biosynthesis and homeostasis, they must be subject to regulation; 
then what are their regulators and mediators? Two protein families including some of the 
steroid hormone nuclear receptors FXR / LXRs (Russell, 1999) and oxysterol binding 
proteins (OSBPs) appear to mediate many of the activities ascribed to oxysterols.  
 
1.6 LXRs 
     Liver X receptors (LXRs) belong to the nuclear hormone receptor super family of 
ligand-activated transcription factors that regulate the expression of numerous genes 
involved in development and adult physiology (Mangelsdorf and Evans, 1995). Upon 
hormone binding, these receptors undergo conformational changes that trigger the release 
of attached co-repressors and recruit co-activators that allow the receptor to communicate 
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with the general transcription machinery to regulate target gene expression (McKenna et 
al., 1999; Glass and Rosenfeld, 2000). LXRs have been shown to bind oxysterols 
especially 24S-hydrocholesterol and 24, 25-epoxycholesterol with high affinity in vitro 
(Janowski et al., 1999) and be activated in vivo by oxysterols; so oxysterols are generally 
believed to be their most potent physiological ligands. LXRs are profoundly implicated in 
cholesterol metabolism at the transcriptional level. They are able to regulate the 
expression of many genes involved in cholesterol metabolism (Russell, 1999; Repa and 
Mangelsdorf, 2000; Chawla et al., 2001) by forming a heterodimer protein complex with 
retinoid X receptor (Mangelsdorf and Evans, 1995).  They also seem to regulate the 
human cholesterol ester transfer protein and cholesterol 7α-hydroxylase in mice 
(Schroepfer, 2000). LXRα has been shown to regulate enzymes that convert excess 
cholesterol into bile acids (Russell, 1999; Repa and Mangelsdorf, 2000), and cholesterol 
transporters ABCA1 and ABCG1, which are involved in the flux of cholesterol from 
enterocytes and macrophages respectively (Chawla et al., 2001; Repa et al., 2000; 
Venkateswaran et al., 2000a; 2000b).  
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Part 2 The Oxysterol Binding Protein (OSBP) family 
 
2.1 Overview  
 OSBP (oxysterol binding protein) was the first protein shown to interact with 
oxysterols. Kandutsch and co-workers identified OSBP as a high affinity cytosolic 
receptor for a variety of oxysterol regulators of cholesterol synthesis, such as 25-
hydroxycholesterol (Kandutsch et al., 1981). OSBP was then purified and cloned as a 25-
hydroxylcholesterol binding protein in 1989 (Dawson et al., 1989). Homologues have 
been found in many eukaryotes including humans (Levanon et al., 1990), rabbit (Dawson 
et al., 1989), dictyostelium (Fukuzawa and Williams, 2002), mouse (Anniss et al., 2002), 
flies (Alphey et al., 1998), worms (C. elegans sequencing consortium, 1998), and fungi 
(Jiang et al., 1994; Schmalix and Bandlow, 1994; Fang et al., 1996; Daum et al., 1999; 
Hull and Johnson, 1999; Beh et al., 2001). In humans, 11 OSBP homologues have been 
identified and termed ORPs (oxysterol binding protein related proteins) (Letho et al., 
1999; Saara et al., 1999; Xu et al., 2001; Moreira et al., 2001). In Saccharomyces 
cerevisiae, there are 7 OSBP homologues termed OSHs (oxysterol binding protein 
homologue), which are encoded by open reading frames: YHR001w, YKR003w, 
YHR073w, YDL019c, YAR042w, YPL145c and YOR237w respectively (Beh et al., 
2001). All ORPs and Osh proteins share a highly conserved “fingerprint” sequence 
EQVSHHPP, which is within the ligand binding domain (ORD domain) at the carboxy-
terminus. Most ORPs except ORP2 and three long Osh proteins (Osh1p, Osh2p, and 
Osh3p) also contain a pleckstrin homology domain (PH domain, β-sandwich module) at 
their amino-termini, which targets these proteins to membranes by interaction with 
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phosphoinositides in the membranes (Lemmon and Ferguson, 2000). Some proteins also 
have ankyrin repeats, which are believed to mediate protein-protein interactions 
(Sedgwick and Smerdon, 1999; Letho and Olkkonen, 2003). Osh proteins also have at 
least one putative coiled-coil motif at their C-termini, which are believed to mediate 
protein-protein interactions (Beh et al., 2001; Kranz et al., 2001).  
  Although it has been more than one decade since the cloning of OSBP, the molecular 
function of OSBP proteins remains to be defined. Because of its high affinity for 
oxysterols and the potency of oxysterols as feedback regulators, OSBP is believed to 
mediate the feedback control of the mevalonate pathway (Taylor et al., 1984). Although 
other proteins such as SRE binding protein (SREBP) and SREBP cleavage activation 
protein are also known to mediate the feedback control of sterol biosynthesis, they share 
no homology with OSBP.  
 
2.2 The molecular function of OSBP  
  OSBP is a 95-101 kDa protein that has high affinity for oxysterols such as 25-
hydroxysterol (Taylor and Kandutsch, 1985; Taylor et al., 1989; Dawson et al., 1989b). 
Because of the potential role of oxysterols in regulating cholesterol biosynthesis 
(Kandutsch et al., 1978; Kandutsch and Chen, 1978), OSBP is believed to play a role 
primarily in sterol metabolism. First, OSBP binds oxysterols, such as 25-hydroxysterol, 
which are known to exert feedback regulation in the mevalonate pathway (Taylor et al., 
1984), and the potency of this feedback regulation is 1000 times higher than that 
mediated by cholesterol itself. Second, the intracellular localization of OSBP is 
modulated by lipid homeostasis. Upon binding to oxysterols such as 25-
 22
hydroxycholesterol, OSBP undergoes a conformational change, allowing OSBP to 
translocate from cytoplasmic vesicles to the Golgi membrane (Ridgway et al., 1992). In 
addition, OSBP also translocates to the Golgi membrane in response to factors other than 
oxysterols. For example, depletion of cellular cholesterol with cyclodextrins (Ridgway et 
al., 1998), by somatic mutations in CHO cells (Storey et al., 1998) or the Niemann-Pick 
C disorder (Mohammadi et al., 2001), promotes OSBP localization to the Golgi 
membrane. OSBP localization is also sensitive to sphingomyelin lipid concentration 
(Storey et al., 1998; Ridgway et al., 1992). Depletion of plasma membrane 
sphingomyelin and phosphatidylcholine with bacterial phospholipases promotes OSBP 
translocation. Third, OSBP plays a role in cholesterol biosynthesis and esterification, and 
sphingomyelin biosynthesis. Lagace et al. (1997) reported that overexpression of OSBP 
in several cell lines decreased cholesterol ester synthesis by 50% in medium with 
delipidated serum, 25-hydroxycholesterol or low density lipoprotein (LDL); and showed 
a 40-60% decrease in ACAT (acyl-CoA: cholesterol acyltranferase) activity and mRNA. 
In contrast, overexpression of OSBP up-regulated the transcription of three important 
sterol-regulated genes (LDL receptor, 3-hydroxy-3-methylgluraryl HMGCoA reductase 
and synthase) and increased the cholesterol biosynthesis. In addition, over-expression of 
OSBP in CHO-K1 cells displayed enhanced sphingomyelin synthesis (Lagace et al., 
1999). Finally, OSBP is involved in ceramide transport. A recent study showed that 
OSBP interacted with VAMP-associated protein-A (VAP-A) that is a syntaxin-like 
protein implicated in vesicular transport from the ER to Golgi apparatus and phospholipid 
regulation in mammalian cells and yeast (Loewen et al., 2005). An OSBP W174A mutant 
constitutively interacted with VAP-A, thus causing accumulation of misfolded VSVG 
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(ts045-vesicular stomatitus virus G protein) and ceramide in the ER inclusions (Jessica et 
al., 2002). So, it is possible that OSBP, in coordination with other proteins, regulates 
protein maturation as well as ceramide transport from the ER to the Golgi apparatus. 
More recently, in a landmark paper, Wang PY et al. (2005) showed that in response to 
cholesterol binding OSBP interacts with two phosphatases: HePTP and PP2A. These 
phosphatases are brought by OSBP to the vicinity of phosphorylated ERK1/2 within the 
cell to promote its dephosphorylation.  
    
2.3 The molecular function of ORPs 
   Like OSBP, ORPs have been shown to play a role in cholesterol homeostasis and 
intracellular membrane trafficking. ORP1 transcription levels were strikingly high in 
cortical areas of human brain and were regulated by sterols in a cultured human 
neuroblastoma cell line (Laitinen et al., 1999), which suggests ORP1 plays an important 
role in maintaining sterol homeostasis in the central nervous system. Stable 
overexpression of ORP2 caused cholesterol efflux a significant decrease of ACAT 
activity and esterified cholesterol (Laitinen et al., 2002). Overexpression of a splice 
variant of ORP4 (designated ORP4-S) resulted in a 40% reduction in esterification of 
low-density-lipoprotein-derived cholesterol, and ORP4-S interacted with vimentin stably 
thus causing aggregation of intermediate filament network (Wang et al., 2002). A recent 
study showed that ORPs participated in the regulation of sterol-related transcription 
factors (Johansson et al., 2003).  
     Besides a role in sterol homeostasis, ORPs are also believed to play a role in vesicular 
transport. When expressed in yeast, ORP1 complemented Osh4p/Kes1p function with 
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respect to cell growth and the Golgi secretory function; while expression of ORP2 
suppressed cell growth and blocked the Golgi-derived vesicle transport (Xu et al., 2001). 
Inactivation of Kes1p in yeast compromises the essential requirement for Sec14p-a 
phosphotidylinositol/phosphotidylcholine transfer protein required for viability (Fang et 
al., 1996). In addition, transient high-level expression of ORP2 interfered with the 
clearance of a secretory pathway protein marker from the Golgi complex (Xu et al., 2001). 
A more recent study showed that overexpression of the full-length ORP9 or a truncated 
form with PH domain deleted (ORP9S) caused vacuolation of the ER as well as trap of 
the ER-Golgi intermediate compartment marker ERGIC-53/p58 in the ER (Wyles and 
Ridgway, 2004), suggesting disruption of vesicular transport. 
     Like OSBP homologues in Drosophila (Alphey et al., 1998), human ORPs may also 
participate in regulation of cell cycle. Indeed, elevated ORP4 mRNA levels were 
observed in several cancerous cell lines and tumors (Fournier et al., 1999). It has been 
reported that ORP3 expression in hematopoietic cells is dependent on different stages of 
development such as CD34+CD38+ and CD34+CD38-. Expression of ORP3 in CD34+ was 
3-4-fold higher than that in CD34- cell  and was down-regulated with the proliferation of 
CD34+ (Gregorio-King et al., 2001). Consistent with this, two variants of ORP1 were 
found (a short one including the carboxy-terminal ORD domain only-ORP1S, and a 
longer N-terminal form -ORP1L consisting of three ankyrin repeats and a PH domain) to 
be differentially expressed in different tissues and to be up-regulated upon differentiation 
of primary human monocytes into macrophages (Johansson et al., 2003). More recently, 
ORP7 was found to be up-regulated and induced to migrate by insulin-like growth factor 
1(Silva et al., 2003), indicating that ORP7 plays a role in directed cell motility, possibly 
 25
by regulating lipid transport to the highly dynamic leading edge of migrating cells. 
Although these observations are rather descriptive and preliminary, a role for ORPs in 
signaling, cell proliferation and apoptosis could be suggested (Mills and Moolenaar, 2003; 
Panini SR and Sinensky, 2001).  
    
2.4 The molecular function of OSHs  
2.4.1 Secondary structures of Osh proteins 
   In S. cerevisiae, there are 7 OSBP homologues termed OSHs (oxysterol binding 
protein homologue). All Osh proteins share a conserved sequence (amino acid residue 
150 to 200), which is defined as OSBP related domain (ORD) by virtue of its similarity 
to all three subdomains of the OSBP consensus sequence. See Figure 1.4 for Osh 




Figure 1.4 Secondary structures of Osh 
proteins (Beh et al., 2001).  For each 
protein indicated, the top graph plots the 
probability of coil-coil domain formation 
vs. amino acid residue number. The 
second illustration defines blocks of 
potential α-helical regions. The bottom 
graph plots hydrophilicity vs. residue 
number. The bottom figure depicts 
important sequence motifs and their 
relative positions within each protein. 
PH: pleckstrin homology motifs 
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2.4.2 The roles of Osh proteins in maintaining sterol homeostasis  
      None of individual OSHs studied to date is essential, but collectively OSHs are 
essential for cell viability. Loss of the function of all OSHs using a strain deleted for all 
OSHs with methionine-regulated expression of OSH2 caused an increase of ergosterol 
levels by 3.5 fold, accumulation of free sterols in the intracellular membrane 
compartments, vacuolar fragmentation, and accumulation of lipid droplets in the 
cytoplasm and within vacuolar fragments (Beh et al., 2001; Beh and Rine, 2004). These 
observations indicate that collectively OSHs play an essential role in maintaining sterol 
homeostasis, which may be vital for cell viability. Interestingly, re-introduction of any 
single OSH into osh null mutant restored normal growth (Beh et al., 2001); implying 
OSHs share an overlapping function. Consistent with this, exchanging the ORD domain 
of Osh2p with that of Osh1p did not generally affect its function (Olkkonen and Levine, 
2004). However, each OSH seems to possess distinct function. Like mutants that affected 
ergosterol production, the viable combinations of OSH deletion alleles exhibited specific 
sterol-related defects and each deletion mutant showed specific phenotype in sterol 
biosynthesis-related gene expression profile and growth defects when treated with 
nystatin / lovastatin. Loss of the function of individual OSHs resulted in a mild increase 
of steady-state ergosterol levels by 30-80% (Beh et al., 2001). In addition, some genetic 
interactions between the OSHs are antagonistic. For example, spores containing only 
OSH5 and OSH6 or OSH3 and OSH5 could grow only on synthetic medium not on rich 
medium. However, when OSH5 was deleted in these strains, growth was restored on both 
synthetic and rich media (Beh et al., 2001). This indicates that OSH5 is functionally 
antagonistic to OSH3 and OSH6 in cells grown on rich medium. 
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       How do OSHs participate in sterol metabolism? One possibility is that Osh may 
regulate sterol transport thus maintaining proper sterol distribution between membranes 
and within a membrane. When OSH2 or OSH4 was deleted, cells were resistant to 
nystatin but had slightly elevated total ergosterol levels (Beh et al., 2001). This suggests 
that ergosterol resides in intracellular compartments other that the plasma membrane due 
to disruption of transport. More direct evidence comes from a recent study on the 
collective function of all OSHs by Beh and Rine (2004), who showed that gradual or 
rapid inactivation of OSH function caused accumulation of lipid droplets and free sterols 
in the cytoplasm with a decrease of sterols in the plasma membrane. However, in oshΔ 
osh4-ts, rapid activation of OSH4 at 37°C did not change the total levels of ergosterol, 
indicating that Osh family is not directly involved in sterol biosynthesis but rather in 
regulating sterol transport between membranes or sterol distribution within a membrane. 
Strong evidence comes from the study on Osh4p structure. In a recent landmark paper, 
Im et al (2005) showed that Osh4p assumes a β-barrel structure with a hydrophilic 
exterior and a hydrophobic tunnel in the barrel centre. Sterols bind to Osh4p within the 
central tunnel of the β-barrel, with its 3-hydroxyl group buried at the bottom of the tunnel. 
It was proposed that Osh4p is a sterol transporter, which undergoes quick conformational 
change upon sterol loading and unloading (Im et al., 2005).     
 
2.4.3 The role of Osh proteins in membrane trafficking  
               
    The role of OSHs in membrane trafficking is strongly supported by the study of 
Osh4p/Kes1p. Kes1p bypasses the requirement for Sec14p, which is an essential PtdIns 
(phosphatidylinositol)/PtdCho (phosphatidylcholine) transfer protein (Bankaitis et al., 
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1990; Fang et al., 1996). The ∆sec14 mutant is inviable due to its inability to form 
transport vesicles in the Golgi apparatus (Bankaitis et al., 1990). Loss of the function of 
KES1, not any other OSH restored cell viability, which is referred to as ‘bypass 
suppression’ (Fang et al., 1996; Beh et al., 2001). Sec14p plays an essential role in the 
Golgi secretory pathway, possibly by regulating the balance between PtdCho and PtdIns, 
thus maintaining a lipid microdomain favorable for vesicle biogenesis in the Golgi 
(McGee et al., 1994; Skinner et al., 1995). This lipid microdomain has more PtdIns than 
PtdCho, which indicates that PtdIns favors vesicle formation (Levine and Munro, 1998; 
Hiroko et al., 1999), while PtdCho is unfavorable (Xie et al., 2001). Indeed, Sec14p 
represses the production of PtdCho from CDP-choline pathway by inhibiting choline-
phosphate cytidylyltransferase, the rate-determining enzyme of the CDP-choline pathway 
(Skinner et al., 1995). When Sec14p malfunctions, enhanced PtdCho synthesis depletes 
DAG, which is a second messenger in signal transduction and essential for protein 
transport from the Golgi complex (Kearns et al., 1997). Kes1p may function to adjust the 
lipid composition in the Golgi membrane thus inhibiting vesicle formation. A recent 
study suggested that Kes1p negatively regulates ARF (adenosine diphosphate-
ribosylation factor) function through ARFGAP (ARF  GTPase activation protein), which 
is required for activation of ARF GTPase ((Li et al., 2002; Click et al., 2002; Poon et al., 
2001; Yanagisawa et al., 2002). Kes1p may also regulate ARF function through its 
effects on PIP (phosphoinositide), a Golgi complex-associated PI kinase (Li et al., 2002). 
Kes1p could function directly or indirectly as a Pik1p inhibitor in vivo thus reducing the 
PIP concentration in the Golgi membrane.  
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      The roles of other Osh proteins in membrane trafficking are less known. A recent 
study on the seven OSH genes showed that collectively OSHs are essential for endocytic 
trafficking, but dispensable for biosynthetic transport to the vacuole and plasma 
membrane (Beh and Rine, 2004). It is not known whether the defect associated with 
endocytosis is the immediate consequence of inactivation of all OSHs or secondary to 
disrupted sterol homeostasis.  In yeast, sterols are essential for the internalization step of 
endocytosis independently of actin，and specific sterol structures are required for 
postinternalization step of endocytosis, but sterols are dispensable for protein secretory 
pathway (Munn and Riezman, 1995; Munn et al., 1999; Heese-Peck et al., 2002). On the 
other hand, ergosterol in the plasma membrane is delivered to the ER for esterification in 
part via the endocytic pathway (Maxfield and Wustner, 2002). Disruption of endocytic 
trafficking is sometimes associated with a deficiency in cholesterol transport. For 
example, overexpression of an ATPase-defective hVPS4, a Vps4p (yeast vacuolar protein 
sorting) homologue in humans required for efficient transport of biosynthetic or 
endocytosed cargoes from an endosome to the vacuole /lysosome (Fujita et al., 2003; 
Babst et al., 1997; Yoshimori et al., 2000), results in accumulation of cholesterol in the 
enlarged endosomal compartments (class E compartment) (Bishop and Woodman, 2000).  
 
2.4.4 Roles of Osh proteins in other cellular activities  
   It is obvious that Osh proteins are important for maintaining sterol homeostasis as well 
as vesicular transport; they may be also involved in other cellular activities such as 
phospholipid metabolism. Recently, a large-scale characterization of yeast multi-protein 
complexes isolated a protein complex using Scs2p (VAM associated protein /VAP 
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homologue) as bait, which contains Osh1p and Osh2p (Gavin et al., 2002). It was then 
found that human OSBP interacted with a VAP (Jessica et al., 2002), which suggests the 
interaction between ORPs and VAP is conserved among species. Although the exact 
function of Osh1p and Osh2p in Scs2p complex has not been determined, it should be 
highlighted that the complex also includes Opi1p, a negative transcriptional regulator of 
inositol metabolism (Bachhawat et al., 1995) and Stt4p, a phosphatidylinositol-4 kinase 
(Audhya et al., 2000).  
    Osh proteins could be also involved in cell cycle and signaling pathway. It was 
reported that Osh3p interacted with Rok1p, a DEAD-box RNA helicase (Venema et al., 
1997), and was involved in nuclear fusion in a kem1p-specific manner. Osh3p synthesis 
was highly induced by Ste12p, a component of the MAPK pathway (Stone et al., 2000; 
Park et al., 2002).  
     In summary, Osh proteins are involved in a variety of cellular activities. It is plausible 
that Osh proteins may primarily modulate membrane lipid dynamics and intracellular 
lipid homeostasis so that other cellular activities are properly maintained; in other words, 
other cellular defects caused by loss of Osh proteins may be consequences of disrupted 
lipid homeostasis. However, current studies could not delineate the molecular functions 
of individual Osh proteins. 
 
2.5 Membrane targeting of OSBP Proteins  
2.5.1 Multiple membrane targeting of OSBP proteins    
     Members of OSBP family predict to be cytosolic with a peripherally membrane-
associated pool and exhibit multiple membrane-targeting properties (Beh et al., 2001; 
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Olkkonen and Levine, 2004). Under normal physiological conditions, OSBP is soluble in 
the cytoplasm or associated with small transport vesicles, but translocates to the TGN 
upon oxysterol challenge or depletion of intracellular cholesterol (Ridgway et al., 1992). 
In addition, OSBP has also been shown to target the ER by interaction with an ER 
integral membrane protein VAP (VAMP-associated protein) (Wyles et al., 2002). The 
PH-containing ORP3, ORP6 and ORP7 were recently shown to associate with both the 
plasma membrane and ER membranes (Lehto et al., 2004). Osh1p localizes to the Golgi 
membranes while also shows NV junction (nucleus-vacuole junction) targeting when 
cells enter stationary phase. Osh2p targets some structures close to plasma membrane 
while Osh3p is predominantly cytosolic; however, truncated Osh2p and Osh3p (with 
deletion of the ORD domain) localize to punctuate structures and plasma membrane 
respectively (Levine and Munro 2001). A significant advance was made by Loewen et al. 
(2003) who showed that many lipid transfer proteins including many members of OSBP 
family contain a conserved EFFDAxE motif (FFAT), which target these proteins to the 
ER membrane by interaction with the ER-resident membrane protein Scs2p (yeast VAP 
homologue). At least seven ORPs and three Osh proteins containing the FFAT motif 
interact with the ER membrane. In support of this, recently it was shown that ORP9 
targeted the Golgi via its PH domain and the ER through its FFAT motif (Wyles and 
Ridgway, 2004).   
   As introduced in previous chapter, OSBP proteins play an important role in maintaining 
sterol or other lipid homeostasis possibly via regulating lipid transport and vesicular 
transport. Intracellular lipid transport is mainly mediated by vesicle flow, membrane 
contact and monomer transport with the aid of lipid transfer proteins. In order to move 
 32
hydrophobic lipids across the aqueous environment of the cytoplasm independent of 
vesicular membrane traffic (Wirtz, 1991; 1997), the lipid transfer proteins need to interact 
with multiple membranes (Ridgway et al., 1992; Aikawa et al., 1999). A good example is 
Goodpasture antigen binding protein (GPBP), which has a PH domain for Golgi 
targeting, a FFAT motif for ER targeting and a steroidogenic acute regulatory protein 
(StAR)-related lipid transfer (START) domain for lipid binding. With the ability to 
interact with different membranes through its different domains, GPBP mediates vesicle-
independent ceramide transport from the ER to Golgi (Hanada et al., 2003). Likewise, 
with similar domain structures as GPBP and the property of multiple-membrane 
targeting, OSBP family could shuttle between different membranes to transport lipids in a 
vesicle-dependent or independent manner.  
 
2.5.2 Requirement of phospholipids for membrane targeting  
     Peripheral membrane proteins may target the plasma or intracellular membranes by 
interacting with the cytoplasmic domains of integral membrane proteins or specific lipid 
components of the target membranes. PH domain-containing proteins, including some 
members of OSBP family, may target membranes by interaction through their PH 
domains with phosphoinositides on the target membranes (Lemmon and Ferguson, 2000). 
Indeed, targeting of OSBP and Osh1p to the Golgi membrane is dependent on the 
pleckstrin homology (PH) domain at their amino-termini (Ridgway et al., 1992; Levine 
and Munro, 1998; 2001).  
       Phospholipids especially phosphatidylinositides are important for targeting of 
proteins of OSBP family to membranes. OSBP has high affinity for phosphatidylinositol-
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4, 5-biphosphate or other unidentified lipids, thus targeting it to the Golgi membrane 
where these lipids are enriched (Levine and Munro, 1998). Consistent with this, the PH 
domain-mediated Golgi membrane targeting involves both PtdIns-4-kinase Pik1p-
dependent and Arf1p (a Golgi GTPase)-dependent components (Levine and Munro, 
2002). Li et al. also examined the lipid-binding property and functional domains of 
Kes1p and found that Kes1p bound preferably phosphatidylinositol-4, 5-diphosphate in 
vitro and that the binding was required but not sufficient for its targeting to the Golgi 
membrane (Li et al., 2002).  The PIP pool required for Kes1p targeting to the Golgi 
membrane was driven by the activity of Pik1p PI4-kinase, and Golgi targeting was 
essential for Kes1p function in Sec14-dependent Golgi secretory pathway (Li et al., 
2002). PH domain is also important for other lipid binding.  It was reported that full-
length ORP4 including PH and ORD domain bound 25-hydroxycholesterol with high 
affinity and specificity; but ORP4-S with deletion of PH domain and part of OSBP 
domain failed to do so (Wang et al., 2002). However, ORP1 and ORP2 can also bind 
phosphatidic acid strongly and PtdIns (3) P weakly in vitro (Xu et al., 2001), probably not 
via PH domain since ORP2 has no PH domain. The above in vitro and in vivo 
observations suggest a firm role for lipids in targeting OSBP proteins to cellular 
membranes and imply a role for OSBP proteins in the interface between lipid 
homeostasis and membrane trafficking.  
 
2.5.3 Regulation of membrane association of Osh proteins by AAA ATPase 
       AAA ATPase (ATPase associated with a variety of cellular activities) was first 
described by Erdmann et al (1991). AAA ATPases are a new family of p-loop ATPases 
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functioning in diverse cellular activities, which range from peroxisome biogenesis (Pex1, 
Pex6), vesicle transport (Sec18p/NSF), cell division (Cdc48/p97), endosomal biogenesis 
(Vps4p/SKD1) (Lupas and Martin, 2002), and quality control of mRNA maturation 
(Afg2p) (Jungwirth et al., 2001). Although AAA ATPases play diverse roles, they seem 
to share a common working mechanism: energy-dependent unfolding or unwinding of 
proteins and erecting or disassembly of protein complexes (Sheetal and Martin, 1998). 
This mechanical work employs a conserved energy converter, the AAA module, which 
derives its energy by converting ATP into ADP. AAA modules predict to have conserved 
secondary structures (Neuwald et al., 1999). AAA proteins contain either one (D1) or two 
non-identical (D1 and D2) AAA modules, which form a αβα nucleotide binding fold and 
at least three α-helices and tend to oligomerize into hexameric rings (Neuwald et al., 
1999; Lenzen et al., 1998; Zhang et al., 2000). The majority of AAA proteins contain one 
D1 and classified as type I AAA ATPase, and those containing two AAA modules are 
classified as type II AAA proteins (Beyer, 1997).           
     How are Osh proteins related to AAA ATPases? As mentioned above, Osh proteins 
target multiple membranes by interacting with phospholipids or proteins on the target 
membranes and possibly shuttling between membranes to modulate lipid transport or 
membrane trafficking. How do Osh proteins dissociate from membranes? This seems to 
relate AAA ATPases. First, some Osh proteins interact with specific AAA ATPases. In a 
large scale of purification of protein complexes in yeast, Osh1p was found to co-
precipitate with Afg2p, which is a type II AAA ATPase and essential for cell viability 
(Gavin et al., 2002). In our study, Osh7p was shown to interact with Vps4p, a type I AAA 
ATPase which is required for the MVB (multiple vesicle body) pathway (Wang PH et al., 
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2005). Second, AAA ATPases may modulate cellular distribution of Osh proteins. In 
∆vps4 cells, a significant pool of Osh7p translocated from cytosol to membranes (Wang 
PH et al., 2005). Interestingly Vps4p is required for endosome-associated ESCRT 
complexes to dissociate from endosomal membranes so that ESCRT proteins are 
available for subsequent round of action in the MVB pathway (Babst et al., 2002a; 
2002b; Katzmann et al., 2002; Conibear E, 2002). Vps4p also mediates the release of 
Doa4p, a deubiqutination enzyme from ESCRT complex. Thus, Vps4p plays a central 
role in disassembling ESCRTs and directing MVB maturation. The functional relatedness 
between Afg2p and Osh1p is not clear; it is plausible that Afg2p may regulate the Osh1p 
disassociation from membranes in the same way as Vps4p regulates Osh7p membrane 
disassociation.              
     
 36
Part 3 Significance and Objectives of This Study 
3.1 Intracellular cholesterol homeostasis and diseases 
   Genetic disorders that affect human cholesterol homeostasis cause hyper-
cholesterolemia, leading to premature death from atherosclerosis. Deposition of 
atherogenic lipoproteins, including low-density lipoprotein (LDL), into the artery wall is 
the cause of atherosclerosis. Five genetic disorders including familial hyper-
cholesterolemia FH (LDL receptor gene: LDLR) have been implicated in the formation 
of atherosclerosis (Pullinger et al., 2003). In FH, buildup of LDL on the artery wall is due 
to a deficiency in the uptake of LDL, which is mediated by LDL receptors (Brown and 
Goldstein, 1986). However, abnormality of intracellular cholesterol transport also causes 
serious diseases; one of the prominent ones is Nieman–Pick type C (NPC). NPC disease 
is characterized as an abnormal accumulation of cholesterol, sphingomyelin and 
glycosphingolipids in the late endosomal / lysosomal systems, thus causing progressive 
central nervous system degeneration (Liscum and Klansek, 1998). There is no therapy for 
the NPC that alleviates the progressive neurodegeneration, and typical NPC patients 
usually die at early childhood (Pentchev et al., 1995).  Another disease associated with 
intracellular cholesterol trafficking is Tangier disease, which is a rare autosomal recessive 
disorder of reverse cholesterol transport (export) (Oram and Yokoyama, 1996). Tangier 
patients have low plasma HDL levels and accumulate massive amount of cholesterol 
esters within macrophages of various tissues, leading to large yellow-orange tonsils or 
peripheral neuropathy. In older patients, cardiovascular disease is a significant problem 
(Serfaty-Lacrosniere et al., 1994). The molecular basis for Tangier disease is unknown, 
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but the impairment of intracellular cholesterol efflux to plasma HDL in Tangier patients 
is well accepted (Liscum and Munn, 1999).       
 
3.2 Yeast as a good research model for the study of lipid metabolism 
   The Saccharomyces cerevisiae is a powerful experimental system to study biochemical, 
cell biological and molecular biological aspects of lipid synthesis. First, it is a unicellular 
organism but shares similar intracellular membrane structures and lipid components with 
other higher eukaryotes. Second, unlike higher eukaryotes, S. cerevisiae can be grown on 
defined media thus giving the investigator complete control over environmental 
parameters. Third, substantial cellular functions are highly conserved from yeast to 
mammals and corresponding genes can often complement each other. Approximately 
30% of 5885 yeast proteins have their human homologues of known function (Cherry et 
al., 1997). Some important genes involved in sterol metabolism are conserved from yeast 
to humans, making yeast an ideal system for the study of sterol homeostasis and the 
associated human diseases (Sturley, 1998). Although the predominant yeast sterol, 
ergosterol, differs structurally from cholesterol, it is synthesized (Basson et al., 1986), 
regulated (Hampton and Rine, 1994) and esterified (Yang et al., 1996) similarly to those 
in mammalian cells. For example, the key rate-limiting enzyme in the mevalonate 
pathway in yeast is also HMG-CoA reductase (Hampton et al., 1996). Because of the 
absence of receptor-mediated sterol uptake machinery, the unicellular eukaryotic yeast 
can not take up exogenous sterols in aerobic conditions (Brown and Goldstein, 1986). 
However, the intracellular sterol transport (Carstea et al., 1997), sensing, and 
transcriptional regulation of sterol biosynthesis (Dimster-Denk and Rine, 1996; Smith et 
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al., 1996) are strongly conserved from yeast to humans. Fourth, most significantly, 
knowledge of the DNA sequence of the complete genome, which was completed in 1996, 
has provided convenience for and insights into understanding the function of a gene of 
interest (Dujon, 1996; Goffeau et al., 1996). Fifth, S. cerevisiae has both a stable haploid 
and diploid life cycle. Thus, recessive mutations and complementation tests can be 
conveniently performed with haploid and diploid cells respectively. The high 
homologous DNA recombination frequency in yeast makes it very convenient to 
integrate a mutated gene or knock out a gene. Finally, some of other advantages 
including rapid growth, dispersed cells, the ease of replica plating and mutant isolation, 
and being nonpathogenic make yeast particularly suitable for lipid studies (Broach et al., 
1991).   
 
3.3 Why study intracellular cholesterol homeostasis and OSBP family?   
      The past decade has seen a great progress in understanding the molecular basis of 
intracellular lipid homeostasis. The molecular mechanisms underlying uptake, 
biosynthesis and degradation of lipids like cholesterol and phospholipids have been 
relatively well understood. However, much less is known about how lipids move in the 
cell, how intracellular homeostasis is maintained and regulated, and how lipid 
metabolism is linked to other cellular processes. For example, ER is the site of synthesis 
of cholesterol while plasma membrane has the largest amount of cholesterol. How is this 
non-homogenous distribution maintained? What is the molecular basis? Another example 
is how cholesterol is delivered from plasma membrane back to the ER for esterification. 
Although possible transport pathways have been proposed in many studies, direct 
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evidence is lacking; not to mention the molecular basis of intracellular sterol transport. 
One reason that hampers the study of intracellular cholesterol transport is that more than 
one pathway exists for cholesterol transport between two membranes, and thus blocking 
of one pathway gives no obvious phenotype. Moreover, the study of intracellular 
cholesterol trafficking with mammalian cells usually relies on pharmacological approach, 
which is sometimes inconclusive and indirect. 
    Recent studies have revealed the importance of OSBP protein family in maintaining 
lipid homeostasis and other cellular activities possibly by regulating lipid trafficking or 
membrane lipid dynamics; but more effort is needed to elucidate their molecular function 
in these cellular activities. OSBP homologues are present in many eukaryotes including 
the unicellular yeast cells and the complex mammalian cells, and conserved in peptide 
sequence and most possibly in function. This study may help us to better understand the 
molecular function of OSBP family by using the powerful model system- Saccharomyces 
cerevisiae.  
 
3.4 The objectives of this study 
3.4.1 Characterize the cellular localization of Osh6p by fluorescence microscopy, 
subcellular fractionation, membrane extraction and floatation. 
3.4.2 Determine the lipid ligand(s) of Osh6p by protein-lipid overlay assay. 
3.4.3 Examine the role of Osh6p in maintaining sterol homeostasis by gas 
chromatography mass spectrum (GC-MS), thin layer chromatography (TLC), and radio-
labeling.  
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3.4.4 Investigate the role of Osh6p in fluid-phase endocytosis, endocytic trafficking 
and biosynthetic delivery of carboxy peptidase Y (CPY) to the vacuolar lumen by 
fluorescence microscopy and radiophotography.   
3.4.5 Determine the physical interaction between Osh6p and Vps4p, Osh1p and Afg2p 
using glutathione-s transferase (GST) pull-down and yeast two hybrid analysis. 
3.4.6 Examine the functional interactions between Osh proteins and AAA ATPases by 
fluorescence microscopy, TLC, radio-labeling and subcellular fractionation. 
3.4.7 Examine the roles of Vps4p and Afg2p in maintaining sterol homeostasis by GC-











Chapter II Materials and Methods 
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Part 1 Materials 
1.1 Preparation of cell culture media  
Table 2.1 Media used in this study                                                                                                              
Medium                         Ingredients Preparation 
YPD rich 
medium 
2% dextrose, 1%yeast extract, 2% peptone, 
2% agar (optional, for solid medium).  
Autoclaved at 115˚C 
for 15min 
SC/ synthetic 
complete dropout  
2% dextrose, 0.67%yeast nitrogen base, 





2% dextrose, 0.67%yeast nitrogen base, 2% 
agar (optional, for solid medium). 
As above 
LB broth 1.5%NaCl, 1% tryptone, 0.5% yeast extract, 
2% agar (optional, for solid medium).  
Autoclaved at 121˚C 
for 20min 
SC/X-gal plate 2% dextrose, 0.67%yeast nitrogen base, 
dropout powder, 2% agar, 70mM potassium 
phosphate pH7.0, 40µg/ml X-gal.  
Autoclaved at 115˚C 
for 15min. X-gal 
was added when 




2% galactose, 1% raffinose, 0.67%yeast 
nitrogen base, dropout powder, 2% agar, 




1.2 Drugs and special chemicals 
PIP strips were purchased from Echelon Research Laboratories, Salt Lake City, Utah, 
U.S.A. Fatty acid free BSA (bovine serum albumin), nystatin, lyticase, Nile red, DAPI 
(4', 6-diamidino-2-phenylindole), and cycloheximide were purchased from Sigma-
Aldrich (St. Louis, MO, U.S.A). X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside) was purchased from BioRad and ONPG (O-nitrophenyl-β-D-
galactopyranoside) from Amresco (Solon OH 44139 U.S.A). FM4-64 and Lucifer yellow 
were obtained from Molecular Probes (Eugene, OR, U.S.A). Protein A Sepharose CL-4B, 
Glutathione-agarose beads, and chemiluminescent substrate kit were obtained from 
Amersham/Pharmacia (Uppsala, Sweden). Zymolyase 20T was purchased from US 
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Biologicals (Swampscott, MA, U.S.A). Filipin was purchased from Polyscience (Niles, 
IL, U.S.A). Phospholipids were purchased from Avanti Polar Lipids (Alabaster, Alabama 
U.S.A). Restriction enzymes and ligases were obtained from Promega (Madison WI, 
U.S.A). ABI PRISM DNA sequencing kit (Big Dye) was purchased from Applied 
Biosystems (Foster City, CA, U.S.A).  Plasmid purification kits were purchased from 
QIAGEN (Valencia, CA U.S.A).   
 
1.3 Antibodies 
Mouse anti-Pep12p, Dpm1p, Vps10p, Vph1p, CPY, VATPase60kDa subunit, Porin, and 
rabbit anti-GFP and Hexokinase antibodies were purchased from Molecular Probe 
(Eugene, OR, U.S.A). Mouse anti-GST was purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, U.S.A).  Rabbit anti Tlg1p was a gift from Prof.W Hong (IMCB, 
Singapore) (John et al., 1999). Rabbit anti Gas1p was a gift from Dr. Alan Munn (IMCB, 
Singapore). Secondary anti IgG horseradish peroxidase conjugate was obtained from 
Amersham/Pharmacia Biotech (Uppsala, Sweden). 
 
 1.4 Radio chemicals 
[35S]-methionine/cystein (7.9mCi/ml) and [14C]-acetate (1.0mCi/ml) was purchased from 
PerkinElmer, MA, USA). [3H]-oleic acid (5.0mCi/ml, 10.0Ci/mmol oleic acid) and [14C] 
cholesterol (0.1mCi/ml) were obtained from Amersham Biosciences (Uppsala, Sweden).  
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Part 2 Methods 
2.1 DNA manipulation 
2.1.1 PCR (Polymerase Chain Reaction)  
1) Principles of PCR (Bej et al., 1991): PCR was first developed by Kary B Mullis in 
 
1985. The principles of PCR were illustrated in Figure 2.1 and 2.2 
 
    
Figure 2.1 Illustrations of one PCR cycle.  
 As shown in Figure 2.1, during denaturing at high temperature, the double strand 
template DNA melts open to a single-stranded DNA. When temperature is lowered down 
(annealing), the forward and reverse primers that complement the gene of interest are 
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jiggling around the DNA templates; hydrogen bonds are constantly formed and broken 
between the single-stranded primer and the single-stranded template. When more stable 
hydrogen bonds are formed, the polymerase can then attach and start copying the 
template. The temperature is increased again allowing extension. At this elevated 
temperature, primers annealed to the wrong template (not the DNA to be amplified) get 
disassociated and nonspecific amplification is avoided. In the next cycle, not only the 
original DNA but also the newly synthesized DNA in the first cycle can act as template 
thus amplifying double strand DNA by two-fold, then 4 fold in the third cycle… More 
importantly, with the use of some polymerase like Pfu with proof-reading feature, the 
fidelity of PCR products is guaranteed.  
.    
  
Figure 2.2 Schematic diagram of exponential amplification of DNA in a PCR.   
 
 2) Procedures of a PCR. Polymerase chain reaction was performed according to 











small genes   
25mM MgCl2 4µl 4µl 0 
10X PCR buffer without MgCl2 5µl 5µl 0 
10mM dNTP mix  1µl lµl 1µl 
Forward primer 10µM 1µl 1µl 1µl 
Reverse primer 10µM 1µl 1µl 1µl 
10X PCR buffer with MgCl2 0 0 5µl 
Template DNA 10pg-1µg in 2µl 10pg-1µg in 2µl 10pg-1µg in 2µl 
Sterile distilled water 35.5µl 35.25µl 39.5µl 
DNA Polymerase 1.25U/0.5µl 2.6U/0.75µl 1.25U/0.5µl 
Final volume 50µl 50µl 50µl 
 
different purposes. In a 50µl of reaction mixture, the following reagents were assembled 
sequentially (See Table 2.2)  
 











PCR programs were optimized for each DNA amplification reaction based on DNA size, 
primer Tm, polymerase used and etc. The following general program was applied:  
Step1: initial denaturing, 94-95 ºC, 2min 
Step2:  denaturing, 95 ºC, 30 seconds 
Step3: annealing, 45-55 ºC, 30 seconds 
Step4: extension, 68-72 ºC, 2-4min, back to step2, 30-35 cycles 
Step5: final extension, 68-72 ºC, 4-8min 





2.1.2.0 Strategy:  
                    
Figure 2.3 Schematic overview of subcloning procedures. 
As shown in Figure 2.3, a gene of interest was amplified using two primers containing 
restriction sites. The PCR products and circular plasmid vector were digested with 
restriction enzymes to produce sticky ends, and then ligated together by ligase. The 
recirculized DNA was then transformed into E.coli. The desired plasmids were extracted 
from E.coli cells and checked by restriction digestion, which showed two DNA fragments 
corresponding to the vector and insert respectively. To lastly verify positive clones, DNA 
sequencing was performed.  
2.1.2.1 Purification of PCR products: 100µl of PCR products were extracted with one 
volume (100µl) of phenol/chloroform/isoamyl alcohol (25:24:1) once and precipitated 
with 1/10 volume of 3M sodium acetate and two volumes of 95% ice-cold ethanol at –
20°C for 1 hour. DNA was spun down at 12,000xg, 4°C for 30 min and washed once 
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with 100µl of ice-cold 75% ethanol. DNA were dried and lastly dissolved in 50µl of 
sterile distilled water for future use.    
2.1.2.2 Digestion of DN A: All PCR products and vector plasmids were digested with 
appropriate restriction enzymes in compatible buffers at appropriate temperature for 2-16 
hours according to the manufactures’ instruction. 
2.1.2.3 Gel Purification of DNA: The digested DNA was separated by agarose gel (1%) 
electrophoresis and then purified using DNA extraction columns (Amersham GFX DNA 
purification kit from solution and gel band). Briefly, the cut-to-size gel band was 
dissolved in an appropriate volume of capture solution (1 µl per mg of gel weight) by 
heating at 65 °C for 5-15 min. The gel solution was transferred to a GFX column and 
incubated at room temperature for 1 min. The column was centrifuged at 12,000xg for 30 
seconds and washed once with 500µl of wash buffer (10 mM Tris-HCl pH 8.0, 1mM 
EDTA, and 80% ethanol).  DNA was eluted with 50µl of sterile water or 1xTE pH8.0 (10 
mM Tris-HCl pH 8.0) by incubation for 1 min. DNA elute was pooled in a fresh 
microfuge tube by centrifugation at 14,000xg for 1 min.                                                            
 2.1.2.4 Ligation:  1:3 molar ratio of vector: insert DNA and 0.5 Weiss unit of ligase 
(Promega) for sticky ends or 1 Weiss unit for blunt ends were assembled and ligation mix 
was incubated at room temperature for 3 hours or 4°C overnight or 16°C for 4-18 hours.    
2.1.2.5 Preparation of DH5α chemical-competent cells: A single DH5α colony was 
inoculated in 3 ml of LB broth at 37 °C overnight with gentle shaking. 0.5ml of overnight 
culture was diluted in 50ml of fresh LB broth and grown to cell density of 4-7 x 107 
viable cells / ml at 37°C with mild shaking. Cells were harvested by centrifugation at 
1000xg for15 min at 4°C. The resultant supernatant was completely removed and the cell 
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pellet was resuspended by moderate vortexing in 15 ml of ice-cold RF1 buffer (100mM 
RbCl, 50mM MnCl2, 30mM potassium acetate, 10mM CaCl2, 15 %(w/v) glycerol, final 
pH5.8 adjusted with acetic acid, filter-sterilized with 0.22µ membrane). The cell 
suspension was incubated on ice for 15min and centrifuged at 1000xg for15 min at 4°C. 
The resultant cell pellet was resuspended in 2ml of ice-cold RF2 buffer (10mM MOPS, 
10mM RbCl, 75 mM CaCl2, 15 %( w/v) glycerol, final pH6.8 adjusted with NaOH and 
filter-sterilized through 0.22µ membrane). 50µl of cells were distributed in a sterile 1.5ml 
microfuge tube and frozen in dry ice/ethanol bath. 
2.1.2.6 E.coli Transformation: Heat-shock competent DH5α cells were used for 
transformation. A 50µl of frozen competent cells was thawed on ice. A 5µl of ligation 
reaction mix was added the competent cells and mixed gently by flicking few times. The 
competent cells were incubated on ice for 30 minutes, allowing DNA to be adsorbed to 
cell surface. After incubation, the cells were transferred to a 42°C water bath and heat-
shocked for 30 seconds. The cells were then immediately transferred to ice and incubated 
for 2 minutes. The cells were resuspended in 1ml of LB broth and then incubated at 37 
°C with shaking for one hour allowing recovery. After incubation, cells were pelleted 
down by centrifugation at 3000rpm for 2 minutes within a microfuge. 800µl of 
supernatant was removed; cells were mixed well with remaining LB and then spread on a 
LB plate supplemented with 100µg/ml amphicilin. The LB plate was incubated at 37°C 
overnight until bacterial colony formed.    
 2.1.2.7 Mini-preparation of plasmid DNA: A single colony was inoculated in 2ml LB 
broth with 100µg/ml amphicilin and incubated at 37°C overnight with shaking (200rpm). 
A 1.5 ml of overnight culture was centrifuged at 12,000xg for 30 seconds at 4°C in a 
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microfuge. The supernatant was completely removed by aspiration and the cell pellet was 
resuspended well in 100µl of ice-cold buffer I (50mM glucose, 10mM EDTA, pH8.0, 
25mM Tris.Cl pH8.0). 200µl of buffer II (0.2N NaOH, 1% SDS) was added to the cell 
suspension and mixed by inversion. 150µl of ice-cold buffer III (3M potassium acetate, 
11.5% v/v glacial acid) was added subsequently to the cell suspension. The cell 
suspension was incubated on ice for 5min and centrifuged at 12,000xg, 4 °C for 5 min. 
400µl of supernatant was transferred to a fresh microfuge tube and DNA was precipitated 
with 0.8ml of absolute ethanol. DNA was spun down by centrifugation as above and 
washed once with 1 ml of ice-cold 70% ethanol. DNA was lastly dissolved in 60µl of TE 
buffer (10mM Tris.Cl, 1mM EDTA, pH8.0, 20µg/ml DNAase free pancreatic RNAase, 
boiled for 15min).   
2.1.2.8 Diagnostic digestion: Plasmid DNA was digested with restriction enzymes 
according to product manuals.  
2.1.2.9 DNA sequencing: In a 20µl reaction, 4µl of BigDye, 4µl of 5x buffer, 1µl of 
10µM sequencing primer, 1µl of plasmid DNA (about 50 pg) and 10µl of sterile distilled 
water were assembled and subjected to a PCR cycle as following: 96°C for 30 seconds, 
50°C for 30 seconds, 60°C for 4 min, 25 cycles. The PCR product was transferred to a 
0.6ml microfuge tube with 50µl of 95% ethanol, 2µl of 3M-sodium acetate pH5.2. The 
tube was incubated at room temperature for 15min and centrifuged at 12,000xg in a 
microfuge for 15min.  The resultant DNA pellet was washed with 200µl of 70% ethanol 
once and dried. DNA was sequenced by NUMI DNA sequencing center, NUS.  
2.1.2.10 Midi-preparation of plasmid DNA: To make a large amount of pure plasmid 
DNA, midi-preparation was performed according to a QIAGEN protocol. A single 
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colony was inoculated in 2-5ml of LB containing 100µg/ml of amphicilin and the starter 
culture was incubated at 37°C with vigorous shaking (about 300rpm) for 8 h. The starter 
culture was diluted in 100ml fresh medium and grown for 12-16 h with vigorous shaking. 
Bacterial cells were harvested by centrifugation at 6000x g for 15 min at 4°C. The cell 
pellet was then resuspended in 10ml of Buffer P1 (50mM Tris.Cl pH8.0, 10mM EDTA, 
100µg/ml RNase A, stored at 4°C). 10ml of Buffer P2 (200mM NaOH, 1%SDS) was 
added, mixed thoroughly with cell suspension by inverting 4-6 times and then incubated 
at room temperature for 5 min. Subsequently, 10ml of Buffer P3 (3.0M potassium acetate 
pH5.5) was added and mixed immediately but gently by inverting 4-6 times and 
incubated on ice for 20 min. The sample was centrifuged at more than 20,000xg for 30 
min at 4°C. The resultant supernatant was transferred to a fresh centrifuge tube promptly 
and centrifuged again at more than 20,000xg for 30 min at 4°C. The supernatant was 
transferred to a QIAGEN-tip 500 column (pre-equilibrated by applying 10 ml of Buffer 
QBT [750mM NaCl, 50mM MOPS pH7.0, 15% isopropanol]) and flowed through the 
column by gravity. The column was washed twice with 30ml of Buffer QC (1.0M NaCl, 
50mM MOPS pH7.0, 15% isopropanol) by gravity flow. Plasmid DNA was eluted with 
15 ml of Buffer QF (1.25M NaCl, 50mM Tris.Cl pH8.5, 15% isopropanol) from the 
column and precipitated by adding 10.5 ml of room-temperature isopropanol to the elute. 
Precipitated DNA was pelleted down by centrifugation at more than 15,000xg for 30 min 
at 4°C. The DNA pellet was then washed with 5 ml of 70% ethanol followed by 
centrifugation at more than 15,000xg for 10 min. Finally, highly pure DNA pellet was 
air-dried and dissolved in a suitable volume of 10mM Tris.Cl pH8.5.  
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2.1.2.11 Filling 5’-protruding ends (Blunting):  For one-end blunting reaction, both 
vector and insert DNA were digested with respective restriction enzyme and gel-purified. 
Blunting reaction mix consisted of digested 1-4µg DNA in 10µl H2O, 0.8 µl of 1mM 
dNTP, 4µl of 0.1mg/ml acetylated BSA, 2µl of 10xbuffer(500mM Tris-HCl pH 8.0 , 
50mM MgCl2, 10mM DTT), 1-4 units of DNA Polymerase I Large (Klenow) Fragment 
(Promega, M2201), water added to 20µl. The reaction mix was incubated at room 
temperature for 10 min and the reaction was terminated by heating at 75°C for 10 min. 
DNA was lastly gel-purified and used for restriction digestion and ligation.  
2.1.3 Construction of yeast strains 
2.1.3.1 Preparation of chemical competent yeast cells: A yeast strain of interest was 
grown in 3ml of YPD or SC dropout according to its genotype at 30°C overnight. 1 ml of 
overnight culture was diluted in 50ml of fresh medium and incubated at 30°C for 8 h. 
Cells were pelleted down at ~1000 x g for 5 min and washed once with 25 ml of sterile 
distilled water. The cell pellet was resuspended in 1.0 ml of buffer I (100mM lithium 
acetate, 10mM Tris-HCl pH 7.5, 1mM EDTA). The cell suspension was transferred to a 
sterile microfuge tube and centrifuged again. The cell pellet was finally resuspended in 
500µl of buffer I and stored at 4°C for transformation. 
2.1.3.2 Yeast transformation: Expression plasmids were transformed into yeast using a 
heat-shock method. Before transformation, 1.0 ml of 10mg/ml of salmon sperm single 
strand DNA was boiled for 15 min and quickly chilled in ice water. 100µl of competent 
cells were pelleted down (supernatant removed). Then the following reagents were added 
to the cell pellet sequentially: 240ul of polyethyl glycerol PEG (50% w/v), 36ul of 1.0 M 
LiAc, 36ul of 10xTE (0.1M Tris-HCl pH 7.5, 10mM EDTA), 5ul of SS-DNA (10 
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mg/ml), 39µl of water and DNA (plasmid or PCR products). The transformation mix was 
vortexed vigorously and then incubated standing at 30°C for 30 min. The mix was 
incubated at 42°C in a water bath for 15 min. Cells were pelleted down by centrifugation 
at 6,000rpm in a microfuge for 1 min. The supernatant was discarded and the cell pellet 
was resuspended in 200µl of sterile water. Cells were plated on selective solid medium 
and grown at 30°C for 2-3days for colony formation.     
2.1.3.3 PCR-based gene disruption:  
1) Principles: In the aid of high frequency of homologous DNA recombination in yeast 
cells, a PCR-based gene disruption technique is fast, efficient and easy. A gene disruption 
cassette is constructed that consists of a selectable marker (HIS3, URA3, LYS2, LEU2, 
TRP1, MET15, Kan-MX4) flanked by sequences (usually 40-50mer) derived from the 5’ 
and 3’ ends of the target gene to be detected. When the linear DNA is transformed into 
yeast cells, homologous recombination between the identical sequences flanking the 
marker and target genes result in replacement of the target gene with the marker gene. 
This replacement allows yeast cells to grow in the medium lacking marker gene products 
eg. leucine, while non-transformed cells fail to grow up.  
2) Procedures: Briefly, PCR products were obtained using a plasmid containing marker 
gene. The linear DNA was resolved on 1% agarose gel and purified using a GFX column. 
The purified DNA was transformed into yeast competent cells by heat-shock. 
Transformed cells were spread on selective plates (SC dropout) and incubated at 30°C for 
2-5 days until colonies appeared. To check the correct clones, chromosomal DNA was 
extracted (see Rapid isolation of chromosomal DNA) and PCR reaction was performed 
using primers different from those for disruption cassette. The forward primer was an 
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upstream sequence of the target gene and the reverse primer was an inner sequence of the 
selection marker. PCR positive clones were considered correct gene knockout.  
 2.1.3.4 Rapid isolation of chromosomal DNA: A single colony was inoculated in 5 ml 
of YPD and grown overnight. The overnight culture was centrifuged at 1200xg for 5 min 
at room temperature. The resultant cell pellet was washed with 1 ml of water and 
resuspended in 200µl of breaking buffer (2%v/v Triton X-100, 1% w/v SDS, 100mM 
NaCl, 10mM Tris.Cl pH8.0, 1mM EDTA pH8.0). 200µl of glass beads and 
phenol/chloroform/isoamyl alcohol were added to the cell suspension. Cells were lysed 
by vigorous vortexing for 3 min. 200µl of 1xTE (10mM Tris-Cl pH8.0, 1mM EDTA) 
was added to the lysate and vortexed briefly. The cell lysate was centrifuged at 12, 000xg 
for 5 min and the resultant aqueous phase was transferred to a fresh tube. DNA was 
precipitated by 1ml of 100% ethanol and pelleted down by centrifugation at 12,000xg for 
3 min. DNA was dried properly and dissolved in 200µl of 1xTE buffer.   
 
2.2 Protein expression, purification and production of antibody 
2.2.1 Protein expression in E.coli and purification by affinity chromatography   
Expression plasmid was transformed into BL21 E.coli strain by heat shock.  A single 
colony was cultured in 100 ml of LB supplemented with 100µg/ml amphicilin and grown 
at 37°C for 12-15 h in a shaking incubator. The cell culture was diluted in 1 liter of fresh 
medium and grown for 1 h (optimal cell density was O.D600 of 0.5-0.6). Protein 
expression was induced by IPTG (isopropyl-beta-D-thiogalactopyranoside) at a final 
concentration of 0.2mM for 4 hours.  After induction, cells were spun down by 
centrifugation at 6000xg, 4°C for 15 min. Cells were washed once with 500 ml of ice-
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cold water and pelleted down. The cell pellet was then resuspended in 20 ml of ice-cold 
(1ml/1g wet cells) phosphate buffered saline (1xPBS, pH 7.3) supplemented with 1mM 
PMSF, 10mM DTT, and 10mM MgCl2. The cell suspension was sonicated with a 5mm 
probe on ice until a change in color from a rich straw brown to a dull gray brown was 
observed (sonication setting: 10s pulse-on, 10s pulse-off, at intensity of 3-4). The lysate 
was adjusted with 10%Triton X-100 to 1% and incubated on ice for 10 min. Cell debris 
was removed by centrifugation at 10,000x g, at 4 °C for 30 min. The resultant clear 
supernatant was incubated with 1 ml of 50% slurry of glutathione-agarose beads for 2 
hours at 4 °C. Beads were then pelleted down by brief centrifugation (1000xg for 1 min) 
and washed 5 times with 50 ml of ice-cold 1xPBS. Fusion protein was eluted with 200ul 
of elution buffer (50mM Tris.Cl pH 8.0, 10mM reduced glutathione) 5 times. The purity 
of protein was estimated by SDS-PAGE and coomassie brilliant blue staining. Usually, 
yields were ~5mg/liter and >90% pure.  
2.2.2 Production of antibody: GST-Osh6p fusion protein was mass-produced in BL21 
Ecoli, and affinity-purified. The purified protein was cleaved by thrombin and separated 
by SDS-PAGE. A predominant coomassie-stained gel band corresponding to 50kDa was 
excised and homogenized in 200µl of 1xPBS by passing through a needle a few times. 
The gel slurry was then mixed   well with Freund’s adjuvant (for first injection, complete 
adjuvant, and incomplete for following injections was used) and injected into the 
subcutaneous of a New Zealand white rabbit. Pre-immune bleed was required before 
immunization as a control. 0.2mg of antigen was required for first immunization and 
0.1mg for following boosts once every month. Blood was withdrawn and incubated 
standing at room temperature for 4 hours. The blood sample was then incubated at 4°C 
 56
overnight allowing clot to form and retract. The serum was transferred to a fresh tube and 
centrifuged at 2700 x g, 4°C for 10 min resulting in crude anti-serum. The antibody titer 
and specificity were tested by immunoblotting against yeast proteins from wild type and 
gene knockout cells.     
 
2.3 Fluorescence microscopy 
2.3.1 FM4-64 staining: This was done according to a method previously described by 
Vida (Vida and Emr, 1995). 10ml of cells at O.D600=0.2 were incubated with FM4-64 at a 
final concentration of 1.2µg/ml at 15°C for 20min for preliminary labeling. Excess stain 
was removed by washing with 10 ml of ice-cold labeling medium. Cells were then re-
suspended in 5 ml of pre-warmed fresh labeling medium and incubated at 30°C with 
timing started immediately. 1ml cell culture was removed at 0, 5, 10 and 30 min time 
point and endocytosis was stopped by addition of ice-cold NaF/NaN3 to a final 
concentration of 12mM. All samples were thoroughly washed with ice-cold wash buffer 
(1xPBS containing 10mM NaF/NaN3) thrice. FM4-64 images were visualized using a 
Leica fluorescence microscope via a Texas Red filter.  
2.3.2 Lucifer yellow staining: LY labeling in live cells was performed according to a 
method of Yeo et al (Yeo et al., 2003). 1ml of cell culture at O.D600=0.2 was harvested by 
brief centrifugation at 1000xg. The cell pellet was resuspended in 90µl of fresh medium. 
The lid of the microfuge tube was punctured several times. 10 µl of Lucifer yellow was 
added to the cell suspension and incubated at 30°C with occasional flicking for aeration 
for 1 hour. 1ml of ice-cold wash buffer (1xPBS containing 10mM NaF/NaN3) was added 
to the sample and cells were spun down at 4°C by gentle centrifugation. Cells were 
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washed thrice with 1ml of ice-cold wash buffer, and then Lucifer yellow staining was 
viewed using a Leica fluorescence microscope via an E4 filter. 
 2.3.3 GFP imaging: GFP fusion proteins in live cells were visualized using a 
fluorescence microscope according to method described by Levine and Munro (2001). 
Briefly, log-phase culture (OD600=0.8) was collected by brief centrifugation at 1000xg for 
1 min. Cells were mounted on glass slide and visualized with a Leica fluorescence 
microscope via a GFP filter.  
2.3.4 Filipin staining:  Filipin staining was performed according to a protocol of Beh et 
al (2004). Cells were grown to log-phase equivalent to O.D600=0.7-0.8 at 24 or 30 °C. For 
temperature sensitive strain, cells were further incubated at 37 °C for one hour.1ml of 
cells was harvested by brief centrifugation at 1000xg for 1 min. The resultant cell pellet 
was resuspended in 1 ml of fixation solution (1x PBS, 3.7% formaldehyde) and incubated 
at room temperature for 20 min. Cells were washed with 1 ml of 1xPBS thrice and 
resuspended in 1 ml of staining solution (1xPBS, 20µg/ml filipin). Cells were stained at 
room temperature for 15 min. Cells were pelleted down and resuspended in 50µl of 
1xPBS. Filipin staining pattern was observed using a Leica fluorescence microscope via a 
special filter.    
2.3.5 DAPI staining:  DAPI staining was performed according to the method of Zhang et 
al (2003). Cells were grown to mid log phase (O.D600=0.5-0.8) at 30 °C and harvested by 
brief centrifugation. Cells were washed once with 1xPBS and then fixed with 
formaldehyde at a final concentration of 3.7% for 30 min at 30°C. (For temperature 
sensitive strain, cells were incubated at 37 °C for 1 h before fixation). Fixed cells were 
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washed once with 1xPBS containing 1% Nonidet P-40 and twice with 1xPBS, and then 
stained with DAPI at a final concentration of 2.5µg/ ml for 5 min. 
2.3.6 Nile Red staining: Nile red staining was done following the method of Greenspan 
et al (1985) with minor modification. Cells were grown to mid log phase (O.D600=0.5-
0.8) or stationary phase (O.D600=4-6 depending on the culturing medium) at 30 °C and 1 
ml of cells was harvested by brief centrifugation. Cells were washed twice with 1xPBS 
and resuspended in 1 ml of staining solution (1xPBS, 1µg/ ml Nile Red). Nile Red 
staining pattern was visualized using a Leica DMLB fluorescence microscope via a Texas 
Red filter. 
      
2.4 Lipid assay  
2.4.1 Analysis of ergosterol by GC-MS: Sterol lipids were extracted using a method of 
Beh et al (2001). For triplicate analysis of a same culture, 150ml of exponentially 
growing yeast (O.D6OO =0.5-0.8) cells were split into 3 equal volumes and harvested by 
brief centrifugation (2 ml was removed for dry weight). Cells were washed once with 
50ml of distilled water and spun down by brief centrifugation. The pellets were re-
suspended in 1.25 ml of 0.1M HCl and boiled for 20 min. Cells were washed twice with 5 
ml of distilled water and then re-suspended in 0.5ml of 67% methanol. 200µl of glass 
beads were added to the suspension and vortexed twice for 3 min each. For total sterol 
analysis (free and esterified), 1.25 ml of methanol and 0.63 ml of 60% KOH were added 
to the slurry (after vortexing) and water-bathed at 70°C for 90min. Sterols were extracted 
with 2 ml of hexane four times. 30µg of cholesterol was added to the hexane extracts and 
mixed well. The hexane extracts were blown dry under a stream of N2. Dried lipids were 
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dissolved in 200µl of chloroform: methanol (2:1). Ergosterol was identified and 
quantified by GC-MS (gas chromatography-mass spectroscopy).  
2.4.2 Sterol esterification: Sterol esterification was measured by incorporation of [3H]-
oleic acid into sterol esters following a method of Yang et al (1996). 10ml of cells at 
O.D600=0.7-0.8 were pulsed with 1µl of [3H]-oleic acid (5.0mCi/ml, Amersham) in 
taloxapol/ethanol for 0.5-1 hour at 30°C. The cell culture was adjusted with 0.5M NaN3 
to a final concentration of 20mM and then chilled on ice. Cells were spun down and 
washed twice with 5ml of wash buffer (0.5% NP-40, 20mM NaN3). Cells were then 
resuspended in 1.5ml water and split into 3 aliquots and spun down again. The cell pellets 
were lyophilized overnight and weighed. Dried cells were resuspended in 50µl of lysis 
buffer (1700U/ml lyticase, 10% glycerol, and 0.02% sodium azide) and incubated at 
37°C for 15 min. The cell suspension was frozen at -70 °C for 1 hour and then thawed at 
37°C for 15min. As an internal standard, 0.1µl of [14C]-cholesterol (0.1mCi/ml, 
Amersham) in 200µl isopropanol was added and incubated for 30 min. 5ml of hexane and 
KCl/methanol (2M KCl: methanol=2:1) were sequentially added and mixed properly. 
The hexane phase containing lipids was collected by centrifugation and blow-dried under 
a nitrogen stream. Dried lipids were dissolved in 100µl of chloroform: methanol (2:1) 
and separated by TLC (thin layer chromatography). Sterol esters and TAG were finally 
quantified with a Beckman scintillation counter. 
2.4.3 Measurement of the rate of sterol biosynthesis: Sterol biosynthesis rate was 
determined by incorporation of [14C]-acetate (1.0mCi/ml, PerkinElmer, MA, USA) into 
fatty acids and sterols, and calculated as the ratio of sterols to fatty acids (Yang et al., 
1996).  3ml of cells at O.D600=2 was pulsed with 10µCi of [14C]-acetate for 3 hours at 30 
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°C. Cells were then spun down and washed with 4 ml water twice. The cell pellet was 
resuspended in 0.5ml of 0.1M HCl and incubated at 95 °C for 20 min. Cells were washed 
with water and resuspended in 100 µl of 67% methanol. Cells were lysed with 100µl of 
acid-washed glass beads by vigorous vortexing. 1ml of methanol and 0.5 ml of 60% (wt/v) 
KOH were added to the slurry, which was then incubated at 70 °C for 2 hours. Sterol 
lipids were extracted with 2ml of hexane thrice. The remainder was acidified with 1ml of 
37% HCl, from which fatty acids were extracted with 2ml of hexane thrice. All hexane 
extracts were blow-dried under a nitrogen stream and dried lipid extracts were dissolved 
in 200µl of chloroform: methanol (2:1). Sterols and fatty acids were separated by TLC 
and quantified with a scintillation counter.  
2.4.4 TLC chromatography  
1) Principles of TLC:  A TLC (thin layer chromatography) plate is a sheet of glass, metal, 
or plastic, which is coated with a thin layer of a solid adsorbent (usually silica or 
alumina). A small amount of lipid mixture to be analyzed is spotted near the bottom of 
this plate. The TLC plate is then placed in a shallow pool of a solvent in a developing 
chamber so that only the very bottom of the plate is in the liquid. This liquid, or the 
solvent, is the mobile phase, and it slowly rises up along the TLC plate by capillary 
action. The interaction strength between an organic compound and the TLC plate 
depends on the strength of the following types of interactions: ion-dipole, dipole-dipole, 
hydrogen bonding, dipole induced dipole, and van der Waals forces. With silica gel, the 
dominant interactive forces between the adsorbent and the materials to be separated are 
of the dipole-dipole type. Highly polar molecules interact fairly strongly with the polar 
Si—O bonds of these adsorbents and will tend to stick or adsorb onto the fine particles of 
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the adsorbent while weakly polar molecules are held less tightly. Weakly polar molecules 
thus generally tend to move through the adsorbent more rapidly than the polar species.  
2) Procedures of TLC:  A TLC plate was streaked with a metal comb into 17 sample 
lanes. 100µl of lipid sample was loaded on the TLC plate automatically using a spotter. In 
a sealed TLC glass chamber, solvent (69% hexane, 30% diethyl ester, 1% glacial acetic 
acid) was added and equilibrated. The TLC plate was placed in the chamber until the 
solvent reached about 3 cm away from its top end. The TLC plate was air-dried and then 
developed in an iodine chamber. The desired lipid spots were excised and incubated with 
4 ml of scintillation solution overnight. Lipids were quantified using a Beckman 
scintillation counter.   
    
 2.5 Biochemical assay 
2.5.1 Extraction of yeast total proteins  
1) Osmotic lysis of cells: Cells were grown to midlog phase at 30 °C with vigorous 
shaking. Cells were harvested by centrifugation at 1500xg for 5 min at 4 °C. The cell 
pellet was weighed in grams (equivalent to packed cell volume in milliliters) and 
resuspended in 3 volumes of ice-cold water and immediately centrifuged at 1500xg for 5 
min. The pellet was resuspended in 1 volume of lysis buffer A (50mM Tris.HCl pH8.0, 
1% 2-mercaptoethanol). The cell suspension was then incubated at 30°C for 10min. Cells 
were spun down and then spheraplasted with 1 volume of lysis buffer B (1.2M sorbitol, 
50mM KH2PO4 pH7.5, 1mM MgCl2 and 0.15mg/ml 20T zymolase) by incubation at 
30°C for 40min. Spheroplasts were washed once with 1 volume of 1.2M sorbitol and then 
osmotically lysed in ice cold lysis buffer C (50mM Tris.HCl pH7.5, 1mM EDTA, 0.2M 
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sorbitol) containing protease inhibitor (100X contained 200µg/ml aprotinin, 100 µg/ml 
pepstatin A, 50 µg/ml leupeptin, 10 mM benzamidine, 100mM PMSF) with 15-20 strokes 
of a tight-fitting pestle in a Dounce homogenizer. The lysate was lastly cleared at 500xg 
for 5min to remove cell debris. Total proteins were determined by Bradford protein 
quantification method and mixed with 6 x SDS sample buffer (12% SDS, 0.12mg/ml 
bromphenol blue, 0.093g/ml DTT, 30% glycerol, 0.35M Tris.Cl pH 6.8).   
2) Cell disruption using glass beads:  Cells were grown to midlog phase at 30 °C with 
vigorous shaking. Cells were harvested by centrifugation at 1500xg for 5 min at 4 °C. 
The cell pellet was weighed in grams (equivalent to packed cell volume in milliliters) and 
resuspended in 3 volumes of ice-cold water and immediately centrifuged at 1500xg for 5 
min. Cell pellet was resuspended in 3 volumes of ice-cold glass bead disruption buffer 
(20mM Tris.Cl pH 7.9, 10mM MgCl2, 1mM EDTA, 5% glycerol, 1mM DTT, 0.3mM 
ammonium sulphate, 2µg/ml aprotinin, 1 µg/ml pepstatin A, 0.5 µg/ml leupeptin, 0.1mM 
benzamidine, 1mM DTT, 1 mM PMSF). Cells were disrupted with 4 volumes of glass 
beads by a bead-beater at high-speed pulse for 30 seconds thrice. 2 volumes of glass bead 
buffer were added and cell lysate was separated from beads by centrifugation. Lysate was 
cleared at 500 x g, 4 °C for 10 min to remove cell debris.  Total proteins were determined 
by Bradford protein quantification method and mixed with 6 x SDS sample buffer (12% 
SDS, 0.12mg/ml bromphenol blue, 0.093g/ml DTT, 30% glycerol, 0.35M Tris.Cl pH 
6.8).   
2.5.2 Differential centrifugation: Different organelles with different sizes can be 
separated by centrifugation according to their sedimentation speed. Organelles and 
particles of the same size will settle out into the same layers. In this study, this 
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experiment was performed following that described by Gaynor et al (1994). Briefly, 10 
O.D600 units of cells were harvested by brief centrifugation at 1500 x g for 5 min at 4 °C 
and washed with 1 ml of ice-cold water once. The cell pellet was resuspended in 1 ml of 
lysis buffer A (50mM Tris.HCl pH8.0, 1% 2-mercaptoethanol). The cell suspension was 
incubated at 30°C for 10min. Cells were then spheraplasted with 1 ml of lysis buffer B 
(1.2M sorbitol, 50mM KH2PO4 pH7.5, 1mM MgCl2 and 0.15mg/ml 20T zymolase) by 
incubation at 30°C for 40min. Spheroplasts were washed once with 1 ml of 1.2M sorbitol 
and then osmotically lysed in 1 ml of ice cold lysis buffer (50mM Tris.HCl pH7.5, 1mM 
EDTA, 0.2M sorbitol) containing protease inhibitor (100X contained 200µg/ml aprotinin, 
100 µg/ml pepstatin A, 50 µg/ml leupeptin, 10 mM benzamidine, 100mM PMSF) . The 
lysate was cleared at 500xg, 4°C for 5min resulting in supernatant S5. S5 was then 
subjected to centrifugation at 13,000xg, 4°C for 15min resulting in supernatant S13 and 
pellet P13. S13 was centrifuged at 100,000xg, 4°C for 45min to produce pellet P100 and 
supernatant S100. Proteins in S100 were trichloride acetic acid (TCA)-precipitated at a 
final concentration of 10% by incubation on ice for 30 min. Protein precipitates were 
spun down by centrifugation at 12,000xg, 4°C for 30 min. All pellets were dissolved in 
appropriate volume of SDS-PAGE sample buffer (5%SDS, 40mM Tris.HCl pH6.8, 
0.1mM EDTA, 0.4mg/ml bromphenol blue, 10%2-mercaptoethanol) containing 8 M urea 
and resolved by SDS-PAGE.  
2.5.3 Sucrose density gradient centrifugation: This method is able to separate different 
membranes with different density on a density gradient upon high speed centrifugation.  
Membranes with the same density regardless of size will equilibrate in the sucrose zone 
that has same density as itself. In this study, density gradient centrifugation was adapted 
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from a method previously described (Kolling and Hollenberg, 1994). A sucrose linear 
gradient (20-50%w/w) was used to separate different membranes. Briefly, cells were 
lysed with a bead beater in STED10 (10% sucrose w/w in 10mM Tris.HCl pH7.6, 1mM 
EDTA, 10mM Tris.HCl pH7.6, 2µg/ml aprotinin, 1 µg/ml pepstatin A, 0.5 µg/ml 
leupeptin, 0.1mM benzamidine, 1mM DTT, 1 mM PMSF). The lysate was cleared at 
300xg for 10min. The gradient was prepared as following: 3.8ml of each STED 50, 30, 
20 (53%, 35%, 20% w/w sucrose, 10mM Tris.HCl pH7.6, 1mM EDTA, 2µg/ml 
aprotinin, 1 µg/ml pepstatin A, 0.5 µg/ml leupeptin, 0.1mM benzamidine, 1mM DTT) 
were loaded onto an ultracentrifuge tube from bottom to top sequentially and the gradient 
was put horizontally allowing diffusion for 3-5hr. The cleared lysate was loaded onto the 
top of the gradient and then centrifuged at 100,000xg for 14-16hr. 13 equal volumes of 
fractions were collected from top to bottom and analyzed by Western blotting.  
2.5.4 Membrane extraction: was performed according to a formerly described method 
(Horazdovsky and Emr, 1993) with modification. 50 O.D600 units of log-phase cells were 
lysed as described in 2.5.2. Cleared lysate was split into 6 aliquots and centrifuged at 
100,000x g, 4 °C for 45 min. The resultant supernatants were discarded and the pellets 
were resuspended in 200µl of ice-cold 1%TritonX-100, 6 M urea, 0.1M Na2CO3 pH11, 
1M NaCl, or lysis buffer (50mM Tris.HCl pH7.5, 1mM EDTA, 0.2M sorbitol) (mock) 
respectively. The samples were incubated on ice for 30min and then centrifuged at 100, 
000xg, 4 °C for 30 min resulting in S (supernatants) and P (pellets). Proteins in the 
supernatants were TCA-precipitated. All samples were dissolved in 100µl of sample 
buffer (5%SDS, 40mM Tris.HCl pH6.8, 0.1mM EDTA, 0.4mg/ml bromphenol blue, 10% 
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2-mercaptoethanol, 8 M urea) and resolved on 10% SDS-PAGE and analyzed by Western 
blotting.  
2.5.5 Membrane floatation: According to a method described earlier (Horazdovsky and 
Emr, 1993),  P13 or P13+P100 pellets were re-suspended in 2.5ml 60%w/w sucrose 
solution in lysis buffer (50mM Tris.HCl pH7.5, 1mM EDTA, 0.2M sorbitol ) and 
transferred to an ultracentrifuge tube, then over-laden with 2.5ml 35%w/w sucrose 
solution. The gradient was centrifuged at 170,000xg for 18h. 2.6 ml (F-floated fraction) 
and 2.4 ml (N-non-floated fraction) of sucrose solution were collected from the top of the 
gradient to the bottom and proteins were precipitated by addition of TCA to a final 
concentration of 10%. Precipitated proteins were dissolved in SDS-PAGE /urea sample 
buffer. The pellet (P fraction) in the bottom of the centrifuge tube was dissolved in a 
same volume of sample buffer.  
2.5.6 Pulse-chase radiolabeling and immuno-precipitation: CPY maturation 
experiment was done according to that of Yeo’s et al (2003) with modification.  
20O.D6OO units of overnight cell culture in SCYE (SC containing 0.2% yeast extract and 
necessary supplements according to strain genotype) was harvested by centrifugation at 
1000xg for 5 min and washed with 50ml of SC containing necessary supplements. Cells 
were resuspended in 2.5ml labeling mix (SC containing necessary supplements and 
2mg/ml BSA bovine serum albumin) and incubated at 30°C for 10 min. 50µl of 35S-
methionine/cystein (7.9mCi/ml PerkinElmer MA USA) was added to sample, mixed and 
incubated for 5min. 50µl of 50x chase solution (0.1M Na2SO4, 1mg/ml cystein, 1mg/ml 
methionine) was then added, and 0.5ml of sample was transferred out immediately to a 
microfuge tube containing 50µl of stop solution (0.2M NaF and NaN3) on ice (labeled 
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0min). Subsequently, at the time of 5, 10, and 30 min, same amount of sample was 
removed and treated with stop solution as previously. All the tubes were centrifuged at 
6000rpm at 4°C for 3 min in a microfuge. The resultant supernatants were cleared again 
to remove residual cells and the cleared supernatants were transferred to fresh tubes 
labeled ‘medium’. The resultant cell pellets were resuspended in 0.15 ml of freshly-
prepared lysis buffer (1.4 M sorbitol, 50mM Trs.Cl pH7.5, 20mM β-mercaptoethanol, 
2mM MgCl2, 20mM NaF, and 20mM NaN3) and incubated at 30°C standing for 45 min 
allowing cells to be spheroplasted. Spheroplasts were pelleted down by centrifugation at 
6000rpm at 4°C for 3 min resulting in supernatants ‘periplasm’ and pellets ‘spheroplast’. 
The ‘periplasm’ samples were cleared at 6000rpm at 4°C for 3 min once to remove 
residual cells. 5µl of 100xPI mix (50mM PMSF, 100µg/ml leupeptin, 100µg/ml 
pepstatin, dissolved in DMSO), and then 0.5ml of boiling 1% SDS were added to 
‘spheroplast’ samples and mixed by pipetting up and down several times. To the 
‘medium’/ ‘periplasm’ samples, 5/1.5µl of 100xPI mix and 50/15µl of boiling 10% SDS 
were added. All samples were heated at 95°C for 4 min and then centrifuged at 6000rpm 
at 4°C for 10 min to remove debris. The resultant supernatants from ‘spheroplast’ were 
transferred to 15ml Iwaki tubes and labeled ‘intracellular’. The supernatants resulting 
from ‘periplasm’ and ‘medium’ were combined as ‘extracellular’. 7.5ml of TNET 
(100mM Tris.Cl pH8.0, 100mM NaCl, 5mM EDTA pH8.0, 1% Triton X-100) and 15µl 
of anti-CPY antibody were added to all samples. Samples were incubated at room 
temperature for 3 hours or 4 °C overnight with gentle rocking. 50µl of 30% protein A 
sepharose slurry pre-soaked in TNET was added followed by 1 hour-incubation at room 
temperature. The beads were washed thrice with 10ml, 1ml, 1ml of TNET, and once with 
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1ml of 20mM Tris.Cl pH7.5.  Bound proteins were eluted with 200µl 2xLaemmli sample 
buffer (125mM Tris.Cl pH6.8, 20% glycerol, 4% SDS, 0.02% bromphenol blue, 4% β-
mercaptoethanol) by heating at 95°C for 3 min. Samples were centrifuged at 13,000rpm, 
room temperature for 1 min. The resultant supernatants were transferred to fresh 
microfuge tubes. 100µl of samples were resolved on 7.5% SDS-PAGE gel. The gel was 
immersed in de-staining solution (methanol: glacial acetic acid: water=4.5: 1: 4.5 by 
volume) overnight at room temperature and then washed with distill water for 30 min 
thrice. The gel was dried using a gel drier and lastly exposed to X-ray sensitive film at -
70°C for two weeks or longer.  
2.5.7 GST pull-down:  Because of the ease of expression and purification of GST fusion 
proteins, GST fusion and its interacting proteins can be easily co-purified. New 
interactors can be identified either by immunoblotting, MALDI-TOF MS or protein 
sequencing. In this study, in vitro GST pull down was done according to a method of 
Darsow et al (2001) with modification. In brief, GST fusion proteins were expressed in 
E.coli BL21 and purified by affinity chromatography using GSH (glutathione) beads 
(Amersham). The purified GST fusion proteins were visualized by coommasie staining 
on a SDS-PAGE gel. Yeast lysate was prepared from Y10000 strain bearing YCpVPS4-
MYC. Cells were lysed with a bead beater in yeast extraction buffer (0.2M sorbitol, 
20mM HEPES pH7.5, 1mM EDTA, 10mM MgCl2, 0.1M K-Acetate, 1mM DTT, plus 
protease inhibitor). 10% TritonX-100 was added to the lysate at a final concentration of 
1% and incubated on ice for 10min; the lysate was then cleared at 100,000xg for 0.5h. 
GST fusion protein-bound beads were mixed with cleared yeast lysate. After incubation 
for 2hr at room temperature, the beads were washed thrice respectively with ice-cold 
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yeast extraction buffer, yeast extraction buffer containing 0.3M NaCl, and 1xPBS 
containing 1%Triton X-100. Bound proteins were then eluted with SDS-PAGE sample 
buffer (bound) by heating at 95°C for 3min. Proteins in the supernatant (unbound) were 
TCA-precipitated and dissolved in SDS-PAGE sample buffers with 8M urea. All samples 
were resolved by SDS-PAGE and Western blotting was performed using anti-Myc 
antibody.  
2.5.8 SDS-PAGE electrophoresis: Separation of proteins by SDS-PAGE is based on the 
molecular size of proteins regardless of protein charges because excess SDS binds 
proteins and renders all proteins negatively charged. In an electric field, small proteins 
will run faster towards plus pole than large ones on the gel.  In this study, 10% and 8% 
gels were most frequently used. Preparation of gels was as follows: Resolving gel 
components were assembled and loaded in the gel cassette. When resolving gel 
polymerized, stacking gel was loaded with a comb inserted. 10-40 µl of protein sample 
was loaded in gel wells and run at 150V for 1.5 to 2 h. 1x SDS-PAGE running buffer 
consisted of 1% SDS, 14.4g/liter glycine, and 3.02g/liter Tris base.  After electrophoresis, 
the gel was either soaked in transfer buffer for Western blotting or staining buffer for 










Table 2.3 components of a SDS-PAGE gel   
Reagents 10% resolving 
gel  
8% resolving gel Stacking gel 
30% acrylmide  
0.8% bisacrylmmide  
3.3 ml 2.7 ml 0.26 ml 
1.5M Tris.Cl pH 8.8 2.5 ml 2.5 ml X 
0.5 M Tris.Cl pH 6.7 X X 0.5 ml 
10% SDS 100 µl 100 µl 20 µl 
Water 4.05 ml 4.65 ml 1.22 ml 
10% ammonium 
persulphate 
50 µl 50 µl 10 µl 
TEMED 5 µl 5 µl 2 µl 
  
                 
2.5.9 Western blotting: Protein gel, one piece of cut-to-size of nitrocellulose membrane 
and two pieces of cut-to-size thick filter paper were soaked in ice-cold transfer buffer 
(25mM Tris base, 192mM glycine, 20% methanol) for 30 min. The gel was placed in 
close contact with membrane and sandwiched by filter papers. Proteins were transferred 
down to the membrane on a BioRad semi-dry transfer machine at 22V for 60-70 min. 
After transfer, the membrane (referred to as the blot thereafter) was incubated with 
blocking buffer (5% skim milk, 20 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween 20, and 
0.02% sodium azide) for 1 h at room temperature or 4 °C overnight. The following steps 
were performed at room temperature unless specified. The blot was washed with 3 
changes of TTBS (20 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween 20) over 30 min 
with shaking and then incubated with primary antibody (1:300-1:5000, in TTBS). The 
blot was washed again with 3 changes of TTBS over 30 min with shaking and then 
incubated with secondary antibody goat anti-mouse/rabbit HRP conjugate at dilution of 
1:5000 for 1 h. The blot was lastly washed with 6 changes of TTBS over 1 h and then 
rinsed with distilled water. The blot was incubated with substrate solution (mix of equal 
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volume of enhancer solution and substrate, Amersham products) for 5 min. The blot was 
exposed to chemiluminescent film and image was acquired with a Kodak film processor.    
      
2.6 Protein lipid overlay assay  
The principle of PLO is very similar to that of immunoblotting. Lipids are immobilized 
on a nitrocellulose membrane and then incubated with GST fusion proteins. If the protein 
can bind certain lipids, it is also immobilized on the membrane. The bound protein can 
then be detected by immunoblotting.     
   In this study, PLO assay was carried out following a method of Dowler et al (2000). 
GST fusion proteins were expressed in E.coli and purified by affinity chromatography. 
Proteins were eluted with elution buffer (50mM Tris.HCl pH8.0, 5mM reduced form 
glutathione). PIP strips containing 100pmol of desired lipids were purchased from 
Echelon Research Laboratories, USA. PIP strips were blocked in blocking solution (3% 
w/v fatty acid free BSA in TBST [50mM Tris.HCl, pH7.5, 150mM NaCl and 0.1% v/v 
Tween-20]) at room temperature for 2 hr. PIP strips were then incubated with GST fusion 
proteins at a concentration of 30nM for 2hr at room temperature. After wash with 6 
changes of TBST over 0.5hr, the PIP strips were incubated with anti-GST monoclonal 
antibody (1:3000) for 1hr, washed again as previously, and then incubated with mouse 
anti-IgG horseradish peroxidase conjugate (1:4000) for 1hr. The PIP strips were finally 
washed with 12 changes of TBST over 1hr. Protein-bound lipid ligands were determined 





2.7.1 Principles of yeast two-hybrid: Yeast two-hybrid was developed by Fields and 
Song (1989). Briefly, two plasmids are constructed; one encoding protein X fused in-
frame with the DNA-binding domain (BD) of a transcription factor such as GAL4, the 
second encoding protein Y fused in-frame with a transcription activation domain (AD). 
The plasmids are co-transformed into a suitable yeast strain where the fusion proteins are 
expressed. Interaction between proteins X and Y reconstitutes an active transcription 
factor which specifically binds to elements upstream of the reporter genes and activates 
their expression. See Figure 2.4  
 
                 
Figure 2.4 Principles of yeast two hybrid assay. 
 
2.7.2 X-gal plate assay: For GAL4 system, pAS2-1 (GAL4BD, BD Biosciences)-based 
plasmids and pACT-2 (GAL4AD BD Biosciences)-based plasmids were transformed into 
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pJ69-4A (James et al., 1996) and grown on SC lacking leucine and tryptphan plates. 
Transformants were grown on SC-Leu-Trp plates containing 80µg/ml X-gal at 30 °C 
until desirable color developed. For LexA system, pLexA (B42 BD, BD Biosciences)-
based plasmids and p JG4-5 (B42AD, BD Biosciences)-based plasmids, together with the 
LacZ reporter plasmid PSH18-34, were transformed into EGY48 (BD Biosciences). 
Transformants were selected out on SC-Trp-Ura-His plates and grown on SC-Trp-Ura-
His-Leu plates containing 80µg/ml X-gal (negative control) or SC/Gal/Raf-Trp-Ura-His-
Leu plates containing 80µg/ml X-gal at 30 °C until desirable color developed. 
2.7.3 Liquid assay with ONPG: To quantify the β-galactosidase, a liquid culture assay 
using ONPG was performed (Yeo et al., 2003). Briefly, 1.5 ml of cell culture at O.D600 of 
0.5-0.8 was collected by brief centrifugation at 1500xg for 5 min. Cell were washed with 
1.5ml of Z-buffer (16.1g / L of Na2HPO4.7H2O, 5.5 g/L of NaH2PO4.H2O, 0.75g/L of 
KCl, 0.246g/L MgSO4.7H2O, pH7.0), and resuspended in 300µl of fresh Z buffer. Cells 
were lysed by 3 freeze-thaw cycles using liquid nitrogen. 0.7ml of Z buffer was then 
added to the lysate followed by addition of 160µl of ONPG (4mg/ml, pH7.0 in Z buffer) 
(timing started). The reaction tubes were incubated at 30°C until desired yellow color 
appeared. 0.4ml of 1M Na2CO3 was immediately added to the reaction tube to terminated 
color developing. The reaction tubes were centrifuged at 13,000xg for 10 min and 
supernatants were removed for measurement of O.D420. β-Galactosidase unit was 
calculated according to the formula: β-galactosidase units = 1000x O.D420 / (t x v x 
O.D600) where: t=elapsed time in min of incubation, v=0.1 ml x concentration factor (in 
this case 5), O.D600= A600 of 1ml of culture. 
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Table 2.4 Primers used in this study 
 
 
Name Primer sequence Remarks 
GSTOSH6 F: 5'-CGGGATCCGGCTCCAAAAAACTGACCGT-3'  BamH1 
R: 5'-CCGCTCGAGCTATTGTTTGCTGGGTTCTGC-3' XhoI 
pYEXOSH6 
pGEXOSH6 
OSH6GFP F: 5'-AACTGCAGTGCCAGATGAAGTTTTCGA-3'    Pst1 















OSH6OE F: 5'-CGAAGCTTATGGGCTCCAAAAAACTGA-3' HindIII 
R: 5'-AAGCGGCCGCCTATTGTTTTGCTGGGTTC-3'  Not1 
pADNSOSH6 
OSH6DB1 F:5'-CGGGATCCGTATGGGCTCCAAAAAACTGAC-3 BamH1 




F: 5'-CGGGATCCGTCAACCTCGTTCTTCACCA-3'  BamH1 




F: 5’-CGGAATTCCAACCTCGTTCTTCACCAA-3'   BamH1 















F: 5'-GCGAATTCATGGCTCCTAAATCTAGTTC-3’  EcoRI 





F: 5'-GCGAATTCGACAAGGAGATTGAATCA -3’  EcoRI 
R: 5'- GCGGATCCTTAGGGTCTGATATCAACCATG-3’ BamHI  
pLexA-AFG2-
A  251-500 
AFG2AD-
B 
F: 5'-GCGAATTCAGCGCAATGAGAGAAATCT -3’  EcoRI 





F: 5'- GCGAATTCAATACAGAAGAGTCTGGAG -3’  EcoRI 











F:5’-GCGAATTCGACAAAAAAGCCAATGATT-3’ EcoRI  





F:5’-GCGAATTCCATGGCTGGACCTCAGCC -3’ EcoRI  






























IR:5'-CAGATGACAAGCTTATGAC-3’     HindIII 















IR:5'-GGGAGCTGCAGCGGTCGAA-3’    PstI 
IIF:5'-TTCGACCGCTGCAGCTCCC-3’  PstI  
IIR:5'-GCGTCGACAAAAATGTCACCACAATCT-3’SalI 
pRS316OSH2-
GFP.    2 steps 
 75
         




Plasmid Description References 
YCp VPS4-MYC YCplac111, VPS4 promoter, VPS4-MYC                     Zahn et al., 2001 
YCpOSH4-GFP YCplac111-scGFP, OSH4 promoter, OSH4, GFP        This study   
YEpOSH6-GFP YEplac181-scGFP, OSH6 promoter, OSH6, GFP        This study 
pJGOSH6 pJG4-5,  LexAop AD, OSH6 (1-448/end)                      This study     
 pJGOSH6CC pJG4-5,  LexAop AD, OSH6 (240-448/end).                 This study   
pLexAVPS4 pLexA,  LexAop BD, VPS4,                                         Yeo et al., 2003 
pRS316VPS4 pRS316,  VPS4 promoter, VPS4,                                  This study   
pRS316VPS4m pRS316, VPS4 promoter,vps4E233Q  This study 
PSH18-34 PSH18-34, pGAL1, LexA op, LacZ                               BD Biosciences      
pGEX4T-1 GST, copper inducible promoter, AmpR                                  Amersham 
pYEX4T-1 Pcup1, GST, URA3, leu-2d, 2µ                                                             BD Biosciences 
YCplac111 CEN, LEU2                                                                   Longtine et al., 1998 
YCplac111-scGFP CEN, LEU2, GFP                                                         Yeo et al., 2003 
YEplac181-scGFP 2 µ, LEU2, GFP                                                             Yeo et al., 2003 
pAS2-1 GAL4opBD, TRP1                                                         BD Biosciences 
pACT2 GAL4opAD, LEU2                                                       BD Biosciences 
pLxA-AFG2-N pLexA,  LexAop BD, AFG2(1-250/end )                      This study 
pLxA-AFG2-A pLexA,  LexAop BD, AFG2(251-500/end)                   This study 
pLxA-AFG2-B pLexA,  LexAop BD, AFG2(500-700/end)                   This study 
pLxA-AFG2-C pLexA,  LexAop BD, AFG2(701-780/end)                   This study 
pJGOSH1-CC pJG4-5,  LexAop AD, OSH1(615-725/end)                   This study 
pJGOSH1-OB pJG4-5,  LexAop AD, OSH1(726-1000/end).                This study 
pJGOSH1-C pJG4-5,  LexAop AD, OSH1(1001-1188/end)               This study 
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Plasmid Description Reference 
pGEXOSH6 pGEX4T-1,GST-OSH6 (1-448/end)                                      This study 
pGEXOSH6CC pGEX4T-1, GST-OSH6 (301-448/end)                               This study    
pGEXOSH6OB pGEX4T-1,GST-OSH6(1-300/end)                                        This study 
pRS426OSH2-GFP pRS426, OSH2 promoter, OSH2, GFP  This study 
pRS426OSH3-GFP pRS426, OSH3 promoter, OSH3, GFP  This study 
pGEX-EEA1 pGEX303,GST-EEA1                                                                        Xu et al., 2001b 
YCpOSH6-GFP YCplac111-scGFP, OSH6 promoter, OSH6, GFP        This study 
YCpOSH7-GFP YCplac111-scGFP, OSH7 promoter, OSH7, GFP        This study 
pRS314OSH2-GFP pRS314, OSH2 promoter, OSH2, GFP  This study 
pRS316OSH3-GFP pRS316, OSH3 promoter, OSH3, GFP  This study 
YEpOSH1s-GFP YEplac181-scGFP, OSH1 promoter, 
OSH1(615-1188) 
This study 
pRS316-OSH6-GFP pRS316,OSH6 promoter, OSH6, GFP                          This study 
pASOSH6 pAS2-1, GAL4opBD, OSH6                                          This study 
pACTVPS4 pACT2, GAL4opAD, VPS4  This study 
pLexA LexAop BD, HIS3                                                          BD Biosciences 
pJG4-5   LexAop AD, TRP1                                                         BD Biosciences 
pRS314 CEN, TRP1                                                                  Sikorski et al.1989 
pRS316 CEN, URA3                                                                  Sikorski et al. 1989 
pRS426 2μ, URA3                                                                    Sikorski et al. 1989 
pLexAVPS4N pLexA,  LexAop BD, VPS4 N (1-128)         Yeo et al., 2003 
pLexAVPS4AAA pLexA,  LexAop BD, VPS4 AAA (129-350)      Yeo et al., 2003 
YCpVPS4 YCplac111, VPS4  Zahn et al., 2001 
YCpvps4-ts YCplac111, vps4 M307T and L327S Babst et al., 1997 
YEp-POSH1-GFP YEplac181, OSH1 promoter, GFP This study 
pESC GAL1, GAL10 promoter, LEU2    Stratagene 
pESCOSH7CC pESC, GAL1 promoter, OSH7CC (366-437/end), LEU2      
pESCOSH7 pESC, GAL1 promoter, OSH7 (1-437/end), LEU2                
YEpOSH6(1-254)-
GFP 
YEplac181, OSH6 promoter, OSH6(1-254), GFP 
YEpOSH6(255-448)-
GFP 
YEplac181, OSH1 promoter, OSH6(255-448),      GFP 
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Strain name                         Genotype Ref. or source 
W303-1A  MATa, ade 2-1; ura3-1; his3-11, 15; trp1-1; leu2-3, 
112; can1-100 
Nunnari et al., 1997 
Y10000 BY4742 MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0 EUROSCARF 
afg2-ts W303-1A; afg2 L435S  Nunnari et al., 1997 
Y15074  BY4742 MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0; 
osh6∆::KanMX4 
EUROSCARF 
pJ69-4A MATa; trpl-901; leu2-3; 112; ura3-52; his3-200; 
ga14∆; ga18O∆; LYS2::GAL1-HIS3;  GAL2-ADE2 
met2::GAL7-lacZ 
James et. al., 1996  
EGY48 MATα; his3; trp1; ura3; 6LexAop-LEU2.   BD  Biosciences 
JRY6326 SEY6210; TRP1::PMET3-OSH2; osh1∆::kan-
MX4 ;osh2∆::kan-MX4; osh3∆::LYS2; osh4∆::HIS3; 
osh5∆::LEU2; osh6∆::LEU2; osh7∆::HIS3 
Beh et al, 2001 
Y15588             BY4742;  vps4∆::kanMX4 EUROSCARF 
Y0000 BY4741; MATa;  his3∆1;  leu2∆0;  lys2∆0; ura3∆0 EUROSCARF 
PHY01 W303α; afg2-18; scs2∆::HIS3 This study 
PHY02 W303α; scs2∆::HIS3 This study 
CBY351 SEY6210; osh1∆:: URA3;  osh2∆:: URA3;  osh3∆:: 
LYS2 
Beh et al., 2001 
CBY343 SEY6210; osh1∆:: URA3;  osh2∆:: URA3 Beh et al., 2001 
CBY315 SEY6210; osh2∆:: URA3;  osh3∆:: LYS2 Beh et al., 2001 
CBY189 SEY6210; osh1∆:: URA3; osh3∆:: LYS2 Beh et al., 2001 
CBY311 SEY6210; osh2∆:: URA3 Beh et al., 2001 
CBY194 SEY6210; osh1∆:: URA3 Beh et al., 2001 
CBY47 SEY6210; osh3∆:: LYS2 Beh et al., 2001 
SEY6210 MATα; ura3-52; his3∆200; trp1∆901; leu2-3, 112; 
suc2∆9; lys2-801 
Beh et al., 2001 
RH448 MATa; his4; leu2; ura3; bar1; lys2 Zahn et al., 2001 
RH2906 MATa; his4; leu2; ura3; bar1; lys2; vps4Δ:: URA3 Zahn et al., 2001 
BL21GOLD(DE3) F-ompT [lon] hsdSB (rB-mB-; an E. coli B strain) with 




DH5alpha F-, φ80dlacZ∆M15, endA1, recA1, hsdR17 (rk-,mk+), 





















Y14850 BY4742; MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0; 
YKL002w::kanMX4 
EUROSCARF 
Y14890 BY4742; MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0;  
YKL041w::kanMX4 
EUROSCARF 
Y13416 BY4742; MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0; 
YCL008c::kanMX4 
EUROSCARF 
Y15381 BY4742; MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0;  
YNR006w::kanMX4 
EUROSCARF 
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Part 1 Characterization of Osh6p 
 
1.1 Expression and purification of GST fusion proteins. 
GST fusion proteins were expressed in E.coli and purified using affinity 
chromatography. Compared with 6xHis tagged proteins, GST fusion proteins have better 
solubility which makes purification much easier, and active form of GST fusion proteins 
are obtainable without refolding processes. In the beginning, we tried with M15 strain but 
ended up with very low expression of fusion proteins though with high GST expression. 
Troubleshooting with all possible approaches didn’t improve protein production. We 
reasoned that the strain itself could be the reason. Indeed, fusion protein expression in 
BL21 was greatly improved (Figure 3.1).  GST had a calculated molecular weight of 
27.5kDa, but showed a molecular weight (Mw) of 30kDa on  
 
10% SDS-PAGE gels. Correspondingly, the fusion proteins GST-Osh6p (calculated Mw 
of 77.5kDa), GST-Osh6pOB (about 60.5kDa) and GST-Osh6pCC (about 44.5kDa) 
showed slightly larger Mw than expected. However, the net Mw of Osh6p, Osh6pOB and 
Osh6pCC on the gel were very close to the calculated values based on primary sequences. 
Figure 3.1Purification of GST 
fusion proteins. GST fusion 
proteins were expressed in 
E.coli and purified by affinity 
chromatography. Eluted 
proteins were separated by 
SDS-PAGE and stained with 
coomassie blue. 







The purified proteins in their active forms would be used for PLO assay and antibody 
production.   
  
1.2 Production of anti-Osh6p antiserum 
       
     In order to better understand the molecular function of Osh6p, we raised antibody 
against Osh6p. To immunize a rabbit, GST-Osh6p was expressed in BL21 E.coli and 
purified by affinity chromatography. GST tag was then removed by digestion with 
thrombin, and Osh6p antigen was injected into the rabbit subcutaneous. Antiserum was 
harvested and tested for specificity. To test the antibody with yeast extracts, equal 
amount of yeast proteins obtained from wild type (Y10000) and ∆osh6 (Y15074) were 
separated on a 10% SDS-PAGE gel and subjected to Western blotting. Figure 3.2 shows 
that a ~50 kDa band was observed in the cell extracts from wild type, which was absent 






Figure 3.2 Assessment of anti-Osh6p antiserum by Western blotting. Yeast proteins were obtained as 
described in Chapter 2 and separated by SDS-PAGE. Osh6p was detected using rabbit anti-Osh6p serum at 
1:300 dilutions. Dpm1p was used as internal loading controls. 
 
Although Osh7p shares almost 70% identity with Osh6p, the antibody raised did not 





mannosyltransferase)-an ER membrane protein (Heesen et al., 1994) was observed in 
both WT and ∆osh6 lanes with almost equal intensity.  
 
1.3 Osh6p is localized to cytosol and membranes  
1.3.1 Construction of Osh6p-GFP  
The observations that deletion of all OSHs was lethal and any OSH could restore cell 
viability suggest that OSHs play an essential overlapping function (Beh et al., 2001). So it 
is necessary to characterize the cellular location of these proteins in order to better 
understand their molecular function. In this study, we first used Osh6p-GFP fusion 
protein to investigate its location directly by fluorescence microscopy. The full-length 
encoding sequence of OSH6 (1347bp) with its native promoter was cloned into 
YCplac111 with GFP (green fluorescence protein) fused to its C-terminus. The 
expression of Osh6p-GFP driven by OSH6 promoter on a CEN plasmid YCplac111 was 
low.  
 
1.3.2 Osh6p-GFP localizes to both cytosol and membrane structures.  
  We continued to examine the localization of Osh6p using this GFP cassette. As a 
control, Osh4p-GFP was also investigated together. Direct examination of Osh6p and 
Osh4p-GFP using a Leica fluorescence microscope via a GFP filter revealed that Osh6p-
GFP mainly distributed in the cytosol as well as associated with a few small punctate / 
patch structures in the vicinity of the plasma membrane (Figure 3.4).  In contrast, Osh4p-
GFP was localized to the cytoplasm and a few large punctuate structures, a typical Golgi 
pattern (Li et al., 2001).  This suggested that a small pool of Osh6p-GFP localized to 
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membrane structures rather than the Golgi. As a negative control, GFP alone was 



















Figure 3.4 Fluorescence images of GFP, Osh6p, Osh7p and Osh4p-GFP expressed from the YCp111 
(CEN) vector. PlasmidsYCpPOSH1-GFP, YCpOSH6-GFP, YCpOSH7-GFP and YCpOSH4-GFP were 
transformed into Y10000 (wild type) cells, and cells were grown in SC-LEU medium to O.D600 of 0.8. 
Fluorescence images were acquired using a Leica DMLB fluorescence microscope via a GFP filter. Scale 








      In order to further address this issue, we performed a series of subcellular 
fractionation experiments. First, cellular components were roughly separated according to 
their sedimentation velocity by differential centrifugation. As shown in Figure 3.6, in 
addition to a large pool in S100, a small amount of Osh6p-GFP was found to associate 
with both P13 and P100 fractions. Membranes such as vacuole, endoplasmic reticulum 
(ER), plasma membrane (PM), and mitochondria associate with P13 predominately, 
while the Golgi membranes and the endosomal membranes are present in both P13 and 
P100 with varying ratio. Small transport vesicles associate with P100 fraction 
predominantly. As Figure 3.5 shows, membrane markers such as Gas1p (PM, Nuoffer et 
al., 1991), and Dpm1p (ER, Heesen et al., 1994) were found in P13; while Pep12p (late 
endosome. Becherer et al., 1996) and Tlg1p (late Golgi/early endosome, Nichols et al., 
1998; Coe et al., 1999) were present in both P13 and P100. Hexokinase, a soluble protein 
(van Tuinen and Riezman, 1987) was observed only in S100. Another soluble protein 
Osh7p was distributed predominantly in S100 with a minute pool associated with P100.  
The distribution patterns of fusion protein Osh6p-GFP and native protein Osh6p were 
similar to those of Tlg1p and Pep12p, indicating a possible colocalization.  
   Next we performed density gradient fractionation experiment, which is able to 
differentiate cellular membranes with unique density. Membranes with the same density 
will stay in the same sucrose gradient when subjected to ultracentrifugation regardless of 
membrane sizes and sedimentation velocity. As shown in Figure 3.6, Osh6p-GFP was 
distributed from F1 to F8; indicating Osh6p-GFP was not restricted to one membrane. 
However, two peaks were still resolved: F1-F3 representing cytosolic protein pool, and 
the F6-F8 representing dense membranes like early endosome (Tlg1p) and ER (Dpm1p). 
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However, this distribution peak of Osh6p-GFP significantly overlapped with those of 
almost all other membrane markers including mitochondrial (Porin), vacuolar (ALP), the 
Golgi (Vps10p) and late endosomal (Pep12p); thus we could not precisely localize Osh6p 
based on the result of sucrose gradient fractionation. In addition, a minute pool of Osh6p 
colocalized with the plasma membrane marker, Gas1p, corresponding to fraction 12 to 13.  
Taken together, our results suggested a pool of Osh6p was possibly localized to 













 Figure 3.5 Localization of Osh6p by differential centrifugation. Y10000 cells expressing GFP fusion 
proteins were lysed and cleared by centrifugation at low speed. The cleared lysate was centrifuged at 
13,000xg resulting in P13 (pellet fraction) and the resultant supernatant was further centrifuged at 
100,000xg resulting in P100 (pellet) and S100 (supernatant). Osh4p/Osh6p/Osh7p-GFP was detected using 
a rabbit anti-GFP antiserum.  Osh6/7p was detected using anti-Osh6/7p sera. 
 
 
























Figure 3.6 Localization of Osh6p by sucrose density gradient centrifugation. Wild type (Y10000) cells 
carrying YCpOSH6-GFP were lysed using a bead-beater and the cleared lysate was loaded onto the top of a 
continuous sucrose gradient ranging from 20-50% w/w. The gradient was centrifuged at 100,000xg for 14 h 
and 13 fractions were taken from the top to bottom. Proteins in the sucrose solution were separated on a 
10% SDS-PAGE gel and indicated proteins were detected by Western blotting. Osh6/7p-GFP was probed 







Figure3.7 Measurement of sucrose concentration. The sucrose concentration of each fraction was 
































1.4 Osh6p is a peripheral membrane protein 
   A possible integral membrane protein has at least one contiguous stretch of 19-20 
residues predicted to form α-helix with a hydrophilicity score of <-1.6 over the entire 
length (Kyte and Doolittle, 1982). Based on this criteria, Osh6p is unlikely a 
transmembrane protein. To investigate how Osh6p associated with membranes, we 
performed membrane extraction and membrane floatation experiments. As shown in 
Figure 3.8, when subjected to treatments with: 6M urea, 1% Triton, 1M NaCl and 0.1M 
Na2CO3 pH11, the Osh6p-GFP pool associated with P13 and P100 were solublized 
almost completely. Pep12p (trans-membrane protein, Becherer et al., 1996) was 
completely solublized by 1% Triton and partially solublized by 6M urea; but it was not 
affected by treatments with NaCl and Na2CO3, which are known as conditions to 
dissociate peripheral membrane proteins only (John et al., 1999). As a mock control, 
treatment with lysis buffer alone didn’t extracted Osh6p-GFP from membranes. Thus 






Figure 3.8 Osh6p-GFP is a peripheral membrane protein. The P13 + P100 pellets from wild type cells were 
treated with indicated reagents on ice and centrifuged  at 100,000xg again resulting in pellet (P) and 
supernatant (S). The proteins in the supernatant were TCA-precipitated and all protein samples were 
separated by SDS-PAGE. Osh6p-GFP was detected using a rabbit anti-GFP antiserum and Pep12p was 
probed using a mouse anti-Pep12p antibody.  
S     P     S     P     S     P     S    P      S     P




   Triton is able to disrupt non-raft membrane bi-layer structure and liberate membrane 
proteins at 4 °C (Munro, 2003). The observation that Osh6p-GFP was solublized by 1 % 
Triton on ice suggested Osh6p was not associated with membrane raft domains. Urea 
serves to disintegrate protein complexes and high concentration will also disrupt 
membranes. 6M urea was high enough to disrupt membranes on ice but not completely as 
seen for Pep12p which was only extracted from membranes partially. However, Osh6p-
GFP was almost completely solublized by 6M urea, implying that Osh6p-GFP associated 
with membranes via interaction with proteins or lipids.  
To further confirm that Osh6p-GFP was membrane associated, we did membrane 
floatation experiment (Figure 3.9). When subjected to ultracentrifugation, membranes 
migrate out of 60% sucrose and into 35% sucrose due to their intrinsic buoyant density 
(Walworth et al., 1989). Like Tlg1p, the Osh6p-GFP pool in the pellet fractions 
(P13+P100) exhibited ‘float-up’ property, which confirmed its membrane association 
nature. However, a minute pool was observed in the pellet (P) fraction, which might be 
stripped from membranes or associated with non-membranous cellular components. 
 
 
                              
 
Figure 3.9 Osh6p-GFP is membrane associated. The P13+P100 pellets were resuspended in 1ml of 60% 
sucrose, and overlaid with 2ml of 55% and 35% each. After ultracentrifugation, proteins in top 3 ml (F-
denotes floating fraction) and remaining 2ml (N-denotes non-floating fraction) of sucrose solution were 
TCA-precipitated and separated on a 10% SDS-PAGE gel. Indicated proteins were detected by Western 
blotting. Osh6p-GFP was probed using a rabbit anti-GFP antiserum. P denotes pellet.     





       In this part, we characterized the subcellular location of Osh6p using both 
biochemical and cell biological approaches and defined how Osh6p associated with 
membranes. Besides the major cytoplasmic pool, a small portion of Osh6p could be 
localized to endosomal membranes based on the following observations: 1, Osh6p-GFP 
was associated with punctuate and patch structures close to the plasma membrane. 2, 
Osh6p-GFP co-fractionated with endosomal markers like Pep12p and Tlg1p by sucrose 
gradient and differential centrifugation. Lastly, we showed that Osh6p was a peripheral 




Part 2 Functional Studies on Osh6p 
2.1 Osh6p is required for sterol homeostasis.  
     Osh proteins collectively play a critical role in maintaining sterol homeostasis. 
Deletion of each individual OSH was also shown to affect sterol level to certain extent 
(Beh et al., 2001). Moreover, accumulation of free sterols in intracellular compartments 
was observed in some osh mutants (Beh and Rine, 2004). Here we examined the role of 
Osh6p in maintaining sterol homeostasis. We first examined the steady-state ergosterol 
(yeast cholesterol) levels in both deletion and overexpression of OSH6 mutants. Before 
proceeding to sterol analysis, we checked the Osh6p levels in overexpression cells which 
expressed Osh6p from the ADH1 promoter on a 2µ plasmid. As shown in Figure 3.10, the 






Figure 3.10 Osh6p levels in overexpression cells. Yeast proteins were obtained as described in chapter II 
and separated by SDS-PAGE. Osh6p was detected using rabbit anti-Osh6p serum at 1:300 dilutions. 
VATPase60 was used as an internal loading control and probed with an anti-VATPase60 monoclonal 
antibody.  pADNS: yeast extracts from Y10000 cells harboring pADNS, pADNSOSH6: yeast extracts from 
Y10000 cells carrying pADNSOSH6. 
 
Then we examined the amount of yeast major sterol-ergosterol in both OSH6 deletion 





report (Beh et al., 2001), deletion of OSH6 caused an increase of total ergosterol by 
~80%. Introduction of OSH6-GFP expressed from a CEN plasmid into ∆osh6 corrected it 
back to wild type level. However, overexpression of Osh6p reduced ergosterol levels by 









                                                 
Figure 3.11 Analysis of steady-state ergosterol by GC-MS. Cells were grown in SC lacking leucine 
medium to midlog phase and freeze-dried. Cells were disrupted by vigorous vortex and sterol lipids were 
then saponified by potassium hydroxide, extracted by hexane, dried, and identified and quantified by 
GC-MS. X-axis represents ergosterol µg /mg dried cells, Y-axis indicates strains. WT vector: Y10000 cells 
transformed with YCplac111-scGFP; ∆osh6 vector: Y15074 cells transformed with YCplac111-scGFP; 
∆osh6 OSH6-GFP: Y15074 cells transformed with YCpOSH6-GFP. WT pADNS/ WT pADNSOSH6: 
Y10000 cells transformed with pADNS / pADNSOSH6. Data were obtained from two independent 
experiments (n=3).  
 
It is known that the plasma membrane has the majority of cholesterol. We would like 
to investigate that whether the plasma membrane cholesterol was reduced in 
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that binds directly to ergosterol in the cell membrane (Woods, 1971; Walker-Caprioglio 
et al., 1989).  Cells resistant to nystatin have less ergosterol on the cell surface. As shown 
in Figure 3.12, OSH6 overexpressing cells on the control medium (no nystatin) grew as 
well as vector control (lower panel). On nystatin-containing medium, though both 
overexpression and control cells grew much slower (upper panel) than that on the control 
medium, overexpression cells were more resistant to 1.0µg/ml nystatin than vector 
control (10 fold greater). These observations suggested the plasma membrane ergosterol 
was reduced upon overexpression of Osh6p.  
 







Figure 3.12 Cells overexpressing Osh6p are resistant to nystatin. Wild type cells (Y10000) carrying 
pADNS or pADNSOSH6 at midlog phase were serially diluted 10 fold and grown on SC lacking leucine 
solid medium with (upper panel) or without (lower panel) 1µg/ml nystatin at 30°C for 48 hours.  pADNS / 
pADNSOSH6 indicate Y10000 strains transformed with pADNS / pADNSOSH6 plasmids. 
 
   In order to elucidate how Osh6p affected sterol levels, we investigated the rate of sterol 
esterification and the rate of sterol biosynthesis in both ∆osh6 and overexpression strains. 







and the rate of sterol biosynthesis was determined by incorporation of 14C-acetate into 















Figure 3.13 Analysis of oleate incorporation into sterol esters and TAG (on the preceding page). A-B) 
sterol esterification was determined by incorporation of radiolabeled oleic acid into sterol esters and 
calculated as the value of count per minute per mg of dry cells. Cells were labeled with 3H-oleic acid for 1 
hr and excess label was then washed away with 0.5% NP-40. Lipids were extracted as described in Chapter 
II. Results were obtained from two independent experiments (n=4). Results with a p<0.05 (*) were 
considered statistically significant. X-axis denotes strain genotype; Y-axis represents count per minute per 
mg dry cells. WT: Y10000, ∆osh6: Y15074, pADNS / pADNS OSH6 indicates Y10000 strains transformed 












































































3H-labeled sterol esters in ∆osh6 and overexpression cells were slightly decreased (Figure 
3.13A), while TAG biosynthesis was not significantly affected (Figure 3.13B). Although 
a significant reduction of ergosterol was observed when OSH6 was deleted or 
overproduced, the rate of sterol biosynthesis was normal; while sterol biosynthesis was 
slightly accelerated in ∆osh6 cells (Figure 3.14). The difference observed between WT/ 
∆osh6 and pADNS / pADNS-OSH6 in Figure 3.13 and 3.14 was attributable to growth 
medium used. Rich medium was used for gene deletion study, but to maintain plasmids 










Figure 3.14 Measurement of the rate of sterol biosynthesis. Sterol biosynthesis rate was assessed by 
incorporation of radio-labeled acetate into sterols and fatty acids. The rate was calculated as the value of 
total sterols divided by fatty acids. Results were obtained from two independent experiments (n=4). Results 
with a p<0.05 (*) were considered statistically significant.  X-axis denotes strain genotype; Y axis shows 
the ratio of sterols/ fatty acids. WT: Y10000, ∆osh6: Y15074, pADNS / pADNS OSH6 indicates Y10000 
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   Since sterol esterification was affected to some extents in both deletion and 
overexpression mutants, it was necessary to check lipid droplets that are mainly 
comprised of triacylglycerol and sterol esters. The former serves as fatty acid energy 
reserves and the latter functions as storage depots for excess cellular cholesterol (Renold 
and Cahill, 1965; Goldstein and Brown, 1977; Brown and Goldstein, 1983).  Abnormal 
accumulation or reduction of lipid droplets is attributable to many defective cellular 
activities such as sterol esterification, sterol biosynthesis and fatty acid metabolism. As 
shown in Figure 3.15, although deletion of OSH6 elevated ergosterol level by 80%, no 
apparent accumulation of lipid droplets was observed. In both wild type and mutant, there 
were ~ 4 lipid droplets by average per cell (100 cells counted). However, consistent with 
a significant reduction of ergosterol levels (Figure3.10) and a mild decrease of sterol 
esterification (Figure 3.13), there were fewer lipid droplets (average 3-4 per cell, n=100) 
in overexpression mutant than that in control (6-7 per cell, n=100) (Figure 3.15), 
indicating a decrease of sterol esters. It should be noted that the control was not 
comparable with wild type in this study because their growth medium were different. For 
wild type and ∆osh6, YPD was used, while synthetic dropout medium was used for 
overexpression and control in order to maintain plasmids. Cells growing in nutrient-
limited environment tend to reserve more lipid droplets. In tougher growth situations, 
yeast cells tend to grow slower leading to slow sterol biosynthesis. However, yeast cells 
try to reserve more energy storage thereby causing a higher rate of sterol esterification 












                                                                                              
Figure 3.15 Assessment of lipid bodies by Nile Red staining. Cells were grown in YPD A) or synthetic 
medium lacking leucine B) to stationary phase and stained with Nile Red. Images were acquired using a 
Leica DMLB fluorescence microscope via a Texas Red filter. Scale bar: 5µm. DIC: differential interference 
contrast.  WT: Y10000, ∆osh6: Y15074, pADNS / pADNS OSH6 indicates Y10000 strains transformed 












Lastly, we examined the distribution of free sterols by filipin staining. Filipin is a 
fluorescent probe that specifically stains free cholesterol but not cholesterol esters in 
mammalian cells (Kruth and Fry, 1984). It was then successfully adapted to yeast study 
(Beh and Rine, 2004). Because both deletion and overexpression of OSH6 affected yeast 
cholesterol-ergosterol homeostasis, filipin staining might help reveal the distribution 
pattern of free sterols. As shown in Figure 3.16, in wild type cells filipin stained the 
plasma membrane predominantly, especially the sites of active cell growth and 
cytokinesis (Wachtler et al., 2003). In ∆osh6 cells sterols were distributed mainly at the 
budding sites of the plasma membrane but also found in the intracellular compartments, 
which indicated a possible deficiency in sterol trafficking in ∆osh6.  
 
                                
Figure 3.16 Assessment of free sterol distribution by flipping staining. Cells were grown in YPD to midlog 
phase and fixed with formaldehyde. Cells were then stained with filipin at a final concentration of 20µg/ 
ml. Images were acquired using a Leica DMLB fluorescence microscope.   DIC: differential interference 






 2.2 Osh6p is not essential for fluid-phase endocytosis or endocytic 
trafficking of membrane markers from the cell surface to the vacuole   
   Our localization experiments showed that the majority of Osh6p was localized to 
cytosol with a small pool peripherally associated with endosomal membranes. Since 
endocytosis is severely impaired in cells with seven OSHs mutated (Beh and Rine, 2004), 
to investigate whether Osh6p had a role in endocytic trafficking, we examined Lucifer 
yellow uptake and FM4-64 transport. Lucifer yellow (LY) is taken up and delivered to 
the lumen of the vacuole in wild-type cells (Dulic et al., 1991).  As shown in Figure 
3.17A, ∆osh6 exhibited no deficiency in uptake or transport of LY to the vacuole 
compared to wild type. In addition, even when OSH6 was highly over-expressed from the 






                                     
                      
Figure3.17 Osh6p is not essential for LY uptake. Cells at early log phase were labeled with LY for one 
hour and washed thoroughly. Images were captured using a Leica DMLB fluorescence microscope via an 
E4 filter. DIC: differential interference contrast, FITC: fluorescence image. Scale bar: 5µm. A). WT: 
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   We also examined whether Osh6p was important for FM4-64 uptake and transport.  
FM4-64 is a lipophilic dye that intercalates into cell membranes and is delivered to the 
vacuole membrane via the endocytic pathway (Vida and Emr, 1995). ∆osh6 or 
overexpression (pADNSOSH6) cells were labeled with FM4-64 at 15 °C and warmed to 
30°C (chase) then assessed for the distribution of FM4-64 at different time points. At an 
early time point of chase FM4-64 labels small punctate structures representing early 
endosomes, and at later time points it accumulates in large late endosomal/prevacuolar 
structures adjacent to the vacuole. Finally FM4-64 reaches the vacuole limiting 
membrane in wild type cells. As shown in Figure 3.18A, several small punctate structures 
representing early endosomes were seen at 0 min of chase. At 5 min of chase, 1-2 large 
dots were observed around the vacuole, which represent late endosomal/prevacuolar 
structures. At 10min, punctate staining diminished and vacuolar staining increased, and 
finally punctate staining was almost lost with predominant vacuolar staining at 30 min. 
Compared with WT, no delay of FM4-64 transport was observed in ∆osh6. In addition, 
FM4-64 transport was not affected in OSH6 overexpressing cells (only two time points 

























Figure 3.18 Osh6p is not essential for transport of FM4-64 from the cell surface to the vacuolar limiting 
membrane. Cells at log phase were labeled with FM4-64 at 15°C for 20 min and chased for 0, 5, 10, and 
30min at 30°C after complete removal of excess stain. FM4-64 fluorescence was visualized using a Leica 
DMLB fluorescence microscope via a Texas Red (TR) filter. A). Images of WT (Y10000) and ∆osh6 
(Y15074). Genotype is indicated on the left. B). Images of pADNS (control) / pADNSOSH6 
(overexpression) indicates Y10000 cells carrying pADNS / pADNSOSH6 plasmids.   
A
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2.3 Osh6p is not essential for CPY maturation  
     Next we tested whether Osh6p plays a role in biosynthetic trafficking of 
carboxypeptidase Y (CPY) to the vacuole. CPY is modified by core glycosylation in the 
ER (p1 form with Mw of 67kDa), and transported to the Golgi for further glycosylation 
(p2 form with Mw of 69kDa). The p2 form of CPY traverses the Golgi and is packaged 
into vesicles destined for the endocytic pathway which delivers it to the vacuole. Upon 
delivery to the vacuole it is processed to its mature form (M form with Mw of 61kDa). 
Deficiency in this process leads to accumulation of p2 CPY and secretion from cells 
(Robert et al., 1998).  As shown in Figure 3.19, at 0min, p1 CPY was the predominant 
form. The p2 form was seen at the 5min time point. At a later time (10min), mature CPY 
was observed together with some remaining p2 and p1 precursors. At the 30min time 
point, most CPY was in the mature 61kDa form.  Compared with wild type, osh6∆ 
showed no delay in CPY maturation. In addition, no CPY secretion into the medium was 



















Figure 3.19 Osh6p is not essential for CPY transport and maturation. Cells at stationary phase were radio-
labeled, chased for various time, and lysed. CPY was immuno-precipitated from cell lysate (intracellular) 
and extracellular growth medium/periplasm (extracellular). Proteins were resolved by 8% SDS-PAGE and 
detected by radiophotography. p1: core glycosylated ER form, p2: fully glycosylated Golgi form, M: 
mature vacuolar form. Wild type: Y10000, ∆osh6: Y15074. Time points are indicated at the bottom. 
 
2.4 Characterization of the functional domains of Osh6p  
  As a short Osh, Osh6p consists of a conserved OSBP domain that is supposed to 
mediate protein-lipid binding and a putative coiled coil motif for protein-protein 
interaction. We were interested to know whether these domains were important for the 
function of Osh6p. We expressed GST fusion proteins in JRY6326 strain (pMET2-OSH2, 
∆osh1-osh7). In the presence of methionine, OSH2 expression is suppressed thus 
JRY6326 cells are inviable. Reintroduction of any OSHs can restore cell growth except 
OSH1 for which overexpression is required (Beh et al., 2001). When the coiled coil, 
OSBP, full-length, and vector alone were expressed in JRY6326 (Figure 3.20), only full-
length protein was able to rescue JRY6326 in the presence of methionine, which suggests 



















Figure 3.20 Functional domains of Osh6p. pYEX4T-1(vector), pYEXOSH6, pYEXOSH6CC, and 
pYEXOSH6OB were introduced into JRY6326 cells and the transformants were grown on YM solid 
medium containing 2mM methionine for 72hr at 30ºC.  
 
2.5 Characterization of the lipid ligands and lipid binding domain of 
Osh6p  
   As a short Osh protein, Osh6p consists of a conserved ORD domain and a putative 
coiled-coil motif for protein-protein interaction. OSBP binds 25-hydroxylcholesterol and 
mediates its activity (Dawson et al., 1989a, b); it can also bind phosphoinositides for 
membrane targeting (Levine and Munro, 1998; 2002). More recently, in a landmark 
paper, Wang PY et al. (2005) showed that in response to cholesterol binding OSBP 
interacts with two phosphatases: HePTP and PP2A. These phosphatases are brought by 
OSBP to the vicinity of phosphorylated ERK1/2 within the cell to promote its 
dephosphorylation. Some of its homologues were shown to bind phospholipids especially 
phosphoinositides (Xu et al., 2001; Li et al., 2002). In a recent landmark paper, Im et al 
(2005) showed that Osh4p assumes a β-barrel structure with a hydrophilic exterior and a 





the β-barrel, with its 3-hydroxyl group buried at the bottom of the tunnel. It was proposed 
that Osh4p is a sterol transporter, which undergoes quick conformational change upon 
sterol loading and unloading (Im et al., 2005). We examined the lipid ligands of Osh6p 
using a filter assay. As shown in Figure 3.21, Osh6p bound a pool of phosphoinositides 
including PtdIns (4) P, PtdIns (5) P, and PtdIns (3, 5) P2 with strongest binding to PtdIns 
(5) P. The ORD domain (Osh6pOB) showed very similar lipid binding pattern as full-
length protein. While the coiled-coil half (Osh6pCC) and GST alone (control) failed to 
bind any lipid. GST-EEA1, a FYVE protein, preferably bound PtdIns (3) P, and was used 
as a positive control (Gaullier et al., 2000). Although Osh6p bound PtdIns (5) P with a 
higher affinity than   PtdIns (4) P, the physiological level of PtdIns (4) P is much higher 
than that of PtdIns (5) P (Rameh et al., 1997), indicating that PtdIns (4) P may be their 
real ligand in physiological conditions. Interestingly, when more lipids and protein were 
loaded, both Osh6p and the OSBP domain of Osh6p bound PA, while Osh6pCC and GST 
alone failed to bind PA (Figure 3.22). Osh6pOB had 8-fold higher affinity for PA than 
Osh6p did, indicating the conserved ORD domain mediates lipid binding. However, a 
weak binding to PtdIns (3) P by all proteins was also observed, which might be non-
specific. One molecule of Osh4p was shown to bind one molecule of ergosterol (Im et al., 
2005). We observed no binding of Osh6p to ergosterol in our assay system (data not 






















Figure 3.21 Osh6p binds phosphoinositides. GST fusion proteins were expressed in and purified by affinity 
chromatography from Ecoli. 100pmol of desirable lipids were spotted onto a hybond-C membrane, dried 
and then blocked.  The membrane was incubated with 30 nM GST fusion proteins and then incubated with 
mouse anti-GST antibody followed by secondary anti-mouse HRP conjugate. Bound lipids were 
determined by ECL. GST fusion protein is indicated at the bottom of the blot. LPA: lysophosphatidic acid; 
LPC: lysophosphatidylcholine; PI: phosphatidylinositol; PIP: phosphatidylinositol phosphate; PE: 
phosphatidylethanolamine; PC: phosphatidylcholine; S1P: sphingo-1-phosphate; PS: phosphatidylserine; 













































Figure 3.22 Osh6p binds PA. As above except higher concentrations of fusion proteins and more lipids 
were used.  Protein concentration: 60nM for fusion proteins or 120 nM for GST only. Lipid amount is 
indicated on the top of the blot; and lipids used are marked on the left.  
 
 2.6 Characterization of the membrane targeting domains of Osh6p       
In the previous experiments, we examined the lipid binding domains of Osh6p. We 
furthered our study to examine the membrane targeting domains of Osh6p.  As shown in 
Figure 3.23A, Osh6p-GFP was predominantly cytosolic, with a minor pool associated 
with patch-like structures in the vicinity of plasma membrane. However, the N-terminal 
half containing the ORD domain, Osh6p(1-254)-GFP showed strikingly different 
localization. As seen in Figure 3.23A,   Osh6p(1-254)-GFP associated with 1-2 punctate 
structures without discernible peripheral staining. These punctate structures were further 
found to colocalize with the FM4-64 staining endosomes (Figure 3.23B). Most 
interestingly, the C-terminal half containing the coiled coil, Osh6p(255-448)-GFP was 




















confirmed by DAPI-staining.  As Figure 3.23C shows, GFP staining structures were well 
colocalized with the DAPI-staining nucleus.   
                   
 







     
  
Figure 3.23 Membrane targeting domains of Osh6p (on preceding pages). A)  Exponentially growing cells 
(Y10000) expressing GFP fusions from YEplac181 vector were mounted on a glass slide and was 
visualized using a Leica fluorescence microscope. B) Colocalization of Osh6p (1-254)-GFP with FM4-64 
positive compartments. Cells (Y10000) were labeled with FM4-64 in ice-water for 30 min and then shifted 
to 15 °C for 20 min allowing FM4-64 to be internalized. Cells were immediately put back on ice and 
washed thoroughly to remove excess dye. GFP and FM4-64 images were acquired via a GFP filter and 
Texas Red filter respectively. Arrows indicate some colocalizations.  C) Colocalization of Osh6p (255-



















     In this part, our findings suggested that Osh6p played an important role in maintaining 
sterol homeostasis. First, deletion of OSH6 elevated ergosterol levels, while 
overexpression reduced it significantly. Second, in ∆osh6, oleate incorporation into sterol 
esters was down-regulated but sterol biosynthesis was accelerated, contributing to an 
accumulation of excess ergosterol. Third, consistent with a reduction of ergosterol levels 
in the overexpression strain, a mild down-regulation of sterol esterification and nystatin 
resistance were observed. Fourth, less lipid droplets were observed in the overexpression 
strain. Lastly, intracellular distribution of free sterols was disturbed in the deletion mutant, 
suggesting a deficiency in sterol transport. However, no deficiency was found for some 
vesicular transport pathways. Both endocytic trafficking and protein transport from the 
ER to the vacuole were normal in the absence and presence of high levels of Osh6p. The 
integrity of Osh6p was essential for its proper function in vivo, i.e, both the ORD domain 
(1-300) and putative coiled coil CC (301-448) were indispensable for Osh6p function. 
Osh6p bound PtdIns(5)P, PtdIns(4)P, PtdIns(3,4)P2,  PtdIns(3,5)P2 and phosphatidic acid, 
with strongest binding to PtdIns (5)P, and its lipid binding was mediated by ORD domain. 
The ORD and CC domains contained determinants that targeted Osh6p to different 






   Part 3 Interaction between Osh6p and Vps4p 
 3.1 Osh6p physically interacts with Vps4p 
In a large-scale screening of Vps4p-interacting proteins using yeast two hybrid, Osh7p 
was identified as an interacting partner of Vps4p (Yeo et al., 2003). We also investigated 
the possible interaction between Osh6p and Vps4p by in vivo and in vitro approaches, 
since Osh6p and Osh7p share ~70% sequence identity or 80% similarity (Beh et al., 
2001). First, in vivo interaction was examined using yeast two-hybrid assay as shown in 
Figure 3.24. The interaction strength between Vps4p and Osh6p was measured with an 
arbitrary β-galactosidase unit of ~6. Second, in vitro GST pull-down was performed as 
shown in Figure 3.25.  Only GST-Osh6p pulled down Vps4p-Myc from yeast lysate, 
while GST or GST-Osh5p failed to do so, indicating the specificity of the interaction 







Figure 3.24 Vps4p interacts with Osh6p in vivo). The GAL4-based plasmids pASOSH6, pACTVPS4, 
pAS2-1 or pACT2 were introduced into pJ69-4A cells and grown in SC medium lacking leucine and 
tryptophan. Cells were lysed by freeze-thaw cycle with liquid-nitrogen and β-galactosidase activity was 
assessed using ONPG as substrate. 
 


































   
    
 
Figure 3.25 Vps4p interacts with Osh6p in vitro. GST fusion proteins were purified from E.coli using 
glutathione (GSH) agarose beads. The fusion protein adsorbed-beads were incubated with yeast lysate 
(prepared from Vps4p-Myc expressing cells) allowing yeast proteins to bind to bait proteins.  After 
stringency wash, bound proteins were eluted and separated by SDS-PAGE. Vps4p-Myc was detected using 
anti-Myc antibody by ECL. Lane 1, 2: unbound fraction; Lane 3, 4: bound fraction. The bait proteins used 
are indicated on the right.  
 
 3.2 Vps4p regulates the membrane dissociation of Osh6p 
     Since Osh6p physically interacted with Vps4p, we extended our investigation to the 
functional relevance of this interaction. Vps4p is a well-established AAA ATPase 
required for efficient transport in the MVB pathway, where it functions to disassemble 
ESCRT complexes (Babst et al., 1997; 1998; 2002a; 2002b; Katzmann et al., 2001).  Like 
OSBP, Osh proteins could also translocate from cytosol to membranes in response to 
physiological changes (Wang PH et al., 2005). It was possible that Vps4p interacted with 
Osh6p transiently and helped it exit from membranes for next round of action. To test 
this, I expressed Osh6p-GFP in wild type and ∆vps4 cells and investigated their cellular 
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altered significantly. In wild-type cells punctuate structures were small and barely seen; 
while in the mutant there were larger and brighter dots which were probably endosomes 
(Figure 3.26A). As a negative control, the cellular location of a Golgi resident Osh 
protein Kes1p-GFP (Li et al., 2001), remained largely unaffected in the absence of VPS4 
(Figure 3.26B). 






Figure 3.26 Osh6p-GFP is mislocalized in ∆vps4.  Cells were grown to mid-log phase in synthetic medium 
and mounted on a glass slide. Fluorescence images were acquired using a Leica DMLB fluorescence 
microscope via a GFP filter. DIC: differential interference contrast. Strain genotypes are indicated to the 
right. Scale bar: 5µm.   WT: Y10000; ∆ vps4: Y15588.   
                             
    In the MVB pathway, loss of the Vps4p activity results in enlarged late endosomes, i.e, 
the class E phenotype (Basts et al., 1997) and inability of disassociation of ESCRT 
complexes proteins from endosomal membranes (Babst et al., 1997; 1998; 2002a; 2002b; 
Katzmann et al., 2001). To investigate whether Osh6p-GFP associated with endosomal 
membranes in ∆vps4, cells were stained with FM4-64 and colocalization of Osh6p-GFP 
with FM4-64 positive endosomal compartments was examined. FM4-64 is a lipophilic 










vacuole limiting membrane through early endosomes, late endosomes (Vida and Emr, 
1995).  In this experiment, cells were chased with FM4-64 for a short time and FM4-64 
transport was stopped with sodium azide and sodium fluoride before FM4-64 reached the 
vacuolar limiting membranes, thus FM4-64 predominantly associated with the endosomal 
compartments. Osh6p-GFP and FM4-64 images were then visualized through a GFP and 
Texas Red filter respectively. As shown in Figure 3.27B, Osh6p-GFP positive structures 
were well colocalized with FM4-64-staining endosomal compartments. This 
colocalization was more readily observed in ∆vps4 cells than wild type cells. To exclude 
the possibility of fluorescence bleed-through from FM4-64 into the GFP channel, GFP 
alone was also examined. As seen in Figure 3.27A, GFP was completely cytoplasmic 
without any discernible membrane targeting, while FM-4-64  stained endosomal 
compartments clearly, which suggested no bleed-through from FM4-64 channel into GFP 
channel. 






                                               
                                           

















Figure 3.27 Osh6p-GFP is localized to FM4-64-staining membrane compartments. Y15588 (Δvps4) cells 
expressing GFP A) or cells expressing Osh6p-GFP B) were labeled with FM4-64 at a final concentration of 
1µM/O.D600/ml at 0 °C for 30min and shifted to 15°C for 20 min. Cells were immediately chilled on ice 
and washed with 10mM NaN3/NaF. GFP and FM4-64 images were obtained via a GFP filter and Texas 
Red filter respectively. Scale bar: 5 µm. DIC: differential interference contrast. Arrow heads indicate some 
colocalization 
To further confirm that Osh6p-GFP was mislocalized in ∆vps4, subcellular 
fractionation by one-step centrifugation was performed. The yeast cellular components 
were separated into soluble (S) and pellet (P) fraction by centrifugation at 100,000xg thus 
concentrating membrane compartments predominantly in the pellet fraction. As shown in 
Figure 3.28A, more fusion protein Osh6p-GFP and native protein Osh6p were associated 
with P fraction from ∆vps4 than that from wild type cells; in addition, as a positive 
 






control a small pool of Osh7p-GFP was found in P fraction from ∆vps4 cells but not wild 
type cells (Wang PH et al., 2005). Moreover, consistent with the microscopic results, the 
effect of VPS4 on the cellular distribution of Osh proteins was specific for Osh6p/Osh7p-
GFP because Osh4p-GFP and Osh1p (615-1188)-GFP did not translocate in the absence 














Figure 3.28 Osh6p-GFP is mislocalized in vps4.  A). Osh6p is redistributed from cytosol to membranes in 
∆vps4. WT (Y10000) or mutant cells (Y15588) expressing indicated GFP fusion proteins were osmotically 
lysed and cleared, and the cleared  lysate was spun at 100,000xg  resulting in Supernatant and Pellet. GFP 
fusions were detected using rabbit anti-GFP antiserum. Osh6p was probed using rabbit anti-Osh6p anti 
serum.  B). The ATPase activity of Vps4p is required for the normal localization of Osh6p. ∆vps4 +vps4 
E233Q denotes yeast lysate from ∆vps4 cells (Y15588) carrying pRS316vps4-E233Q plasmid encoding the 
ATPase-defective Vps4p-E233Q mutant protein.  ∆vps4 +VPS4 indicates yeast lysate from ∆vps4 cells 
carrying pRS316VPS4 plasmid encoding wild type Vps4p.  
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As an ATPase, Vps4p functions to disassemble protein complexes in the MVB 
pathway by consuming energy, which is, converting ATP into ADP (Babst et al., 1997, 
1998). Since the membrane association of Osh6p is regulated by Vps4p, does this 
regulation process need the ATPase activity of Vps4p? To answer this, we reintroduced 
wild type VPS4 (CEN) allele and vps4 E233Q defective in ATP hydrolysis (Babst et al., 
1997) into ∆vps4 cells, and examined the cellular localization of Osh6p-GFP.  As shown 
in Figure 3.28B, wild type VPS4 corrected the mislocalization of Osh6p-GFP in ∆vps4 
cells, but mutant allele failed to do so, which suggested that the ATPase activity of Vps4p 
was required for regulating membrane association of Osh6p.  
     It was interesting to know whether other class E mutants could affect Osh6p cellular 
location, which might help to understand the molecular function of Osh6p. In the MVB 
sorting pathway, three class E Vps proteins: Vps23p, Vps28p, and Vps37p form a 
conserved 350 kDa complex on the endosomal membrane-ESCRT-I, which recognizes 
and binds ubiquitinated cargo (Katzmann et al., 2001). Binding of cargo by ESCRT-I  
leads to the activation and recruitment of soluble ESCRT-II (Vps22, Vps25, and Vps36p)  
to membranes, which then directly interacts with the ESCRT-III Vps20/Snf7p 
subcomplex and promotes the assembly of multicopies of ESCRT-III on the membrane, 
forming a large oligomer. Finally, Vps4p interacts with the ESCRT-III subcomplex 
Vps2/Vps24p and catalyzes the release of the entire machinery (Babst et al., 1998; 2002a; 
2002b; Katzmann et al., 2001). Vps27p may act in a protein complex upstream of 
ESCRT-I to assist in cargo recruitment (Bilodeau et al., 2002). If Osh6p works in any one 
of the complexes in the MVB pathway, malfunction of these protein complexes will 
result in mislocalization of Osh6p. As seen in Figure 3.29, deletion of VPS2, VPS24 
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(ESCRT complex III), VPS23 (complex I), VPS36 (complex II) and VPS27 (acting 
upstream of ESCRT-I) had no effect on intracellular distribution of Osh6p-GFP.  This 
result indicated that Osh6p might work in concert with Vps4p in a different pathway 
other than the MVB pathway.   
 












Figure 3.29 Osh6p-GFP distribution is not affected in other class E mutants.  WT (Y10000) or mutant cells  
expressing indicated GFP fusion proteins were osmotically lysed and cleared, and the cleared  lysate was 
spun at 100,000xg  resulting in Supernatant and Pellet. Proteins in the supernatants were TCA-precipitated. 
All samples were resolved by SDS-PAGE and subjected to Western blotting. GFP fusions were detected 
using rabbit anti-GFP antiserum.  
    
       It was possible that pellet-associated Osh6p pool in vps4 mutants was membrane 
associated or in a protein complex. To investigate this, the pellet fraction from ∆vps4 
cells was treated with 1% Triton X-100 on ice for 30 min, and fractionated again by 












centrifugation into S (supernatant) and P (pellet). As shown in Figure 3.30, Osh6p-GFP 
was almost completely extracted from the pellet and redistributed into the supernatant, 
indicating the pellet pool of Osh6p-GFP was indeed membrane-associated. As a trans-






Figure 3.30 Osh6p-GFP is membrane associated in ∆vps4. ∆vps4 cells carrying YCpOSH6-GFP were 
lysed by osmotic lysis and the lysate was centrifuged at 100,000xg resulting in the pellet and supernatant.  
The pellet fraction was resuspended in lysis buffer (mock) or 1% Triton X-100 on ice and centrifuged at 
100,000xg again resulting pellet (designated P) and supernatant (designated S). The proteins in the 
supernatant were TCA-precipitated and separated by SDS-PAGE gel. Indicated proteins were detected by 
Western blotting. GFP fusions were detected using rabbit anti-GFP antiserum.  
 
3.3 Conclusions 
    In this section, we characterized the relationship between Vps4p and Osh6p. First, 
Vps4p interacted with Osh6p both in vivo by yeast two-hybrid assay and in vitro by GST 
pull-down. Second, the exit of Osh6p out of endosomal membranes required Vps4p and 
its ATPase activity. Third, the intracellular distribution of Osh6p was not affected in 
other class E mutants and vps27.  
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          Part 4 Interaction between Osh1p and Afg2p 
4.1 Afg2p interacts with Osh1p  
Our above data linked Osh6p to Vps4p with respect to membrane targeting regulation. 
Interestingly, another Osh protein-Osh1p has been shown to be in a protein complex with 
Afg2p-an AAA ATPase (Gavin et al., 2002). This raised the possibility that Afg2p could 
play a similar role in regulating Osh1p membrane association as Vps4p regulates 
Osh6/7p. In order to address this issue, we first examined whether Afg2p interacted with 
Osh1p in vivo by the yeast two-hybrid assay. Afg2p was cut into four fragments 
according its domain structure: The N-terminus Afg2N (amino residue 1-250), Afg2A 
(amino residue 251-500) spanning an AAA domain, Afg2B (amino residue 501-700) 
spanning a second AAA domain and Afg2C C-terminus corresponding 701-780/end. 
Osh1p (615-1188) was further dissected into three fragments: Osh1CC (coiled-coil) 
containing the FFAT motif corresponding amino residues from 615 to 725, Osh1OB 
(amino residue 726-1000) spanning the conserved ORD domain and Osh1C the C-
terminus from amino residue 1001 to 1188/end (See Figure 3.31A ). Interaction between 
these fragments were assessed using X-gal on solid medium and ONPG in liquid 
medium. Figure 3.31B shows that only one pair AFG2-B / OSH1-OB activated LEU2 and 
LacZ reporter genes (Data not shown here demonstrated that AFG2-C alone could 
activate reporter genes and pairs with AFG2-C didn’t show stronger activation than 
AFG2-C alone). Unlike Osh7p whose coiled coil motif mediates protein-protein 
interaction (Wang PH et al., 2005), the coiled coil containing fragments of Osh1p tested 
in this study (OSH1-CC and OSH1-C) seemed not to be the protein-protein interaction 
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domains. To quantify the interaction of OSH1-OB with AFG2-B, we tested β-



















Figure 3.31 Osh1p interacts with Afg2p in vivo. A). The domains of Osh1p and Afg2p. B). Yeast two-
hybrid analysis. The pJG4-5-based plasmids (pJGOSH1C, pJGOSH1OB, pJGOSH1CC) and pLexA-based 
plasmids (pLexA-AFG2-N, pLexA-AFG2-B, pLexA-AFG2-A)  together with LacZ reporter plasmid 
PSH18-34 were transformed into EGY48 and grown on SC/Gal/Raf-URA-TRP-HIS-LEU containing X-gal 
at 30 ºC for 3 days. Positive clones survived leucine selection and developed blue color.  
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Figure 3.32 Osh1p interacts with Afg2p (quantification of interaction strength). Indicated plasmids 
together with PSH18-34 were transformed into EGY 48 and grown in SC/Gal-URA-TRP-HIS to midlog 
phase. Cells were lysed by freeze-thaw cycles with liquid-nitrogen and the β-galactosidase activity was 
assessed using ONPG as substrate. a: pJG4-5 / pLexA ,  b: pJG4-5 /  pLexA-AFG2-B , c: pJG4-5OSH1OB / 
pLexA, d: pJG4-5OSH1OB / pLexA-AFG2-B . 
 
4.2 Afg2p regulates Osh1p/Osh2p disassociation from the ER membrane 
4.2.1 Afg2p regulates Osh1p dissociation from the ER membrane 
Next we investigated the functional relationship between Osh1p and Afg2p using a 
GFP fusion construct Osh1p (615-1188)-GFP, which contained the FFAT motif and 
showed strong ER targeting when Scs2p was overexpressed (Loewen et al., 2003). We 
examined the cellular distribution of Osh1p (615-1188)-GFP by fluorescence microscopy 
and subcellular fractionation using the thermo sensitive afg2-18 mutant (thereafter 
referred to as afg2-ts) (Nunnari et al., 1997; Zakalskiy et al., 2002). This mutant contains 
a L457S exchange at a position between the two AAA domains of Afg2p, which results 
in a ~90% loss of ATPase activity. As shown in Figure 3.33A, at permissive temperature 
Osh1p (615-1188)-GFP was diffusely distributed in the cytoplasm with weak ER 

















temperature the cytoplasm pool was decreased with a significant increase of ER 
targeting. To prove that Osh1p (615-1188)-GFP was associated with the ER; the cell 
nucleus was visualized by DAPI staining. As shown in Figure 3.33B, the circular GFP 















Figure 3.33 Osh1p translocates to ER upon inactivation of Afg2p. A). afg2-ts expressing Osh1p (615-
1188)-GFP was grown to O.D600=0.8-1.0 at 26ºC, and incubated  at 26 or 37ºC for 1 hr. GFP images were 
captured using a Leica fluorescence microscope via a GFP filter. B). For DAPI-staining, afg2-ts cells 
expressing Osh1p (615-1188)-GFP were preincubated at 37ºC for 1 hr before fixation, stained with DAPI 
and images were acquired via appropriate filters.  The arrow indicates a perinuclear ER, the arrow head 








    The redistribution of Osh1p from the cytoplasm to the ER observed above was further 
confirmed by subcellular fractionation as shown in Figure 3.34A. There was more Osh1p 
(615-1188)-GFP associated with P13 at non-permissive temperature than that at 
permissive temperature; while the soluble pool (S13) seemed decreased when shifted to 
restrictive temperature. However, the cellular distribution of other Osh proteins such as 
Osh4p, Osh6p, and Osh7p examined in this study were not affected, implying that Afg2p 
specifically regulated Osh1p membrane dissociation. As an ER resident protein, Dpm1p 
localization was not altered at restrictive temperature, indicating ER morphology was 
normal; so were VATPase60 (vacuolar membrane protein) and Porin (mitochondrial 
membrane protein). To examine whether temperature shift caused redistribution of 
Osh1p, same experiment was repeated using wild type strain. Figure 3.34B shows that the 
cellular distribution of Osh1p (615-1188)-GFP remained unchanged when shifted from 
26 to 37 °C.                
                                                  

























Figure 3.34 Osh1p is redistributed from the cytosol to the ER membrane.  Wild type B) or afg2-ts A) cells 
expressing indicated GFP fusion proteins were grown to O.D600=0.8-1.0 at 26ºC, and incubated at 24 or 
37ºC for 1 hr. Cells were lysed, and S13 and P13 were obtained by centrifugation at 13,000xg. All protein 
samples were resolved by SDS-PAGE and subjected to Western blotting. GFP fusion proteins were 
detected using rabbit anti-GFP anti sera. 
   
   To further examine how Osh1p associated with P13 fraction, we performed membrane 
extraction as well as membrane floatation experiments. As shown in Figure 3.35, Osh1p 
(615-1188)-GFP was almost completely extracted from P13 fraction at permissive 
temperature and only about two-thirds was extracted at non-permissive temperature. Was 
the Triton-insoluble pool associated with membranes or just protein aggregate? To 
address this issue, the P13 fraction at non-permissive temperature was further tested for 
membrane floatation. As shown in Figure 3.36, more than 90% of Osh1p (615-1188)-
A 26°C
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GFP and almost all Dpm1p-an ER resident membrane protein-floated into the F (floating) 
fraction. Still a minute pool of Osh1p stayed in the non-floating fraction, which could be 
stripped from membranes by physical forces or reagents used. Taken together, Osh1p 






Figure 3.35 Membrane extraction. The P13 fraction obtained from 37ºC-treated cell cultures was treated 
with 1%Triton on ice and centrifuged at 100,000xg resulting in S (supernatant) and P (pellet). GFP fusion 







Figure 3.36  Membrane floatation. The P13 fraction obtained from 37 º C-treated cell cultures was subject 
to membrane floatation centrifugation as previously described in this study. GFP fusion proteins were 
detected using a rabbit anti-GFP anti serum.  
 
4.2.2 Scs2p is required for Osh1p (615-1188) targeting to the ER in afg2-ts 
   Osh1p targets the ER membrane via its receptor-Scs2p on the ER (Loewen et al., 2003). 
We also examined Osh1p (615-1188)-GFP location in the ∆scs2 afg2-ts. As shown in 
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Scs2p is indispensable for targeting of Osh1p (615-1188)-GFP to the ER membrane. 
Figure 3.38 shows consistent results that almost no Osh1p (615-1188)-GFP was 
associated with P13 fraction at permissive or restrictive temperature. 
 





Figure 3.37 Association of Osh1p with ER is dependent on Scs2p.  scs2∆ afg2ts cells expressing Osh1p 
(615-1188)-GFP were grown to O.D600=0.8-1.0 at 26ºC, and incubated at 37ºC for 1 hr. A). (on the 
preceding page).  GFP images were captured using a Leica fluorescence microscope via a GFP filter. DIC: 
differential interference contrast. Scale bar: 5µm. B). Cells were lysed, and S13 and P13 were obtained by 
centrifugation at 13,000xg.  GFP fusion proteins were detected using rabbit anti-GFP anti sera. 
VATPase60-a soluble and vacuolar protein-was used as a loading control.  
 
4.2.3 Afg2p regulates Osh2p disassociation from the ER membrane 
   Osh2p shares the highest sequence identity with Osh1p among all Osh proteins (Beh et 
al., 2001). It is possible that they may share a same regulator for membrane association. 
To investigate this, we constructed pRS314-OSH2-GFP and examined its intracellular 
location in afg2-ts. As shown in Figure 3.38A, at permissive temperature Osh2p-GFP 
was mainly cytosolic and a pool was targeted to the plasma membrane-like structures 
particularly budding sites. Consistent with a previous report (Levine and Munro, 2001), 
this polarized membrane targeting was occasionally seen and possibly represented the ER 











polarized periplasma membrane targeting was retained and weak perinuclear ER 
targeting was observed. In contrast, Osh3p-GFP was soluble without obvious membrane 
targeting at permissive temperature, even after being shifted to non-permissive 














Figure 3.38 Localization of Osh2p/Osh3p-GFP in afg2-ts. afg2-ts cells expressing Osh2p-GFP  A) or 
Osh3p-GFP B) were grown to O.D600=0.8-1.0 at 26ºC, and incubated  at 26 or 37ºC for 1 hr. GFP images 
were captured using a Leica fluorescence microscope via a GFP filter. DIC: differential interference 
contrast. Scale bar: 5µm. Arrow indicates the perinuclear ER.   
 
4.3 Deletion of OSH1, 2, 3 affects sterol esterification 
As long Osh proteins containing a PH domain, Osh1, 2, 3p have been demonstrated to 
be involved in maintaining proper cellular ergosterol levels (Beh et al., 2001). As an 
extension of our investigation of Osh functions in sterol metabolism, we examined the 
oleate incorporation into sterol esters when Osh1, 2, 3p were depleted. As shown in 












into sterols; while incorporation into TAG was largely unchanged. Loss of OSH1 caused 
the most severe and significant impairment of sterol esterification. In the absence of these 
three genes, oleate incorporation into sterol esters was even slower, indicating they may 
work in concert to regulate sterol esterification.  







































































Figure 3.39 Deletion of OSH1, 2, 3 affects sterol esterification.  Cells were grown in YPD to mid-log 
phase and labeled with [3H]-oleic acid for half an hour. Cells were washed with ice-cold 0.5% NP-40,  
lyophilized, and then  lysed by lyticase. Lipids were extracted by hexane. Sterol esters (SE) A) and TAG B) 
were separated by TLC and quantified with a Beckman scintillation counter.  Results were obtained from 
two independent experiments (n=3). * : P<0.05  Y-axis represents count per minute per mg dry cells. X-






   In this part, we demonstrated that the Osh1pOB interacted with Afg2pB using the yeast 
two-hybrid approach. Most interestingly, we showed that as Vps4p regulated the 
membrane disassociation of Osh6p, Afg2p regulated the membrane dissociation of both 
Osh1p and Osh2p. As an extension of above study, the roles of OSH1, 2, 3 in sterol 
esterification were also examined. Oleate incorporation into sterol esters was 




Part 5 AAA ATPases and lipid metabolism 
5.1 Afg2p and Vps4p regulate cellular lipid metabolism  
 
     It is possible that Osh proteins play an important role maintaining intracellular sterol 
homeostasis. Deletion of OSH1, OSH6 showed a mild increase of yeast cholesterol-
ergosterol levels (Beh et al., 2001) and a decrease of oleate incorporation into sterol 
esters (this study).  Since Vps4p and Afg2p regulated the membrane dissociation of these 
Osh proteins, they very likely played a role in the metabolism of sterol or other lipids. We 
analyzed the steady-state ergosterol levels in both ∆vps4 and afg2-ts using GC-MS and 
observed no significant differences between wild type and ∆vps4, but a mild increase for 
afg2-ts when shifted to non-permissive temperature (Figure 3.40). As a control, 
ergosterol levels of the wild type strain W303 was not altered at 37 °C.  
 





























Figure 3.40 Analysis of steady-state ergosterol by GC-MS. Cells were grown at 24 ºC to cell density 
equivalent to O.D600=1.0 and shifted to 24 or 37 ºC for 1 h. Cells were harvested and sterols were extracted 




   We next examined the sterol distribution in afg2-ts by filipin staining. Mass 
accumulation of sterols in the cytoplasm of afg2-ts at non-permissive temperature was 
seen. As shown in Figure 3.41, at permissive temperature, sterols were mainly distributed 
in the plasma membrane especially at active growth sites (Wachtler et al., 2003) in both 
wild type and afg2-ts. At restrictive temperature, internal filipin positive structures were 
observed only in afg2ts but not in wild type, indicating sterol distribution was disrupted 












Figure 3.41 Afg2p is required for normal sterol distribution. Wild type or afg2ts cells were grown to mid-
log phase at 26ºC, and incubated at 26 or 37ºC for 1 hr. Cells were then fixed and stained with filipin. 
Filipin images were captured using a Leica DMLB fluorescence microscope. A). DIC (differential 
interference contrast) and fluorescence images of wild type w303 cells. B). DIC and fluorescence images of 
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  We further investigated sterol esterification for both mutants.  Short-time chase with 3H-
oleic acid demonstrated that oleic acid incorporation into sterol esters was decreased 
(Figure 3.42A)significantly in ∆vps4, while incorporation into TAG was not affected 
(Figure 3.42B), indicating fatty acid uptake was normal in ∆vps4. As a positive control, 
deletion the yeast major ACAT-ARE2 (acyl-coenzyme A: cholesterol acyl transferase) 
drastically disrupted sterol esterification (Yang et al., 1996). In order to investigate that 
this effect was a direct and immediate result from loss of Vps4p activity, a temperature 
sensitive vps4 (vps4-ts with mutation M307T and L327S, Babst et al., 1997) was tested 
for oleate incorporation. Both the wild type and vps4ts alleles were introduced into 
RH2906 (vps4∆) and assayed for oleate incorporation into sterol esters and TAG. As 
shown in Figure 3.42C and D, at permissive temperature (26°C), no significant difference 
in oleate incorporation into sterol esters and TAG was observed between wild type and 
vps4-ts. However, consistent with results obtained from the null mutant, when shifted to 
non-permissive temperature, vps4-ts showed a significant decrease in oleate incorporation 
into sterol esters but not TAG. As a control, reintroduction of wild type VPS4 only 
partially suppressed this defect. This could be due to a mild overexpression of Vps4p 
from YCplac111 vector, which gave 2-3 fold higher expression than native levels.  This 
suggested Vps4p participated in sterol esterification process, possibly by regulating sterol 






   













   
 
Figure 3.42 Oleate incorporation into sterol esters is affected in vps4. For A) and B), Cells were grown in 
YPD at 30 °C and labeled with 3 H-oleic acids for 30 min. For C) and D, cells were grown in synthetic 
medium (SC-Leu) at 26°C and either pre-incubated at 37°C or 26°C for half an hour and cells were pulsed 
with 3H-oleate for half an hour at 37°C or 26°C. Lipids were determined as described in Chapter II. X-axis 
represents yeast strain genotype; Y-axis indicates count per minute per mg dry weight. Vector-WT 
indicates RH1800 cells transformed with YCplac111; VPS4-∆vps4 represents RH2906 (∆vps4) cells 
expressing wild type Vps4p from YCpVPS4; vps4ts-∆vps4 stands for RH2906 (∆vps4) cells expressing 
temperature sensitive vps4p from YCpvps4ts. All data were collected from at least two independent 











































































































































   As for afg2ts, at 24 ° C, both TAG biosynthesis and sterol esterification was as normal 
as wild type (Figure 3.43); however was significantly decreased at 37°C compared with 
wild type (Figure 3.43). This suggests that Afg2p may be a regulator of both sterol ester 
and TAG biosynthesis.    
 




































































Figure 3.43 Oleate incorporation into sterol esters and TAG upon inactivation of Afg2p is affected (on the 
preceding page).  Wild type W303 or afg2-ts cells were grown at 24°C to midlog phase and further 
incubated at 24 or 37°C for 10 min, and then labeled with [3H]-oleic acid for 20 min at 24 or 37°C. Lipids 
were determined as described in Chapter II. X-axis represents yeast strain genotype; Y-axis indicates count 







5.2 Functional interaction of Osh6/7p with Vps4p 
In the previous chapter, we showed that Vps4p played an important role in sterol 
metabolism by regulating the membrane dissociation of Osh6/7p. To further examine 
their functional link, we overexpressed Osh6/7p in VPS4 deletion cells and measured 
sterol esterification. As shown in Figure 3.44A, overexpression of OSH7 significantly 
correct the defect associated with vps4∆. Overexpression of OSH6 reduced the rate of 









                                      
                              
Figure 3.44  Overexpression of Osh6/7p suppresses defect in oleate incorporation in ∆vps4 cells. A). Cells 
were grown in glucose medium to mid-log phase and transferred to galactose/raffinose medium for 4 hrs. 
Cells were then labeled with [3H]-oleate for 30 min.  pESC-WT: wild type (Y10000) cells carrying pESC; 
pESC-∆vps4: ∆vps4 (Y15588) cells carrying pESC; pESCOSH7-∆vps4: ∆vps4 (Y15588) cells carrying 
pESCOSH7.  B). Exponentially growing cells were labeled with [3H]-oleic acid at 30°C for 30 min. Vector-
WT: Y10000 cells carrying the vector pADNS; OSH6-WT: Y10000 cells overexpressing Osh6p (~20 fold 
higher than vector control) from the pADNSOSH6; Vector- ∆vps4: Y15588 (∆vps4) cells carrying pADNS; 




























































   Since a strong interaction between the coiled coil domain of Osh7p (Osh7pCC) and 
Vps4p was detected (Wang PH et al., 2005), we wonder whether Osh7pCC could act as a 
dominant negative fragment in vivo. The vacuolar enzyme carboxypeptidase S (CPS) is 
synthesized as a membrane bound precursor (pro-CPS), and is ubiquitylated before sorted 
into the lumenal vesicles of MVBs. Once delivered to the vacuole lumen, pro-CPS is 
proteolytically clipped from its transmembrane domain, resulting in a soluble enzyme 
within vacuole lumen (Katzmann et al., 2001). In the ∆vps4 mutant strain, MVB is not 
formed and a GFP tagged version of CPS (GFP-CPS) was found on the limiting 
membrane of vacuole and an abnormal endosomal compartment (Babst et al., 2002b; 
Figure 3.45A). Overproduction of Osh7pCC, but not the full length Osh7p, caused a 
similar GFP-CPS distribution pattern as in ∆vps4 (Figure 3.45A). Since no 
carboxypeptidase Y sorting defect was observed even when all OSH genes are deleted, 
this MVB sorting defect possibly results from inhibition of normal Vps4p function as a 
result of the strong interaction between Osh7pCC and Vps4p. To further evaluate the 
MVB sorting defect in these strains, GFP-CPS was subjected to western blot analysis. As 
shown in Figure 3.45B, free GFP was detected in wild type cells and in cells 
overexpressing OSH7 or OSH7CC while a GFP product that is 4kDa larger was found in 
∆vps4 cells and interestingly, also in cells overexpressing OSH7CC. As reported 
previously, the larger GFP product corresponds to cleavage immediately beyond the 
transmembrane domain of CPS since a MVB sorting defect prevents the GFP tag from 
entering the vacuole (Reggiori and Pelham, 2001; Shiflett et al., 2004).   
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Figure 3.45 Overexpression of OSH7CC causes an MVB sorting defect (on the preceding page). Wild type 
cells (Y10000) expressing Osh7CC/Osh7p from the pESCOSH7CC/pESCOSH7 were grown in glucose 
medium to mid-log phase and transferred to galactose/raffinose medium for 4 hrs. A) GFP-CPS was 
visualized using a Leica fluorescence microscopy via a GFP filter. DIC: differential interference contrast. 
Scale bar: 5µm. B) Western blot analysis of total cell extracts from indicated strains with anti-GFP 
antiserum. Equivalent amounts of total protein were loaded in each lane. 
 
In a recent landmark paper, Im et al (2005) showed that Osh4p assumes a β-barrel 
structure with a hydrophilic exterior and a hydrophobic tunnel in the barrel centre. Sterols 
bind to Osh4p within the central tunnel of the β-barrel, with its 3-hydroxyl group buried 
at the bottom of the tunnel. It was proposed that Osh4p is a sterol transporter, which 
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2005). Our current study suggests that Osh6p/7p is also a sterol transporter, whose 
membrane dissociation is regulated by AAA ATpase-Vps4p. To determine whether sterol 
loading affects the interaction between Osh and AAA ATPases, bacterially expressed 
Osh7p and Osh7pCC were incubated with or without ergosterol prior to the pull-down 
assay. As shown in Figure 3.46, Osh7p pulled down little Vps4p after incubation with 
ergosterol, whereas the interaction between Osh7pCC and Vps4 was not affected by 
ergosterol. This result implies that: 1) like Osh4p, upon sterol loading Osh7p undergoes 
conformational changes, which prevents the coiled coil domain of Osh7p from interacting 
with Vps4p; 2) consistent with the report of Im et al (2005), the coiled coil of Osh7p does 
not mediate sterol binding; 3) once Osh7p unloads its cargo, Vps4p comes to help Osh7p 
dissociate from membranes.  
 
 




Figure 3.46 Ergosterol regulates the interaction between Osh7p and Vps4p in vitro. GST fusion proteins 
were purified from E. coli using GSH agarose beads. Fusion proteins containing full-length Osh7p or 
Osh7pCC were incubated in the presence or absence of 10µM ergosterol for 2 h at 30°C, and then mixed 
with yeast lysates prepared from Vps4p-GFP-expressing Y10000 cells. After stringency washes, bound 
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   In this part, we established a functional link between the two AAA ATPases and Osh 
proteins in regulating sterol metabolism. In the absence of VPS4, oleate incorporation 
into sterol esters was significantly slowed down; but total ergosterol level was 
unchanged. When Afg2p was inactivated, though ergosterol level was mildly elevated, 
oleate incorporation into both TAG and sterol esters decreased. In addition, free sterols 
accumulated in intracellular compartments in afg2-ts cells at non-permissive temperature, 
indicating a possible deficiency in sterol trafficking.  We also showed that overexpression 
of Osh6/7p suppressed the sterol esterification defect in ∆vps4, and overexpression of the 
coiled-coil domain of Osh7p resulted in a MVB sorting defect. Lastly, we demonstrated 
that the physical interaction between Osh7p and Vps4p was regulated by ergosterol, 
suggesting they function together to regulate sterol metabolism.  
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Part 6 Discussion  
 The oxysterol binding protein (OSBP) and its related proteins (ORP, for OSBP related 
protein) constitute a large conserved family of proteins in eukaryotes (Lehto and 
Olkkonen 2003; Olkkonen and Levine, 2004), which plays very important roles in sterol 
metabolism and vesicular transport; however, the exact function of the OSBP family is 
unknown. There are seven OSBP homologues (OSH) in the budding yeast, a simple but 
powerful experimental system, and recent studies have largely focused on the function of 
all seven OSH gene products (Beh et al., 2001; Beh and Rine, 2004).Those studies have 
provided invaluable insights into understanding the function of this family of proteins in 
yeast and offered useful guidance to future research. On the other hand, although the 
entire Osh protein family shares at least one essential function, each individual Osh 
protein may possess unique roles. One prominent example is OSH4/KES1, the deletion of 
which, but none of the other OSH genes, bypasses the essential requirement for Sec14p 
(Fang et al., 1996). Therefore, it is necessary to analyze individual OSH genes to gain 
deeper insights into the function of this protein family.  
 
6.1 Localization of Osh6p 
In this study, we first characterize the cellular location of Osh6p. This is necessary and 
important for our understanding of the molecular function of the OSHs because they 
share an essential overlapping function and each OSH may perform this function at 
different locations. Using both biochemical and fluorescence microscopic approaches, we 
determine that Osh6p is largely localized to cytosol with a small pool associated with 
endosomal membranes. First, Osh6p-GFP is distributed largely diffusely in the cytosol 
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and associated with punctuate / patch structures (Figure 3.4) that may represent early 
endosomes or ER membranes, and the ORD domain of Osh6p is colocalized with FM4-
64 positive compartments (Figure 3.23). Second, our subcellular fractionation 
experiments provide further evidence (Figure 3.5 and 3.6). However, our study can not 
rule out other possible membrane targeting of Osh6p. Indeed, a small portion co-
fractionates with the plasma membrane protein-Gas1p (Figure 3.6) though the plasma 
membrane localization of Osh6p-GFP is not observed by fluorescent microscopy. 
Moreover, the second peak of Osh6p distribution on the sucrose density gradient is rather 
broad by spanning fractions 5-8, which overlaps with other membrane marker such as the 
ER membrane protein Dpm1p. Our data suggest that Osh6p interacts with more than one 
membrane in order to perform its function. Consistent with this, OSBP and a number of 
its homologues have been shown to localize to multiple membranes (Olkkonen and 
Levine 2004). For example, Osh1p is localized to the Golgi apparatus, NV junction and 
ER (Loewen et al., 2003; Levine and Munro, 2001); ORP3, ORP6 and ORP7 have been 
found to associate with both the plasma membrane and ER membrane (Letho et al., 
2004).  
 
   How does Osh6p associate with membranes? Here we provide evidence that Osh6p is a 
peripheral membrane protein. First, the insoluble fraction of Osh6p is extractable by non-
ionic detergent at low temperature, and exhibits ‘buoyant’ property when subjected to 
sucrose density gradient centrifugation (Figure 3.8 and 3.9). This not only confirms that 
Osh6p is membrane-associated but also further suggests Osh6p is not in the lipid ‘raft’ 
domain, which is enriched in cholesterol and sphingolipids (Brown and Rose, 1992) and 
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resistant to extraction with non-ionic detergent at 4 °C (Edidin, 2003). Second, this 
insoluble fraction is readily solublized by high salt (1M NaCl) and alkaline (0.1M 
Na2CO3, pH11) (Figure 3.8), which are conditions to disassociate peripheral membrane 
proteins from membranes (John et al., 1999). Therefore, this peripheral association with 
membranes may be indirect, that is, through a protein or protein complex associated with 
the target membrane, because Osh6p is almost completely extractable with alkaline and 
urea (Figure 3.8), reagents known to perturb protein-protein interaction (Horazdovsky 
and Emr, 1993).  
 
   The ability of Osh6p and other OSBP homologues to interact with multiple membranes 
peripherally is of functional importance, because this property is commonly shared by 
most lipid transfer proteins (Ridgway et al., 1992; Aikawa et al., 1999). One good 
example is the truncated isoform of Goodpasture antigen-binding protein (GPBP)-
hCERT or GPBP∆26, which shares similar domain structures with Osh1p/Osh2p and 
mediates the non-vesicular transport of ceramide from the ER to Golgi complex in an 
ATP-dependent manner (Hanada et al., 2003; Loewen et al., 2003). More direct evidence 
comes from a study on oxysterol binding proteins, which showed that ORP4 interacts 
with vimentin and affects cholesterol transport (Wang et al., 2002). Ours and other 
studies imply that Osh6p and other OSBP homologues are possible candidates for lipid 
transport.    
 
6.2 Lipid ligands and functional domains of Osh6p  
The lipid binding properties have long been established for OSBP and its homologues. 
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OSBP binds oxysterols through its OSBP domain and phosphoinositides via its PH 
domain (Kandutsch and Shown 1981; Levine and Munro 1998). Here we show that 
Osh6p binds a group of phosphoinositides with the strongest binding to PtdIns (5) P, then 
PtdIns (4) P (Figure 3.21). However, the physiological level of PtdIns (4) P is much 
higher than that of PtdIns (5) P (Rameh et al., 1997), indicating that PtdIns (4) P may be 
the real ligand of Osh6p in physiological conditions. In addition, Osh6p binds 
phosphatidic acid (PA) with much lower affinity since this binding is only observed in 
the presence of a high concentration of lipid and protein (Figure 3.22).  
 
  What is the physiological relevance of lipid binding properties of Osh6p? One 
possibility is that Osh6p may target membranes by interacting with membrane 
phosphoinositides. In support of this, the PH domain-containing Osh1p has been shown 
to target the Golgi membrane through its PH domain and this targeting is dependent on 
PtdIns-4 kinase Pik1p and its product: PtdIns (4) P (Levine and Munro, 2002). Similarly, 
targeting of the short Osh-Kes1p to the Golgi complex requires binding to a 
phosphoinositide pool generated by Pik1p (Li et al., 2001). On the other hand, the 
binding to PA by Osh6p represents a novel and exciting finding given the fact that the 
bypass sec14 mutants require a basal PA level to exert their suppression effects (Xie et 
al., 1998; Sreenivas et al., 1998). Consistent with this, the three OSBP homologues: 
Kes1p, ORP1and ORP2 which are potentially involved in the Golgi secretory function 
are able to bind PA with varying affinity (Fang et al., 1996; Xu et al., 2001a; Li et al., 
2001). Combined with the fact that PA is important for the formation of membrane 
curvature (Schmidt et al., 1999); Osh6p may play a role in a vesicular transport pathway 
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by regulating the PA balance in membranes.  Exactly how phosphoinositides modulate 
Osh6p membrane association and how PA binding by Osh6p affects vesicular transport / 
lipid transport are subjects of future study.       
   Meanwhile, our study demonstrates that the lipid-Osh6p interaction is mediated by its 
conserved OSBP domain (ORD) and this domain is essential and sufficient for lipid 
binding, while the c-terminal coiled coil is dispensable (Figure 3.21 and 3.22). In 
addition, it seems that each domain targets Osh6p to distinct membranes /compartments 
(Figure 3.23). However, both domains are essential for the in vivo function of Osh6p in 
term of cell growth (Figure 3.20). The OSBP domain is believed to mediate protein-
ligand interaction (Letho and Olkkonen, 2002) and the putative coiled coil is supposed to 
bridge protein-protein interaction (Beh et al., 2001; Wang PH et al., 2005). Our study 
provides an important insight into understanding of the function of the conserved OSBP 
domain (ORD), and assigns the lipid binding function for ORD. It is plausible that 
different Osh may bind different lipids through their respective ORD, which may form a 
‘pocket’-like hydrophobic environment. Taken all together, our observations suggest that 
both the ligand binding and protein-protein interaction activity of Osh6p are 
indispensable for its in vivo function.      
    
6.3 Molecular function of Osh proteins 
6.3.1 Osh6p and sterol homeostasis  
In this study, we characterize OSH6 in greater details and depth and provide evidence 
suggesting an important role for Osh6p in maintaining sterol homeostasis. First, 
consistent with previous reports, deletion of OSH6 elevates ergosterol levels by ~ 80% 
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(Figure 3.11). Second, sterol biosynthesis is slightly accelerated in the absence of OSH6 
(Figure 3.14); however, sterol esterification is mildly reduced (Figure 3.13). Third, 
overexpression of Osh6p results in a significant decrease of total ergosterol (Figure 3.11), 
a mild reduction of sterol esterification (Figure 3.13) and lipid droplets, and nystatin-
resistance (Figure 3.12),implying a reduction of ergosterol levels in the plasma 
membrane. Our results imply that a minor increase in the rate of sterol biosynthesis in 
∆osh6 cells may lead to an elevated cellular ergosterol by 80% over time.  
 
   Excess intracellular sterols are normally converted to sterol esters, a process that is 
catalyzed by Are1p and Are2p in yeast (Yang et al., 1996). Sterol esters are deposited 
into the cytoplasm together with TAG (triacylglycerol) to form lipid droplets. Sterol 
esterification is primarily regulated by the availability of sterol substrates (Cheng et al., 
1995). In this study, excess ergosterol in ∆osh6 does not appear to result in enhanced 
sterol esterification (Figure 3.13) or increased lipid droplets as assessed by Nile Red 
staining (Figure 3.15A). It is therefore possible that free sterols are accumulated in 
intracellular compartments in ∆osh6 cells other than the plasma membrane, due to defects 
in lipid trafficking. Indeed, deletion of OSH6 alters free sterol distribution (Figure 3.16A) 
and elevates free sterol levels (unpublished results from our lab). In support of this, it was 
recently reported that free sterols accumulated in internal membranes in OSH null 
mutants (with seven OSHs deleted) (Beh and Rine, 2004). In addition, though some OSH 
mutants including osh2, osh4, osh6 have increased total ergosterol levels, they exhibit no 
nystatin sensitivity but even resistance (Bet et al., 2001), indicating a possible disruption 
of sterol transport and accumulation of free sterols in membranes other than the plasma 
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membrane. In this regard, Osh6p and other Osh could perform a similar cellular activity 
as Arv1p (ARE required for viability)-a protein required for viability in the absence of 
ARE genes. In arv1 mutants, both free sterols and sterol esters increase by 50-75%, and 
free sterols accumulate in the ER and vacuole; but plasma membrane sterol levels reduce. 
It is thus proposed that Arv1p is required for sterol transport to the plasma membrane 
(Tinkelenberg et al., 2000). However, Osh6p may facilitate sterol transport from the 
plasma membrane to the ER for esterification as ∆osh6 shows:  higher sterol levels, no 
sensitivity to nystatin, and a lower rate of sterol esterification and accumulation of free 
sterols in intracellular compartments.  
 
   Collectively, our results and recent results from other labs suggest that Osh6p may 
control subcellular sterol transport in such a way that it facilitates sterol movement to the 
ER. In its absence, less ergosterol reaches the ER, causing activation of HMG CoA 
reductase and inhibition of sterol esterification. Upon overexpression of OSH6, the ER 
pool of free sterols may increase slightly, which causes subtle inhibition of sterol 
biosynthesis (not enough decrease in sterol biosynthesis to be detected by my method 
here). Ultimately, this minor decrease in sterol biosynthesis will lead to a 50% reduction 
in total cellular ergosterol, nystatin resistance and a decrease in the rate of sterol 
esterification. Lastly, our results do not rule out other possible functions for Osh6p. For 
instance, it is possible that OSBP and its homologues (in this case Osh6p) regulate 
transcription factors which in turn regulate transcription of genes required for sterol 
metabolism. It was recently shown that overexpression of ORP1L enhanced the LXRα 
(liver X receptor α)-mediated transactivation of a reporter gene (Johansson et al., 2004). 
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6.3.2 Osh6p and membrane trafficking 
Although deletion of all OSH genes impairs endocytosis and vacuole morphology (Beh 
and Rine, 2004), our results presented here suggest that Osh6p is not essential for 
endocytic trafficking and protein transport to the vacuole. Neither FM4-64, LY uptake 
and transport from the plasma membrane (Figure 3.17 and 3.18) nor CPY transport from 
the ER (Figure 3.19) to the vacuole is affected in the absence of Osh6p or in the presence 
of high levels of Osh6p. The discrepancy may be due to the fact that a more drastic 
disruption of sterol homeostasis is incurred upon loss of all Osh function. For instance, 
total cellular ergosterol is increased by 3.5 fold in osh null mutant cells compared with an 
80% increase in ∆osh6 cells. Indeed, sterols that are mainly found in the plasma 
membrane (Heiniger et al., 1976) are required for endocytosis in yeast (Munn et al., 
1999) and cellular levels of cholesterol affect the movement of proteins through 
endosomal compartments (Mayor et al., 1998; Grimmer et al., 2000). Nonetheless, my 
results do suggest that the primary function of Osh6p is likely to be in lipid metabolism, 
instead of vesicular transport.  
 
6.3.3 Osh1p and sterol homeostasis 
At last, the role of Osh1p in sterol metabolism is also examined. Deletion of OSH1 leads 
to a significant decrease of oleate incorporation into sterol esters (Figure 3.39). Osh1p 
shows multiple membrane targeting including the Golgi complex, nuclear-vacuole 
junction (Levine and Munro, 2001; Kvam and Goldfarb, 2004), and ER (Loewen et al., 
2003); and is proposed to play a role in a lipid transport pathway at membrane contact 
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sites (Olkkonen and Levine, 2004). Recently, Osh1p was shown to interact with the 
nucleus vacuole (NV) junction resident integral membrane protein Nvj1p directly (Kvam 
and Goldfarb, 2004), and expression of NVJ1 increases and NV junctions expand during 
nutrient limitation (Gasch et al., 2000; Roberts et al., 2003). Interestingly the Osh1p pool 
targeting to NV junctions is directly proportional to cellular levels of Nvj1p (Kvam and 
Goldfarb 2004). It should be highlighted that during nutrient limitation such as glucose 
starvation, sterol esterification is significantly accelerated (my unpublished observations), 
and the sterol substrate mainly comes from the plasma membrane (Lange et al., 1993). 
Although the molecular mechanism underlying sterol transport from the plasma 
membrane to ER is not clear,   at least one pathway transits through late endosomes / 
vacuoles (Skiba et al., 1996; Zha et al., 1998). Therefore it is plausible that Osh1p may 
facilitate sterol transport from the vacuole to the sites of ACAT in the ER for 
esterification passing through the nuclear-vacuole junction. In the absence of Osh1p, 
sterol transport is delayed, which causes a decrease in the rate of sterol esterification.  
 
6.4 Osh proteins, AAA ATPases and lipid transport 
 Lipids are essential components of all cell membranes, but each subcellular organelle has 
a unique lipid profile. In order to maintain a non-homogenous distribution of lipids in 
different membranes, cells must selectively transport certain lipids in a desired direction. 
The molecular mechanisms for subcellular lipid transport are poorly understood, 
however, recent studies point to at least two possible mechanisms: vesicular and non-
vesicular lipid transport (Funanto and Riezman, 2001; Hanada et al., 2003). Vesicular 
lipid transport occurs through budding of vesicles from donor membranes and fusion with 
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acceptor membranes. Non-vesicular lipid transport is less defined, but is likely to take 
place in membrane contact sites (MCS) with the aid of a wide range of lipid transfer 
proteins (Levine, 2004). To meet the criteria as cytosolic lipid carriers between 
membranes, the lipid transfer proteins should ideally be able to interact with different 
membranes, be able to bind and extract lipids and lastly, be able to associate with and 
dissociate from membranes in a regulated manner for efficient lipid transport.  A large 
family of proteins in eukaryotic cells, the oxysterol binding protein and certain ORPs 
possess a well conserved lipid binding motif (ORD) and can target multiple membranes; 
therefore, they have been proposed to mediate non-vesicular lipid transport (Olkkonen 
and Levine, 2004; Levine, 2004). Our results here support such a hypothesis by providing 
a mechanism whereby the membrane association of putative lipid transfer proteins, such 
as ORPs, is regulated by a subset of AAA proteins. 
 
6.4.1 AAA ATPases and lipid metabolism 
 AAA proteins have been implicated in functions as diverse as peroxisome biogenesis 
(Pex1p and Pex6p), vesicle transport (Sec18p/NSF), cell division (Cdc48p/p97), and 
endosomal function (Vps4p/SKD1) (Lupas and Martin, 2002). They may also play a role 
in lipid trafficking: it was recently shown that overexpression of an ATPase defective 
VPS4/SKD1 caused a delay in cholesterol transport out of endosomes (Bishop and 
Woodman, 2000). We also demonstrate here that vps4 and afg2 mutants exhibit specific 
defects in sterol metabolism. In the absence of VPS4, oleate incorporation into sterol 
esters is significantly slowed down; but total ergosterol levels are maintained normally 
(Figure 3.40 and 3.42). Our results on Vps4p represent a novel finding since yeast Vps4p 
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has been mainly implicated in the endocytic trafficking from the cell membrane (Zahn et 
al., 2001) to and biosynthetic transport from the Golgi or late endosomes to the vacuole 
(Babst et al., 1997). Although the mammalian homologue of Vps4p indeed plays a role in 
transport of LDL-cholesterol through the endocytic pathway (Bishop and Woodman, 
2000); Vps4p has not been shown to regulate ergosterol transport in this pathway in yeast 
since yeast lacks the LDL receptor-mediated cholesterol uptake machinery. However, our 
data (Figure 3.42) suggest that Vps4p is important for sterol etherification and further 
suggest that this sterol esterification defect is unlikely caused by a decrease of ACAT 
activity as we observed no obvious reduction of lipid droplets and sterol esters in vps4 
mutant (unpublished observations from our lab), or due to disruption of 3H-oleic acid 
uptake and transport to the ER as TAG biosynthesis that takes place in the ER (Zhang et 
al., 2003) is normal. Rather, Vps4p could regulate sterol transport from the plasma 
membrane to the ER through an unknown pathway. 
     
   Similar to vps4 mutant, inactivation of Afg2p causes severe defects in sterol 
metabolism.  When Afg2p is inactivated, though ergosterol levels are only mildly 
elevated (Figure 3.40), oleate incorporation into both TAG and sterol esters is severely 
decreased (Figure 3.43). In addition, free sterols accumulate in intracellular 
compartments in afg2-ts cells at non-permissive temperature (Figure 3.41), indicating a 
possible deficiency in sterol trafficking. Both vps4 and afg2 mutants share a common 
defect in sterol esterification. However, it should be noted that in afg2 mutant TAG 
biosynthesis is also affected. This raises that possibility that 3H-oleic acid uptake and 
transport may be affected. Free fatty acids are hydrophobic and are able to rapidly diffuse 
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through the membrane lipid bilayer within seconds especially when present in high 
concentrations (Kamp and Hamilton, 1992). Protein-mediated transport also plays a role 
at very low substrate concentrations (Phol et al., 2004). The initial concentration of 3H-
oleic acid employed in this study is 50nM, at which protein-mediated transport could play 
a part in taking up fatty acids. However, take into account the cold fatty acids in the rich 
medium (YPD) used in our experiments, protein-mediated transport of fatty acid may be 
ignored.  In addition, though AFG2 is essential for cell viability, afg2-ts cells show 
normal morphology even shifted to 37°C for one hour. Therefore, as confirmed by our 
filipin staining experiment, impairment of sterol transport to the ER seems more likely to 
be attributable to defect in sterol esterification. Nonetheless, our results suggest that 
Afg2p is involved in both TAG and sterol metabolism through an unknown mechanism.    
 
   Taken together, our data suggest that both Vps4p and Afg2p are potentially involved in 
sterol metabolism, most probably in the aspect of sterol trafficking. However, a clear 
bridge linking AAA proteins and lipid transport does not exist. Next, we provide 
evidence suggesting that AAA proteins may regulate lipid transport by controlling 
membrane association/dissociation of soluble lipid carriers. We show that members of the 
Osh protein families interact with AAA proteins and that they become trapped on 
membranes when AAA proteins’ function is compromised.  
 
6.4.2 Regulation of Osh6p membrane association by Vps4p   
First, Osh6p interacts with Vps4p (Figure 3.25 and 3.26), an AAA ATPase that plays a 
vital role in the multi-vesicular body (MVB) sorting pathway by catalyzing the 
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dissociation and disassembly of all three ESCRT (Endosomal Sorting Complex Required 
for Transport) complexes from endosomal membranes (Katzmann et al., 2002). We show 
that Osh6p interacts with Vps4p by the yeast two-hybrid assay and by GST pull-down 
(Figure 3.25 and 3.26). Deletion of VPS4 results in a significant redistribution of Osh6p 
from cytosol to the membrane fraction (Figure 3.27 and 3.28), a phenotype shared by 
components of the ESCRT complexes. We further demonstrate that the accumulation of 
Osh6p in membrane fraction is a specific and direct consequence of loss of Vps4p 
ATPase activity (Figure 3.29). Like class E proteins that are localized mainly to the 
cytosol and are transiently recruited to the endosomal compartments in order to execute 
the sorting of endosomal cargo and the formation of MVBs and whose dissociation 
requires Vps4p; our results also suggest that Osh6p transiently associates with cellular 
membranes and that its dissociation requires the ATPase activity of Vps4p. However, our 
results suggest that Osh6p is not one of the unidentified components of ESCRT 
complexes. Osh6p from vps4∆ cell extracts is soluble with non-ionic detergent (Figure 
3.30); however, the stable ESCRT complexes formed in the absence of Vps4p have high 
molecular weight and are not readily solublized by detergents. Consistent with this, 
deletion of OSH6 has no significant effect on ubiquitin-dependent MVB sorting, which 
requires the function of the three ESCRT complexes (Babst et al., 1998; 2002a; 2002b; 
Katzmann et al., 2001; 2002). Further evidence comes from the examination of Osh6p 
localization in some of ESCRT mutants. Malfunction of ESCRT complexes and VPS27 
has no influence on Osh6p localization (Figure 3.29), which implies that Osh6p is 
unlikely a candidate in MVB sorting.  Rather, our data suggest a new role for Vps4p in 
regulating lipid trafficking through Osh proteins. Like the deficiency associated with 
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Niemann-Pick type C (NPC) mutants (Liscum and Klansek, 1998), mutation of human 
VPS4 causes accumulation of low-density lipoprotein (LDL)-derived cholesterol in 
endosomes (Bishop and Woodman, 2000). Similarly, deletion of either VPS4 or OSH6 in 
yeast causes a decrease of the rate of oleate incorporation into sterol esters, implying a 
delay of sterol transport to the ER. Moreover, it should be highlighted that Vps4p not 
only regulates ubiquitin-dependent MVB sorting, it also regulates the sorting of non-
ubiquitylated proteins, such as Sna3p (Reggiori and Pelham, 2001; Yeo et al., 2003), and 
possibly other cellular processes. It should be also mentioned here that Vps4p binds to 
ESCRT-III via coiled-coil interaction with the Vps2/Vps24 subcomplex and that this 
interaction is necessary for the Vps4p-dependent dissociation of ESCRT-III; therefore it 
is interesting to investigate whether there is such an ‘anchor’ for Vps4p to regulate the 
dissociation of Osh6p from membranes.  Another major task at hand is to identify a 
cellular function that is specifically regulated by Osh6p and Vps4p.   
 
6.4.3 Regulation of Osh1p membrane association by Afg2p 
Second, as an extension of my studies on Osh6p, we show that Osh1p functionally 
interacts with Afg2p, an essential AAA protein that shares the highest homology to 
Cdc48p (Patel and Latterich, 1998). A large scale characterization of multi-protein 
complexes in yeast has previously identified Afg2p and Osh1p in the same protein 
complex (Gavin et al., 2002). Here, we prove that the AAA domain-containing fragment 
(amino residue 501-700) of Afg2p interacts with the OSBP domain-containing fragment 
of Osh1p (amino residue 726-1000) (Figure 3.31 and 3.32). When Afg2p is inactivated, a 
significant pool of Osh1p is associated with ER membrane stably, thus suggesting that 
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Afg2p is required for the dissociation of Osh1p from ER membrane. It should also be 
noted that when Afg2p function is compromised, the insoluble fraction (P13) of Osh1p is 
only partially solublized by non-ionic detergent at low temperature (Figure 3.35) though 
it is membrane-associated (Figure 3.36). One possibility is that this insoluble membrane 
pool of Osh1p is associated with sterol-enriched membrane ‘raft’, where Osh1p plays a 
role in sterol transport. Indeed, lipid rafts have been proposed to play an important role in 
cholesterol transport (Simons and Ikonen, 1997; Ikonen, 2001; Fielding and Fielding, 
2001). Alternatively, this pool of Osh1p may be attached to ER membrane through a 
large protein complex, which is sedimentable by ultracentrifugation. I t has been shown 
that Osh1p, Osh2p and Scs2p are in the same protein complex with six other proteins but 
without Afg2p (Gavin et al., 2002). However, if the interaction of Afg2p with other 
proteins is rather weak and transient, it is not surprising that Afg2p is not always readily 
purified with protein complexes during a large-scale purification study. Indeed, strong 
interaction is only observed between short fragments of Osh1p and Afg2p, not full-length 
proteins (Figure 3.31 and 3.32).   
 
Interestingly, Afg2p seems to regulate Osh1p association with the ER membrane as 
Vps4p regulates Osh6p membrane association. Inactivation of Afg2p results in a pool of 
Osh1p to translocate from the cytosol to ER membrane (Figure 3.33 and 3.34). This 
indicates that it may be a common mechanism for AAA protein to regulate membrane 
association of Osh proteins.  Although AFG2 is an essential gene, its molecular function 
is largely unclear. It is suggested that Afg2p is involved in quality control of mRNA 
(Jungwirth et al., 2001); however our data suggest that Afg2p also play an important part 
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in sterol metabolism by regulating the membrane association of Osh1p and possibly other 
proteins. Linking the fact that the rate of sterol ester biosynthesis is decreased in both 
osh1 and afg2 mutants, it is possible that Osh1p and Afg2p work together to control 
sterol trafficking in a sterol transport pathway.  
 
Most interestingly, Osh1p is redistributed from the cytosol to the ER membrane 
(Figure 3.33 and 3.34) upon inactivation of Afg2p and this membrane association is 
Scs2p-dependent (Figure 3.37), which suggests that Afg2p regulates the interaction 
between Scs2p and Osh1p. Scs2p is a yeast homologue of synaptobrevin-associated 
protein, deletion of which results in inositol auxotrophy at temperatures above 34 °C 
(Kagiwada et al., 1998). It would be interesting to determine whether Afg2p also 
regulates the interaction between Scs2p and other proteins containing the FFAT motif. To 
extend our results one step further, it is conceivable that AAA proteins such as Afg2p 
could also regulate the membrane association of other lipid carriers, especially that of 
CERT, since this protein also possesses an FFAT motif and could potentially interact 
with mammalian VAP-A. One of the outstanding issues in CERT-mediated ceramide 
transport is the requirement for ATP, which might be needed to produce 
phosphatidylinositol-4-phosphate or required for phosphorylation as proposed by Hanada 
et al (2003) and Munro (2003).  Our data, however, suggest that ATP might be required 
for AAA proteins to regulate the recycling of CERT.  
 
6.4.4 Functional interaction between Vps4p and Osh6/7p  
 156
In this study, we not only show that Vps4p regulates the membrane association of 
Osh6p/7p but also provide solid evidence to prove that Osh6/7p functionally interacts 
with Vps4p. Deletion of VPS4 causes a decrease in sterol esterification, while this defect 
can be significantly suppressed by overexpression of Osh6/7p (Figure 3.44). In addition, 
overexpression of the protein-protein interaction motif –the coiled-coil of Osh7p results 
in a MVB sorting defect (Figure 3.45). As we know that deletion of all OSHs shows no 
defect in MVB pathway (Beh and Rine, 2004), this MVB sorting defect is rather due to 
the strong interaction between Osh7pCC and Vps4p. Overexpression of Osh7pCC may 
sequester Vps4p thus result in a vps4-like phenotype.  Another line of evidence to prove 
the functional interaction between Osh7 and Vps4p is that their physical interaction is 
regulated by ergosterol (Figure 3.46). In a recent landmark paper, Im et al (2005) showed 
that Osh4p assumes a β-barrel structure with a hydrophilic exterior and a hydrophobic 
tunnel in the barrel centre. Sterols bind to Osh4p within the central tunnel of the β-barrel, 
with its 3-hydroxyl group buried at the bottom of the tunnel. It was proposed that Osh4p 
is a sterol transporter, which undergoes quick conformational change upon sterol loading 
and unloading (Im et al., 2005). Similarly, Osh6/7p might also be a sterol transporter that 
shuttles between membranes. Upon sterol loading Osh6/7p undergoes conformational 
changes, which prevents Osh6/7p from interacting with Vps4p; however, once sterol 
molecule is unloaded, Osh6/7p dissociates from membranes for next round of trip with 
the aid of Vps4p by consuming energy.   
 
6.5 A proposed working model for concerted action of Osh and AAA 
proteins in regulating lipid transport   
 157
Based on our results and previous studies, we could propose a model for the concerted 
action of Osh and AAA proteins in lipid trafficking (Figure 3.47): the cytosolic Osh 
proteins target the lipid donor membranes possibly by interacting with phosphoinositides 
and pick up lipid cargoes. After delivering cargoes to their destination membrane such as 
the ER or other membranes by interaction with their receptors (Scs2p for Osh1p) on the 
surface of membranes, Osh proteins dissociate from membranes for next round of trip 
with the aid of AAA ATPases by consuming energy.  This kind of transport would 
happen quickly and efficiently most probably at membrane contact sites.  
 
Recent work from various laboratories does point to a putative function of OSBP and 
ORPs in non-vesicular lipid transport between membranes (Wang PY et al., 2005; Im et 
al., 2005). Experimental evidence to date also suggests that ORPs are recruited to specific 
subcellular compartments to adjust local lipid composition, possibly by concentrating 
certain lipid species, and thereby to control membrane dynamics (Olkkonen and Levine, 
2004). Regardless of the exact function of OSBP and ORPs, our results offer exciting 
new avenues for future research. For instance, is there an AAA protein which interacts 
with Osh4p/Osh5p and regulate their membrane association? If so, how would it affect 
the SEC14 pathway? What about AAA proteins and mammalian OSBP and ORPs? Do 
AAA proteins play any role in the regulation of CERT, whose function requires ATP? 
Studies along these lines may not only provide mechanistic insights into the function of 
OSBP and ORPs, but may also further our understanding on the mechanism(s) of cellular 
lipid transport.  
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